View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Oct. 31, 2019	Nov. 29, 2019
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2019
Document Transition Report	false
Entity File Number	001-38933
Entity Registrant Name	CROWDSTRIKE HOLDINGS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-3788918
Entity Address, Address Line One	150 Mathilda Place
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Sunnyvale
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94086
Title of 12(b) Security	Class A common stock, par value $0.0005 per share
Trading Symbol	CRWD
Security Exchange Name	NASDAQ
City Area Code	888
Local Phone Number	512-8906
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001535527
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A common stock
Entity Common Stock, Shares Outstanding		40,871,355
Class B common stock
Entity Common Stock, Shares Outstanding		164,673,516

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Current assets:
Cash and cash equivalents	$ 743,605	$ 88,408
Marketable securities	90,083	103,247
Accounts receivable, net of allowance for doubtful accounts of $1.4 million and $1.0 million as of October 31, 2019 and January 31, 2019, respectively	145,694	92,476
Deferred contract acquisition costs, current	35,924	28,847
Prepaid expenses and other current assets	37,914	18,410
Total current assets	1,053,220	331,388
Property and equipment, net	129,504	73,735
Deferred contract acquisition costs, noncurrent	58,260	9,918
Goodwill	7,794	7,947
Intangible assets, net	637	1,048
Other assets	6,639	9,183
Total assets	1,256,054	433,219
Current liabilities:
Accounts payable	5,244	6,855
Accrued expenses	29,460	32,541
Accrued payroll and benefits	36,905	19,284
Deferred revenue	335,801	218,700
Other current liabilities	8,194	4,040
Total current liabilities	415,604	281,420
Deferred revenue, noncurrent	111,838	71,367
Other liabilities, noncurrent	11,570	10,313
Total liabilities	539,012	363,100
Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock, $0.0005 par value; no shares and 137,419 shares authorized as of October 31, 2019 and January 31, 2019, respectively; no shares and 131,268 shares issued and outstanding as of October 31, 2019 and January 31, 2019, respectively; liquidation preference $0 and $545,000 as of October 31, 2019 and January 31, 2019, respectively		557,912
Stockholders’ Equity (Deficit)
Preferred stock, $0.0005 par value; 100,000 shares and no shares authorized as of October 31, 2019 and January 31, 2019, respectively; no shares issued and outstanding as of October 31, 2019 and January 31, 2019, respectively	0	0
Common stock, value		24
Additional paid-in capital	1,326,116	31,211
Accumulated deficit	(609,079)	(519,126)
Accumulated other comprehensive income (loss)	(98)	98
Total stockholders’ equity (deficit)	717,042	(487,793)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	1,256,054	$ 433,219
Class A and Class B common stock
Stockholders’ Equity (Deficit)
Common stock, value	$ 103

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Oct. 31, 2019	Jan. 31, 2019
Accounts receivable, allowance for doubtful accounts	$ 1,400,000	$ 1,000,000.0
Redeemable preferred stock, par value (in dollars per share)	$ 0.0005	$ 0.0005
Redeemable preferred stock, shares authorized (in shares)	0	137,419,000
Redeemable preferred stock, shares issued (in shares)	0	131,268,000
Redeemable preferred stock, shares outstanding (in shares)	0	131,268,000
Redeemable preferred stock, liquidation preference	$ 0	$ 545,000,000
Preferred stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Preferred stock, shares authorized (in shares)	100,000,000	0
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	0	220,000,000
Common stock, shares issued (in shares)	0	47,421,000
Common stock, shares outstanding (in shares)	0	47,421,000
Class A common stock
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	2,000,000,000	0
Common stock, shares issued (in shares)	20,761,000	0
Common stock, shares outstanding (in shares)	20,761,000	0
Class B common stock
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	300,000,000	0
Common stock, shares issued (in shares)	184,718,000	0
Common stock, shares outstanding (in shares)	184,718,000	0

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Revenue
Total revenue	$ 125,119	$ 66,379	$ 329,304	$ 169,369
Cost of revenue
Total cost of revenue	37,355	22,274	98,211	60,243
Gross profit	87,764	44,105	231,093	109,126
Operating expenses
Sales and marketing	68,675	46,614	190,792	123,344
Research and development	35,992	25,968	91,497	62,546
General and administrative	21,615	13,614	63,737	28,868
Total operating expenses	126,282	86,196	346,026	214,758
Loss from operations	(38,518)	(42,091)	(114,933)	(105,632)
Interest expense	(132)	0	(297)	(428)
Other income (expense), net	3,579	303	3,523	(1,739)
Loss before provision for income taxes	(35,071)	(41,788)	(111,707)	(107,799)
Provision for income taxes	(434)	(535)	(1,664)	(1,018)
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	204,096,000	45,287,000	128,009,000	44,344,000
Subscription
Revenue
Total revenue	$ 114,221	$ 57,651	$ 297,787	$ 146,570
Cost of revenue
Total cost of revenue	29,221	17,302	77,858	47,077
Professional services
Revenue
Total revenue	10,898	8,728	31,517	22,799
Cost of revenue
Total cost of revenue	$ 8,134	$ 4,972	$ 20,353	$ 13,166

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Statement of Comprehensive Income [Abstract]
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Other comprehensive loss:
Foreign currency translation adjustments	410	(415)	(213)	(1,105)
Unrealized gain (loss) on available-for-sale securities, net of tax	22	(11)	17	(13)
Other comprehensive income (loss)	432	(426)	(196)	(1,118)
Total comprehensive loss	$ (35,073)	$ (42,749)	$ (113,567)	$ (109,935)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Redeemable Convertible Preferred Stock
Beginning Balance at Jan. 31, 2018						$ 351,016
Beginning Balance (in shares) at Jan. 31, 2018						118,693,000
Redeemable Convertible Preferred Stock
Issuance of Series E redeemable convertible preferred stock, net of issuance costs						$ 206,896
Issuance of Series E redeemable convertible preferred stock, net of issuance costs (Shares)						12,575,000
Ending Balance at Oct. 31, 2018						$ 557,912
Ending Balance (in shares) at Oct. 31, 2018						131,268,000
Beginning Balance at Jan. 31, 2018	$ (369,474)	$ 22	$ 8,482	$ (378,948)	$ 970
Beginning Balance (in shares) at Jan. 31, 2018		44,231,000
Stockholders' Deficit
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs ( in shares)		106,000
Issuance of common stock upon exercise of options	2,792	$ 1	2,791
Issuance of common stock upon exercise of options (in shares)		2,418,000
Issuance of common stock related to early exercise options (in shares)		38,000
Vesting of early exercised options	191		191
Stock-based compensation expense	17,403		17,403
Net loss	(108,817)			(108,817)
Other comprehensive income	(1,118)				(1,118)
Issuance of restricted stock awards (in shares)		36,000
Repurchase of stock options	(2,330)		(2,330)
Ending Balance at Oct. 31, 2018	(461,353)	$ 23	26,638	(487,866)	(148)
Ending Balance (in shares) at Oct. 31, 2018		46,829,000
Beginning Balance at Jul. 31, 2018						$ 550,912
Beginning Balance (in shares) at Jul. 31, 2018						130,843,000
Redeemable Convertible Preferred Stock
Issuance of Series E redeemable convertible preferred stock, net of issuance costs						$ 7,000
Issuance of Series E redeemable convertible preferred stock, net of issuance costs (Shares)						425,000
Ending Balance at Oct. 31, 2018						$ 557,912
Ending Balance (in shares) at Oct. 31, 2018						131,268,000
Beginning Balance at Jul. 31, 2018	(433,429)	$ 22	11,814	(445,543)	278
Beginning Balance (in shares) at Jul. 31, 2018		45,609,000
Stockholders' Deficit
Issuance of common stock upon exercise of options	1,278	$ 1	1,277
Issuance of common stock upon exercise of options (in shares)		1,220,000
Vesting of early exercised options	87		87
Stock-based compensation expense	13,460		13,460
Net loss	(42,323)			(42,323)
Other comprehensive income	(426)				(426)
Ending Balance at Oct. 31, 2018	(461,353)	$ 23	26,638	(487,866)	(148)
Ending Balance (in shares) at Oct. 31, 2018		46,829,000
Stockholders' Deficit
Cumulative effect of accounting change			101	(101)
Beginning Balance at Jan. 31, 2019	$ 557,912					$ 557,912
Beginning Balance (in shares) at Jan. 31, 2019	131,268,000					131,268,000
Ending Balance at Oct. 31, 2019						$ 0
Ending Balance (in shares) at Oct. 31, 2019	0					0
Beginning Balance at Jan. 31, 2019	$ (487,793)	$ 24	31,211	(519,126)	98
Beginning Balance (in shares) at Jan. 31, 2019		47,421,000
Stockholders' Deficit
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs	659,218	$ 11	659,207
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs ( in shares)		20,700,000
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	557,912	$ 66	557,846			$ (557,912)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		131,268,000				(131,268,000)
Reclassification of redeemable convertible preferred stock warrant liability to additional paid-in capital upon initial public offering	10,559		10,559
Net exercise of common stock warrants ( in shares)		322,000
Issuance of common stock upon exercise of options	9,391	$ 2	9,389
Issuance of common stock upon exercise of options (in shares)		4,731,000
Issuance of common stock related to early exercise options (in shares)		1,037,000
Vesting of early exercised options	1,816		1,816
Stock-based compensation expense	55,577		55,577
Capitalized stock-based compensation	511		511
Net loss	(113,371)			(113,371)
Other comprehensive income	(196)				(196)
Ending Balance at Oct. 31, 2019	$ 717,042	$ 103	1,326,116	(609,079)	(98)
Ending Balance (in shares) at Oct. 31, 2019		205,479,000
Beginning Balance at Jul. 31, 2019						$ 0
Beginning Balance (in shares) at Jul. 31, 2019						0
Ending Balance at Oct. 31, 2019						$ 0
Ending Balance (in shares) at Oct. 31, 2019	0					0
Beginning Balance at Jul. 31, 2019	$ 728,097	$ 103	1,302,098	(573,574)	(530)
Beginning Balance (in shares) at Jul. 31, 2019		205,193,000
Stockholders' Deficit
Issuance of common stock upon exercise of options	824		824
Issuance of common stock upon exercise of options (in shares)		286,000
Vesting of early exercised options	962		962
Stock-based compensation expense	21,966		21,966
Capitalized stock-based compensation	266		266
Net loss	(35,505)			(35,505)
Other comprehensive income	432				432
Ending Balance at Oct. 31, 2019	717,042	$ 103	$ 1,326,116	(609,079)	$ (98)
Ending Balance (in shares) at Oct. 31, 2019		205,479,000
Stockholders' Deficit
Cumulative effect of accounting change	$ 23,418			$ 23,418

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2018	Oct. 31, 2018
Statement of Stockholders' Equity [Abstract]
Payments of deferred offering costs	$ 104	$ 104

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Operating activities
Net loss	$ (113,371)	$ (108,817)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,023	10,199
Loss on disposal of fixed assets	0	223
Amortization of intangible assets	385	435
Amortization of deferred contract acquisition costs	24,125	19,312
Change in fair value of redeemable convertible preferred stock warrant liability	6,022	2,935
Allowance for doubtful accounts	413	485
Stock-based compensation expense	55,577	17,403
Accretion of marketable securities purchased at a discount	(1,313)	(625)
Non-cash interest expense	293	187
Changes in operating assets and liabilities
Accounts receivable	(53,631)	(17,936)
Deferred contract acquisition costs	(55,238)	(27,531)
Prepaid expenses and other assets	(19,883)	(2,307)
Accounts payable	(3,773)	(6,280)
Accrued expenses and other current liabilities	3,405	(2,331)
Accrued payroll and benefits	17,621	3,498
Deferred revenue	157,239	72,219
Other liabilities, noncurrent	(58)	155
Net cash provided by (used in) operating activities	33,836	(38,776)
Investing activities
Purchases of property and equipment	(66,848)	(21,664)
Capitalized internal-use software	(5,208)	(5,042)
Purchases of marketable securities	(187,697)	(135,253)
Proceeds from sales of marketable securities	4,473	0
Maturities of marketable securities	197,764	30,600
Net cash used in investing activities	(57,516)	(131,359)
Financing activities
Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts	665,092	0
Proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs	0	206,896
Repayment of loan payable	0	(6,158)
Proceeds from revolving line of credit	0	10,000
Repayment of revolving line of credit	0	(20,000)
Repayment of notes receivable from related parties	0	198
Payments of contingent consideration	0	(184)
Payments of indemnity holdback	0	(500)
Repurchase of stock options	0	(2,330)
Payments of deferred offering costs	(5,872)	0
Proceeds from issuance of common stock upon exercise of stock options	9,350	2,792
Proceeds from the issuance of common stock upon exercise of early exercisable stock options	10,264	0
Net cash provided by financing activities	678,834	190,714
Effect of foreign exchange rates on cash and cash equivalents	43	(296)
Net increase in cash and cash equivalents	655,197	20,283
Cash and cash equivalents, beginning of period	88,408	63,179
Cash and cash equivalents, end of period	743,605	83,462
Supplemental disclosure of cash flow information:
Interest paid	3	449
Income taxes paid	1,054	576
Supplemental disclosure of non-cash investing and financing activities:
Indemnity holdback consideration associated with business combinations	0	1,299
Contingent consideration associated with business combinations	0	420
Conversion of redeemable convertible preferred stock to common stock	557,912	0
Conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital	10,559	0
Net (decrease) increase in deferred offering costs, accrued but not paid	(2,858)	552
Net (decrease) increase in property and equipment included in accounts payable and accrued expenses	$ (715)	$ 625

Description of Business and Basis of Presentation	9 Months Ended
Description of Business and Basis of Presentation	Oct. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	1. Description of Business and Basis of Presentation CrowdStrike Holdings, Inc. (the “Company”) was formed on November 7, 2011. The Company provides a leading cloud-delivered solution for next-generation endpoint protection that offers 10 cloud modules on its Falcon platform via a SaaS subscription-based model that spans multiple large security markets, including endpoint security, security and IT operations (including vulnerability management), and threat intelligence. The Company is headquartered in Sunnyvale, California. The Company conducts its business in the United States, as well as locations internationally, including in Australia, Germany, India, Romania, and the United Kingdom. On June 14, 2019, the Company closed its initial public offering (“IPO”), in which it sold 20,700,000 shares of Class A common stock. The shares were sold at a public offering price of $34.00 per share for net proceeds of $659.2 million, after deducting underwriters’ discounts and commissions and offering expenses of $44.8 million. Immediately prior to the closing of the IPO, all outstanding shares of redeemable convertible preferred stock automatically converted into 131,267,586 shares of Class B common stock on a one-to-one basis. Additionally, in connection with the IPO all of the Company’s outstanding common stock was reclassified into shares of Class B common stock on a one-for-one basis. Redeemable convertible preferred stock warrants also converted into 336,386 warrants to purchase Class B common stock on a one-to-one basis.

Summary of Significant Accounting Policies

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2019, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all of the information required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three and nine months ended October 31, 2019 are not necessarily indicative of the results to be expected for the year ending January 31, 2020 or for any other interim period or for any other future year.

Certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable required disclosures and regulations of the SEC. Therefore, the accompanying interim unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2019 included in the Company’s prospectus dated June 11, 2019 filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

JOBS Act Accounting Election

The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”). An EGC may take advantage of specified reduced reporting requirements that are otherwise applicable generally to public companies, including, but not limited to, delayed adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

The Company may take advantage of these exemptions until it is no longer an EGC. The Company would cease to be an EGC upon the earliest to occur of: (i) the first fiscal year following the fifth anniversary of its initial public offering; (ii) the first fiscal year after annual gross revenue is $1.07 billion or more; (iii) the date on which the Company has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the date on which the Company qualifies as a “large accelerated filer,” as defined in Rule 12b-2 under the Exchange Act, which would occur at the end of any fiscal year in which the market value of the Company’s common stock held by non-affiliates exceeded $700.0 million as of the end of the second quarter of that fiscal year, and as of the end of such fiscal year the Company has been a reporting company for at least 12 months.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Actual results may differ from these estimates and such difference could be material to the Company’s condensed consolidated financial statements.

Estimates and assumptions used by management affect revenue recognition, the allowance for doubtful accounts, the carrying value of long-lived assets, the useful lives of long-lived assets, the fair value of financial instruments, the period of benefit for deferred contract acquisition costs, the recognition and disclosure of contingent liabilities, income taxes, stock-based compensation, and the fair value of the Company’s common stock and redeemable convertible preferred stock warrants.

Concentration of Credit Risk and Geographic Information

The Company generates revenue from the sale of subscriptions to access its cloud platform and professional services. The Company’s sales team, along with its channel partner network of system integrators and value-added resellers (collectively, “channel partners”), sells the Company’s services worldwide to organizations of all sizes. Due to the nature of the Company’s services and the terms and conditions of the Company’s contracts with its channel partners, the Company’s business could be affected unfavorably if it is not able to continue its relationships with them.

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. The Company’s cash is placed with high-credit-quality financial institutions and issuers, and at times exceed federally insured limits. The Company limits its concentration of risk in cash equivalents and marketable securities by diversifying its investments among a variety of industries and issuers. The Company has not experienced any credit loss relating to its cash equivalents and marketable securities. The Company performs periodic credit evaluations of its customers and generally does not require collateral.

No channel partner or direct customer accounted for 10% or more of the Company’s consolidated accounts receivable as of October 31, 2019. There were no channel partners who accounted for 10% or more of the Company’s consolidated accounts receivable as of January 31, 2019. Outstanding accounts receivable from two of the Company’s direct customers accounted for 10% and 19% of its consolidated accounts receivable as of January 31, 2019.

Revenue from sales to one of the Company’s channel partners accounted for 10% and 15% of its consolidated revenue for the three months ended October 31, 2019 and October 31, 2018, respectively, and 11% and 17% of its consolidated revenue for the nine months ended October 31, 2019 and October 31, 2018, respectively.

There were no direct customers who represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Cash Equivalents and Marketable Securities

The Company considers all highly liquid investments with original maturities of three months or less at date of purchase to be cash equivalents. Cash equivalents as of October 31, 2019 and January 31, 2019 consisted of corporate debt securities and money market funds stated at fair value. The Company classifies investments in marketable securities as available-for-sale securities at the time of purchase. The Company classifies its available-for-sale securities as current or long-term based on the nature of the investments and their availability for use in current operations. Available-for-sale securities are carried at fair value with unrealized gains and losses, if any, included in accumulated other comprehensive income (loss). Unrealized losses are recorded in other income (expense), net, for declines in fair value below the cost of an individual investment that is deemed to be other-than-temporary. The Company did not identify any marketable securities as other-than-temporarily impaired as of October 31, 2019 and January 31, 2019. The Company determines realized gains or losses on the sale of marketable securities on a specific identification method and records such gains or losses in Other income (expense), net. Marketable securities as of October 31, 2019 and January 31, 2019 consisted of corporate debt securities and U.S. treasury securities.

Strategic Investments

In July 2019, the Company agreed to commit up to $10.0 million to a newly formed entity, CrowdStrike Falcon Fund LLC (“Falcon Fund”) in exchange for 50% of the sharing percentage of any distribution by Falcon Fund. Entities associated with Accel, a holder of more than 5% of the Company’s capital stock, also agreed to commit up to $10.0 million to Falcon Fund, and collectively own the remaining 50% of the sharing percentage of Falcon Fund. Falcon Fund is in the business of purchasing, selling, investing and trading in minority equity and convertible debt securities of privately-held companies that develop applications that have potential for substantial contribution to CrowdStrike and its platform. The Company is the manager of the Falcon Fund and controls the investment decisions and day-to-day operations and accordingly will consolidate the Falcon Fund. Falcon Fund has a duration of ten years and may be extended for three additional years. At dissolution, Falcon Fund will be liquidated and the remaining assets will be distributed to the investors based on their respective sharing percentage. As of October 31, 2019, neither the Company nor Accel had made a contribution to Falcon Fund and Falcon Fund had no net assets or operating activities. The Company has elected the measurement alternative for the non-marketable equity investments of the Falcon Fund. Under the measurement alternative, the equity investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The non-marketable equity investments of the Falcon Fund will be valued using significant unobservable inputs or data in inactive markets which require judgment due to the absence of market prices and inherent lack of liquidity. As a result, there could be volatility in the Company’s consolidated statements of operations in future periods due to the valuation and timing of identical or similar investments of the same issuer.

Fair Value of Financial Instruments

The Company’s financial instruments consist of cash equivalents, marketable securities, accounts receivable, accounts payable, accrued expenses, and redeemable convertible preferred stock warrant liability. The carrying values of cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their short-term nature. Refer to Note 3, Fair Value Measurements and Marketable Securities regarding the fair value of the Company’s marketable securities.

The Company reports the redeemable convertible preferred stock warrant liability at fair value (see Note 3, Fair Value Measurements). The warrants issued by the Company for redeemable convertible preferred stock in January 2015, December 2016, and March 2017 (see Note 7, Redeemable Convertible Preferred Stock) have been recorded as a liability based on “Level 3” inputs, which consist of unobservable inputs and reflect management’s estimates of assumptions that market participants would use in pricing the liability. The fair value of the warrants was determined using the Black-Scholes option-pricing model, which is affected by changes in inputs to that model including the Company’s stock price, expected stock price volatility, risk-free rate, and contractual term. Immediately prior to the closing of the IPO on June 14, 2019, the redeemable convertible preferred stock warrants converted into 336,386 warrants to purchase Class B common stock on a one-to-one basis. The redeemable convertible preferred stock warrant liability was reclassified to additional paid-in capital.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount and are non-interest bearing. Accounts receivable are stated at their net realizable value, net of an allowance for doubtful accounts. The Company has a well-established collections history from its customers. Credit is extended to customers based on an evaluation of their financial condition and other factors. The Company generally does not require collateral from its customers; however, the Company may require payment prior to commencing service in certain instances to limit credit risk. The Company records an allowance for doubtful accounts based on management’s assessment of the collectability of accounts. Management regularly reviews the adequacy of the allowance for doubtful accounts by considering the age of each outstanding invoice, each customer’s expected ability to pay, and the collection history with each customer, when applicable, to determine whether the allowance is appropriate. Amounts deemed uncollectible are written off against the allowance for doubtful accounts. As of October 31, 2019 and January 31, 2019, the allowance for doubtful accounts was $1.4 million and $1.0 million, respectively.

Deferred Offering Costs

Deferred offering costs of $2.9 million have been recorded as other assets on the condensed consolidated balance sheet as of January 31, 2019, and consist of expenses incurred in connection with the Company’s IPO, including legal, accounting, printing, and other IPO-related costs. Subsequent to January 31, 2019, the Company capitalized an additional $3.0 million of offering costs. Upon the close of the IPO on June 14, 2019, all of these deferred offering costs were reclassified to stockholders’ equity and recorded against the proceeds from the offering. As of October 31, 2019, the Company had paid all $5.9 million of these deferred offering costs.

Property and Equipment, Net

Property and equipment, net, is stated at historical cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows:


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Expenditures for routine maintenance and repairs are charged to operating expense as incurred. Major renewals and improvements are capitalized and depreciated over their estimated useful lives. Upon retirement or other disposition of property and equipment, the cost and accumulated depreciation are removed from the accounts, and any gain or loss is recorded in operating expenses in the condensed consolidated statements of operations.

Capitalized Internal-Use Software

The Company capitalizes certain development costs incurred in connection with its internal-use software. These capitalized costs are primarily related to the Company’s cloud-delivered solution for next-generation endpoint protection. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Capitalized costs are recorded as property and equipment, net. Maintenance and training costs are expensed as incurred. Internal-use software is amortized to cost of revenue on a straight-line basis over its estimated useful life of three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. There were no impairments of internal-use software during the three months ended October 31, 2019 and October 31, 2018. The Company capitalized $2.2 million and $1.8 million in internal-use software during the three months ended October 31, 2019 and October 31, 2018, respectively, and $5.7 million and $5.0 million during the nine months ended October 31, 2019 and October 31, 2018, respectively. Amortization expense associated with internal-use software totaled $1.6 million and $1.2 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $4.6 million and $3.5 million during the nine months ended October 31, 2019 and October 31, 2018, respectively. The net book value of capitalized internal-use software was $12.6 million and $11.5 million as of October 31, 2019 and January 31, 2019, respectively.

Intangible Assets, Net

Intangible assets, net, consisting of developed technology, customer relationships, and non-compete agreements, are stated at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated economic lives of three to five years. Amortization expense related to developed technology is included in cost of revenue, amortization expense related to customer relationships is included in sales and marketing expenses, and amortization expense related to non-compete agreements is included in research and development expenses.

Deferred Contract Acquisition Costs

The Company capitalizes contract acquisition costs that are incremental to the acquisition of customer contracts. Contract acquisition costs are accrued and capitalized upon execution of the sales contract by the customer. Sales commissions for renewal of a contract are not considered commensurate with the commissions paid for the acquisition of the initial contract or follow-on upsell given the substantive difference in commission rates in proportion to their respective contract values. Commissions, including referral fees paid to channel partners, paid upon the initial acquisition of a contract or subsequent upsell are amortized over an estimated period of benefit of four years while commissions paid for renewal contracts are amortized over the contractual term of the renewals. Sales commissions associated with professional service contract are amortized ratably over an estimated period of benefit of six months. The Company capitalized contract acquisition costs of $27.4 million, which is under ASC606, and $13.2 million, which is under ASC 605, during the three months ended October 31, 2019 and October 31, 2018, respectively, and $55.2 million, which is under ASC 606, and $27.5 million, which is under ASC 605, during the nine months ended October 31, 2019 and October 31, 2018, respectively. Contract acquisition cost amortization expense was $9.0 million, which is under ASC 606, and $7.3 million, which was under ASC 605, during the three months ended October 31, 2019 and October 31, 2018, respectively, and $24.1 million, which is under ASC 606, and $19.3 million, which was under ASC 605, during the nine months ended October 31, 2019 and October 31, 2018, respectively.

Impairment of Long-Lived Assets

The Company reviews for impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of the asset (or asset group) may not be recoverable. Events and changes in circumstances considered by the Company in determining whether the carrying value of long-lived assets may not be recoverable, include, but are not limited to: significant changes in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, and changes in the Company’s business strategy. Impairment testing is performed at an asset level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities (an “asset group”). An impairment loss would be recognized when estimated future cash flows expected to result from the use of the asset (or asset group) and its eventual disposition is less than its carrying amount. No impairment indicators were identified by the Company and no impairment losses were recorded by the Company during the three and nine months ended October 31, 2019 and October 31, 2018.

Deferred Revenue

The deferred revenue balance consists of subscription and professional services which have been invoiced upfront and are recognized as revenue only when the revenue recognition criteria are met. The Company typically invoices its customers at the beginning of the term, or in some instances, such as in multi-year arrangements, in installments. Professional services are either invoiced upfront, invoiced in installments, or invoiced as the services are performed. Accordingly, the Company’s deferred revenue balance does not include revenues for future years of multi-year non-cancellable contracts that have not yet been billed.

The Company recognizes subscription revenue ratably over the contract term beginning on the commencement date of each contract, the date that services are made available to customers. Once services are available to customers, the Company records amounts due in accounts receivable and in deferred revenue. To the extent the Company bills customers in advance of the contract commencement date, the accounts receivable and corresponding deferred revenue amounts are netted to zero on the condensed consolidated balance sheets, unless such amounts have been paid as of the balance sheet date.

Redeemable Convertible Preferred Stock Warrants

Warrants related to the Company’s redeemable convertible preferred stock are classified as liabilities on the Company’s consolidated balance sheet. The warrants are subject to reassessment at each balance sheet date, and any change in fair value is recognized as a component of Other income (expense), net, in the condensed consolidated statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the expiration or exercise of the warrants, or upon their automatic conversion into warrants to purchase common stock in connection with a qualified initial public offering (as defined in Note 7, Redeemable Convertible Preferred Stock) such that they qualify for equity classification and no further remeasurement is required.

Immediately prior to the closing of the IPO on June 14, 2019, the redeemable convertible preferred stock warrants converted into 336,386 warrants to purchase Class B common stock on a one-to-one basis. The redeemable convertible preferred stock warrant liability was reclassified to additional paid-in capital. Within the same month, the Company received notice from the holders of 336,386 warrants as to their intentions to exercise the warrants for shares of common stock of the Company. Such shares were settled via net settlement method, which was elected by the holders to reduce the number of shares issued upon exercise to reflect net settlement of the exercise price, resulting in the issuance of 322,278 shares of the Company’s common stock.

Revenue Recognition – ASC 606

The Company adopted ASC 606 on February 1, 2019, using the modified retrospective transition method. Under this method, results for reporting periods beginning on February 1, 2019 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with prior accounting under Topic 605. The Company has shown the effect of applying ASC 606 for the three months ended October 31, 2019 and the nine months ended October 31, 2019 in the disclosures below.

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)

The following tables summarize the effect of the adoption of Topic 606 on the Company’s select line items included in the condensed consolidated financial statements as of and for the three months ended October 31, 2019 and the nine months ended October 31, 2019, as if the previous accounting was in effect:


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

The adoption of Topic 606 had no impact on net cash provided by or used in operating, investing, or financing activities in the Company’s condensed consolidated statement of cash flows for the three or nine months ended October 31, 2019.

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration that the Company expects to be entitled to receive in exchange for these services. To achieve the core principle of this standard, the Company applies the following five steps:

1)Identify the contract with a customer

The Company considers the terms and conditions of contracts with customers and its customary business practices in identifying contracts under ASC 606. The Company determines it has a contract with a customer when the contract is approved, each party’s rights regarding the services to be transferred can be identified, payment terms for the services can be identified, it has been determined that the customer has the ability and intent to pay, and the contract has commercial substance. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer.

2)Identify the performance obligations in the contract

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from the Company or from third parties, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. The Company’s performance obligations consist of (i) subscriptions and (ii) professional services.

3)Determine the transaction price

The transaction price is determined based on the consideration which the Company is expected to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts contain a significant financing component.

4)Allocate the transaction price to performance obligations in the contract

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP”).

5)Recognize revenue when or as performance obligations are satisfied

Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to the customer. Revenue is recognized when control of the services is transferred to the customer, in an amount that reflects the consideration expected to be received in exchange for those services. The Company generates all its revenue from contracts with customers.

Subscription Revenue

The Company’s Falcon Platform technology solutions are subscription, software as a service (“SaaS”) offerings designed to continuously monitor, share, and mitigate risks from determined attackers. Customers do not have the right to take possession of the cloud-based software platform. Fees are based on several factors, including the solutions subscribed for by the customer and the number of endpoints purchased by the customer. The subscription fees are typically payable within 30 to 60 days after the execution of the arrangement, and thereafter upon renewal or subsequent installment. The Company initially records the subscription fees as deferred revenue and recognizes revenue on a straight-line basis over the term of the agreement.

The typical subscription term is one to three years. Most of the Company’s contracts are non-cancelable over the contractual term. Customers typically have the right to terminate their contracts for cause if the Company fails to perform in accordance with the contractual terms. Some customers have the option to purchase additional subscription at a stated price. These options generally do not provide a material right as they are priced at our SSP.

Professional Services Revenue

The Company offers several types of professional services including incident response and forensic services, surge forensic and malware analysis, and attribution analysis, which are focused on responding to imminent and direct threats, assessing vulnerabilities, and recommending solutions. These services are distinct from subscription services. Professional services do not result in significant customization of the subscription service. The professional services are available through hourly rate and fixed fee contracts, one-time and ongoing engagements, and retainer-based agreements. Revenue for time and materials arrangements is recognized as services are performed and revenue for fixed fees is recognized on a proportional performance basis as the services are performed.

Contracts with Multiple Performance Obligations

Some contracts with customers contain multiple promised services consisting of subscription and professional services that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative SSP basis. The SSP is the price at which the Company would sell promised subscription or professional services separately to a customer. Judgment is required to determine the SSP for each distinct performance obligation. The Company determines SSP based on its overall pricing objectives, taking into consideration the type of subscription or professional service and the number of endpoints.

Variable Consideration

Revenue from sales is recorded at the net sales price, which is the transaction price, and includes estimates of variable consideration. The amount of variable consideration that is included in the transaction price is constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue will not occur when the uncertainty is resolved.

If subscriptions do not meet certain service level commitments, the Company’s customers are entitled to receive service credits, and in certain cases, refunds, each representing a form of variable consideration. The Company has historically not experienced any significant incidents affecting the defined levels of reliability and performance as required by its subscription contracts. Accordingly, any estimated refunds related to these agreements in the condensed consolidated financial statements is not material during the periods presented.

The Company provides rebates and other credits within its contracts with certain resellers, which are estimated based on the most likely amounts expected to be earned or claimed on the related sales transaction. Overall, the transaction price is reduced to reflect the Company’s estimate of the amount of consideration to which it is entitled based on the terms of the contract. Estimated rebates and other credits were not material during the periods presented.

Revenue Recognition – ASC 605

Prior to adopting ASC 606 on February 1, 2019, the Company recognized subscription and professional services when: (1) persuasive evidence of the contract exists in the form of a written contract, amendments to that contract, or purchase orders from a third party; (2) delivery has occurred, or services have been rendered; (3) the price is fixed or determinable; and (4) collectability is reasonably assured based on customer creditworthiness and history of collection.

The timing and the amount the Company recognized as revenue was determined based on the facts and circumstances of each customer’s arrangements. Evidence of an arrangement consisted of a signed customer agreement. The Company considered that the delivery of its solution had commenced once it provided the customer with log-in information and the term of the contract had started. Fees were fixed based on stated rates specified in the customer agreement. The Company assessed collectability based on several factors, including the credit worthiness of the customer and transaction history. If collectability was not reasonably assured, revenue was deferred until the fees were collected.

For arrangements that involve the contemporaneous sale of subscription and professional services, the Company applied the multiple-element arrangement guidance to allocate the arrangement consideration to all deliverables based on their relative selling price. The Company determined that the cloud-based platform subscription has standalone value, because once access is given to the customer, the solutions are fully functional and do not require any additional development, modification, or customization. Professional services have standalone value because they are regularly sold by the Company in separate transactions. Additionally, the performance of these professional services generally does not require highly specialized or technologically skilled individuals and the professional services are not essential to the functionality of the solutions.

The Company used a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”); (ii) third-party evidence of selling price (“TPE”); and (iii) best estimate of selling price (“BESP”). BESP reflected the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company’s process for determining BESP involved management’s judgment and considered numerous factors including the nature of the deliverables themselves and historical discounting practices. The Company updated its estimates of BESP on an ongoing basis as events and circumstances required.

Research and Development Expense

Research and development costs are expensed when incurred, except for certain internal-use software development costs, which may be capitalized as noted above. Research and development expenses consist primarily of personnel and related headcount costs, costs of professional services associated with the ongoing development of the Company’s technology, and allocated overhead.

Advertising

All advertising costs are expensed as incurred and are included in sales and marketing expense in the condensed consolidated statements of operations. The Company incurred $2.2 million and $1.5 million of advertising costs during the three months ended October 31, 2019 and October 31, 2018, respectively, and $5.5 million and $2.6 million during the nine months ended October 31, 2019 and October 31, 2018, respectively.

Stock-Based Compensation

The Company accounts for stock-based awards granted to employees and directors based on the awards’ estimated grant date fair value. The Company estimates the fair value of its stock options using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period during which the employee or director is required to provide service in exchange for the award, usually the vesting period, which is generally four years. The Company accounts for forfeitures as they occur.

Prior to the Company’s adoption of ASU 2018-07, stock-based awards issued to non-employees were accounted for at fair value determined by using the Black-Scholes option-pricing model. The Company believes that the fair value of the stock options is more reliably measured than the fair value of the services received. The fair value of each non-employee stock-based award is remeasured each period until a commitment date is reached, which is generally the vesting date. The Company early adopted ASU 2018-07 on February 1, 2019 and began accounting for stock-based awards issued to non-employees the same as it accounts for stock-based awards issued to employees. The effect on the Company’s condensed consolidated financial statements for the three and nine months ended October 31, 2019 was not material.

Restricted stock units (“RSUs”) granted under the 2011 Plan are subject to a service-based vesting condition and a performance-based vesting condition. The service-based vesting condition is generally satisfied based on one of three vesting schedules: (i) vesting of one-fourth of the RSUs on the first “Company vest date” (defined as March 20, June 20, September 20, or December 20) on or following the one-year anniversary of the vesting commencement date with the remainder of the RSUs vesting in twelve equal quarterly installments thereafter, subject to continued service, (ii) vesting in sixteen equal quarterly installments beginning on December 20, 2018, subject to continued service, or (iii) vesting in eight equal quarterly installments beginning on December 20, 2022, subject to continued service. The performance-based vesting condition is satisfied on the earlier of (i) a change in control, in which the consideration paid to holders of shares is either cash, publicly traded securities, or a combination thereof, or (ii) the first Company vest date to occur following the expiration of the lock-up period upon an IPO, subject to continued service through such change in control or lock-up expiration, as applicable. None of the RSUs vest unless the performance-based vesting condition is satisfied. Upon the completion of the IPO, the performance-based vesting condition was met and the Company recognized $17.3 million of deferred expense related to RSUs as of that date in its condensed consolidated statement of operations.

Performance-based stock units (“PSUs”) granted under the 2019 Plan are subject to a performance-based vesting condition. With regard to the performance conditions, the fair value of new or modified awards is equal to the grant date fair market value of the Company’s common stock. PSUs generally vest over a four-year period based on the achievement of specified performance targets for the fiscal year ended January 31, 2020 and subject to continued service through the applicable vesting dates. The compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied. Based on the extent to which the performance targets are achieved, shares ultimately awarded may range from 80% to 100% of the target award amount. If the performance targets are below 80%, no shares will be awarded.

Business Combinations

The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired users, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the condensed consolidated statement of operations.

Goodwill and Intangible Assets

The Company evaluates and tests the recoverability of goodwill for impairment at least annually, on January 31, or more frequently if circumstances indicate that goodwill may not be recoverable. The Company performs the impairment testing by first assessing qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of its reporting unit is less than its carrying amount. The Company has one reporting unit. If, after assessing the totality of events or circumstances, the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company performs the first step of a two-step analysis by comparing the book value of net assets to the fair value of the reporting unit. To calculate any potential impairment, the Company compares the fair value of a reporting unit with its carrying amount, including goodwill. Any excess of the carrying amount of the reporting unit’s goodwill over its fair value is recognized as an impairment loss, and the carrying value of goodwill is written down. In assessing the qualitative factors, the Company considers the impact of certain key factors including macroeconomic conditions, industry and market considerations, management turnover, changes in regulation, litigation matters, changes in enterprise value, and overall financial performance. No impairment was recorded during the three and nine months ended October 31, 2019 or October 31, 2018. The change in the goodwill balance during the three and nine months ended October 31, 2019 and October 31, 2018 was due to changes in foreign currency exchange rates.

Acquired intangible assets consisting of identifiable intangible assets, were comprised of developed technology, customer relationships, and non-compete agreements resulting from acquisitions. Acquired intangible assets are recorded at fair value on the date of acquisition and amortized over their estimated economic lives following the pattern in which the economic benefits of the assets will be consumed which is on a straight-line basis. Acquired intangible assets are presented net of accumulated amortization on the condensed consolidated balance sheets. The Company reviews the carrying amounts of intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The Company measures the recoverability of intangible assets by comparing the carrying amount of each asset to the future undiscounted cash flows it expects the asset to generate. If the Company considers any of these assets to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair value. In addition, the Company periodically evaluates the estimated remaining useful lives of long-lived assets to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation or amortization.

Leases

The Company leases its office space under various noncancelable operating lease agreements and recognizes related rent expense on a straight-line basis over the term of the lease. Certain lease agreements contain rent holidays, scheduled rent increases, lease incentives, and renewal options. Rent holidays and scheduled rent increases are included in the determination of rent expense to be recorded over the lease term. Lease incentives are recognized as a reduction of rent expense on a straight-line basis over the term of the lease. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The Company begins to recognize rent expense on the date that the Company obtains the legal right to use and control the leased space.

Foreign Currency Translation

The functional currencies of the Company’s foreign subsidiaries are each country’s local currency. Assets and liabilities of the subsidiaries are translated into U.S. Dollars at exchange rates in effect at the reporting date. Amounts classified in stockholders’ equity/(deficit) are translated at historical exchange rates. Revenue and expenses are translated at the average exchange rates during the period. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss). Foreign currency transaction gains or losses, whether realized or unrealized, are reflected in the condensed consolidated statements of operations within Other income (expense), net, and have not been material for all periods presented.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities and net operating loss and credit carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for unrecognized tax benefits using a more-likely-than-not threshold for financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. The Company establishes a liability for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. The Company records an income tax liability, if any, for the difference between the benefit recognized and measured and the tax position taken or expected to be taken on the Company’s tax returns. To the extent that the assessment of such tax positions changes, the change in estimate is recorded in the period in which the determination is made. The liability is adjusted considering changing facts and circumstances, such as the outcome of a tax audit. The provision for income taxes includes the impact of liability provisions and changes to the liability that are considered appropriate. As the Company maintains a full valuation allowance against its deferred tax assets, the changes resulted in no additional tax expense during the three and nine months ended October 31, 2019 or October 31, 2018. As of October 31, 2019, the Company does not expect that changes in the liability for unrecognized tax benefits for the next twelve months will have a material impact on its condensed consolidated financial statements.

Sales Taxes

When sales and other taxes are billed, such amounts are recorded as accounts receivable with a corresponding increase to other current liabilities, respectively. The balances are then removed from the condensed consolidated balance sheet as cash is collected from the customer and as remitted to the respective tax authority.

Segment and Geographic Information

The Company’s chief operating decision maker (“CODM”) is its chief executive officer. The CODM reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Accordingly, management has determined that the Company operates as one operating and reportable segment. The Company presents financial information about its geographic areas in Note 12 to the condensed consolidated financial statements.

Net Loss per Share

The Company computes basic and diluted net loss per share attributable to common stockholders for Class A and Class B common stock using the two-class method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. Net loss is attributed to Class A and Class B common stock based on their participation rights. Under the two-class method, basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period.

Diluted earnings per share attributable to common stockholders adjusts basic earnings per share for the potentially dilutive impact of stock options and redeemable convertible preferred stock. As the Company has reported losses for all periods presented, all potentially dilutive securities including redeemable convertible preferred stock, stock options, and warrants, are antidilutive and accordingly, basic net loss per share equals diluted net loss per share.

Recently Adopted Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which provides guidance for revenue recognition. Under the new guidance, revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. In addition, the guidance requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Subsequently, the FASB has issued the following guidance to amend ASU 2014-09: ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date; ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net); ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, which clarifies narrow aspects of Topic 606 or corrects unintended application of the guidance. The Company must adopt ASU No. 2015-14, ASU No. 2016-08, ASU No. 2016-10, ASU No. 2016-12, and ASU No. 2016-20 with ASU No. 2014-09, which are referred to collectively as the “new revenue guidance.” On February 1, 2019, the Company adopted ASU No. 2014-09 using the modified retrospective transition method. Under this method, results for reporting periods beginning on February 1, 2019 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historical accounting under Topic 605. The Company recorded a cumulative effect adjustment to the opening accumulated deficit of $23.4 million, net of tax, as of the date of adoption. The change resulted from a $23.7 million reduction in commissions expense that the Company capitalized under Topic 606, but would have been recognized during the prior period as commissions expense under its historical accounting practices under Topic 605 and a $0.3 million reduction in revenue that would have been recognized during the prior period under Topic 605.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. If substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the set of transferred assets and activities is not a business. On February 1, 2019, the Company adopted ASU No. 2018-07, which did not have a material effect on the Company’s condensed consolidated financial statements.

In June 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This ASU simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. This ASU is effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than the adoption date of Topic 606. On February 1, 2019, the Company adopted ASU No. 2018-07, which did not have a material effect on the Company’s condensed consolidated financial statements.

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification. This release amends certain disclosure requirements that have become redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. The final rule was effective November 5, 2018. The Company adopted this amendment as of February 1, 2019, including presenting the activity of the stockholder’s equity accounts in the accompanying Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) for the periods presented.

Recently Issued Accounting Pronouncements

Under the JOBS Act, the Company meets the definition of an emerging growth company. The Company has elected to use the extended transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the JOBS Act.

In February 2016, the FASB issued ASU No. 2016-02, Leases. The new guidance supersedes current guidance related to accounting for leases and generally requires an entity to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use assets. In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842. This ASU makes 16 technical corrections to the new lease standard and other accounting topics, alleviating unintended consequences from applying the new standard. It does not make any substantive changes to the core provisions or principles of the new standard. In July 2018, the FASB also issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements. This ASU provides (1) an optional transition method that entities can use when adopting the standard and (2) a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are met. As an emerging growth company as defined in the JOBS Act, the Company has elected to delay adoption of this ASU until February 1, 2020. ASU No. 2016-02 can be adopted using either full or modified retrospective approach as of the earliest period presented or as of the adoption date with the cumulative effect adjustment to the opening balance recognized in retained earnings in the period of adoption. The Company is currently evaluating the potential impact of these ASUs on its consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities to require that credit losses on available-for-sale debt securities be presented as an allowance rather than as a write-down. In May 2019, the FASB issued an update for ASU No. 2016-13. The standard replaces the existing incurred loss model with an expected credit loss model for financial assets measured at amortized cost, including trade receivables, and requires that credit losses on available-for-sale debt securities be presented as an allowance rather than as a write-down. The measurement of credit losses for newly recognized financial assets and subsequent changes in the allowance for credit losses are recorded in the consolidated statements of operations. For public business entities that are SEC filers, this ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the potential impact of this ASU on its consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. This ASU simplifies the measurement of goodwill by eliminating step two of the two-step impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. This ASU requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. As an emerging growth company defined in the JOBS Act, the Company has elected to delay adoption of this ASU until February 1, 2022. The Company is currently evaluating the potential impact of this ASU on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. As an emerging growth company as defined in the JOBS Act, the Company has elected to delay adoption of this ASU until February 1, 2020. The Company is currently evaluating the potential impact of this ASU on its consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force). This ASU aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal use software. As an emerging growth company defined in the JOBS Act, the Company has elected to delay adoption of this ASU until February 1, 2021. Entities can choose to adopt this ASU prospectively or retrospectively. The Company is currently evaluating the potential impact of this ASU on its consolidated financial statements.

Fair Value Measurements and Marketable Securities

9 Months Ended

Oct. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements and Marketable Securities

3. Fair Value Measurements and Marketable Securities

The Company follows ASC 820, Fair Value Measurements, with respect to marketable securities that are measured at fair value on a recurring basis. Under the standard, fair value is defined as the exit price, or the amount that would be received to sell an asset or a liability in an orderly transaction between market participants as of the measurement date. The standard also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available in the circumstances.

The hierarchy is broken down into three levels as follows:

Level 1 Assets and liabilities whose values are based on unadjusted quoted market prices for identical assets and liabilities in active markets

Level 2 Assets and liabilities whose values are based on quoted prices in markets that are not active or inputs that are observable for substantially the full term of the asset or liability

Level 3 Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement

Categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The Company’s fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis are as follows:


	October 31, 2019														January 31, 2019
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	(in thousands)														(in thousands)
Assets
Cash equivalents⁽¹⁾
Money market funds	$	693,258	$	—	$	—	$	693,258	$	42,132	$	—	$	—	$	42,132
Corporate debt securities	—		8,598		—		8,598		—		27,941		—		27,941
Total cash equivalents	693,258		8,598		—		701,856		42,132		27,941		—		70,073
Marketable securities
Corporate debt securities	—		76,154		—		76,154		—		91,796		—		91,796
U.S. treasury securities	13,929		—		—		13,929		11,451		—		—		11,451
Total marketable securities	13,929		76,154		—		90,083		11,451		91,796		—		103,247
Total assets	$	707,187	$	84,752	$	—	$	791,939	$	53,583	$	119,737	$	—	$	173,320
Liability
Contingent consideration related to business combinations⁽²⁾	$	—	$	—	$	—	$	—	$	—	$	—	$	474	$	474
Redeemable convertible preferred stock warrant liability ⁽³⁾	—		—		—		—		—		—		4,537		4,537
Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—	$	5,011	$	5,011

__________________________________

(1)Included in “Cash and cash equivalents” on the condensed consolidated balance sheets.

(2)The contingent consideration consists of development milestone payments. The fair value of the contingent consideration was estimated by developing the risk-adjusted discounted value as well as discounted probability-weighted expected payments. That measure is based on Level 3 inputs which are significant inputs that are not observable in the market. Key assumptions at the acquisition date included (a) a discount rate range of 3%-3.02% and (b) three probability-adjusted milestone payments, each $0.2 million. As of January 31, 2019, the first milestone payment of $0.2 million had been made. During the three months ended April 30, 2019, the remaining milestones were deemed not probable of being paid and the remaining contingent consideration of $0.5 million was written off to Other income (expense), net.

(3)Immediately prior to the closing of the IPO on June 14, 2019, the redeemable convertible preferred stock warrants converted into 336,386 warrants to purchase Class B common stock on a one-to-one basis. The redeemable convertible preferred stock warrant liability was reclassified to additional paid-in capital. Within the same month, the Company received notice from the holders of 336,386 warrants as to their intentions to exercise the warrants for shares of common stock of the Company. Such shares were settled via net settlement method, which was elected by the holders to reduce the number of shares issued upon exercise to reflect net settlement of the exercise price, resulting in the issuance of 322,278 shares of the Company’s common stock.

There were no transfers between the levels of the fair value hierarchy during the three and nine months ended October 31, 2019 or October 31, 2018.

At October 31, 2019 and January 31, 2019, the amortized cost of the Company’s cash equivalents and marketable securities approximated their fair value and there were no material realized or unrealized gains or losses, either individually or in the aggregate. In addition, the securities that had been in continuous unrealized loss position per security type and in aggregate are not material as of October 31, 2019 and January 31, 2019. There were no impairments considered “other-than-temporary” as it is more likely than not the Company will hold the securities until maturity or a recovery of the cost basis.

The remaining contractual maturities of marketable securities as of October 31, 2019 and January 31, 2019 were less than one year.

The following summarizes the changes in the redeemable convertible preferred stock warrant liability, which is classified as a Level 3 instrument:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Balance at beginning of period	$	—	$	3,016	$	4,537	$	961
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	—		880		6,022		2,935
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	—		—		(10,559)		—
Balance at end of period	$	—	$	3,896	$	—	$	3,896

The fair value of the redeemable convertible preferred stock warrant liability was estimated using the Black-Scholes option-pricing model and was based on significant inputs not observable in the market, and therefore was classified as a Level 3 instrument. The inputs include the Company’s preferred stock price, expected stock price volatility, risk-free interest rate, and contractual term. No loss and a loss of $0.9 million was recorded as a component of Other income (expense), net, relating to the final remeasurement of the redeemable convertible preferred stock warrant liability during the three months ended October 31, 2019 and October 31, 2018, respectively, and a loss of $6.0 million and $2.9 million during the nine months ended October 31, 2019 and October 31, 2018, respectively.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

9 Months Ended

Oct. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

4. Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Prepaid expenses	$	20,515	$	5,982
Prepaid software licenses	14,793		8,408
Other current assets	2,606		1,105
Prepaid hosting services	—		2,915
Prepaid expenses and other current assets	$	37,914	$	18,410

Property and Equipment, Net

Property and equipment, net consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Data center and other computer equipment	$	67,764	$	44,735
Capitalized internal-use software	27,928		22,209
Leasehold improvements	10,313		10,011
Purchased software	2,557		1,460
Furniture and equipment	3,883		2,553
Construction in process	59,739		19,455
	172,184		100,423
Less: Accumulated depreciation and amortization	(42,680)		(26,688)
Property and equipment, net	$	129,504	$	73,735

Construction in process mainly includes data center equipment purchased that has not yet been placed in service. As of October 31, 2019, $57.0 million of data center equipment was purchased but not yet been placed into service.

Depreciation and amortization expense of property and equipment was $5.8 million and $3.8 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $16.0 million and $10.2 million during the nine months ended October 31, 2019 and October 31, 2018, respectively.

Intangible Assets, Net

Total intangible assets, net consisted of the following:


	October 31, 2019		January 31, 2019		Weighted-Average Remaining Useful Life
	(in thousands)					(in months)
Developed technology	$	1,248	$	1,269	12
Customer relationships	615		632		36
Non-compete agreement	123		126		12
	1,986		2,027
Less: Accumulated amortization	(1,349)		(979)
Intangible assets, net	$	637	$	1,048

Amortization of developed technology, customer relationships, and non-compete agreement are recorded within cost of revenue, sales and marketing expense, and research and development expense, respectively, in the condensed consolidated statements of operations. Amortization expense of intangible assets was $0.1 million during both the three months ended October 31, 2019 and October 31, 2018, and $0.4 million during both the nine months ended October 31, 2019 and October 31, 2018.

The estimated aggregate future amortization expense of intangible assets as of October 31, 2019 is as follows:


	Total
	(in thousands)
Fiscal 2020 (remaining three months)	$	104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	—
Total amortization expense	$	637

The developed technology, customer relationships, and non-compete agreement assets are being amortized over 3 years, 5 years, and 3 years, respectively.

Accrued Expenses

Accrued expenses consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Web hosting services	$	13,141	$	12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042

Accrued expenses	$	29,460	$	32,541

Accrued Payroll and Benefits

Accrued payroll and benefits consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Accrued commissions	$	15,290	$	9,499
Employee Stock Purchase Plan	10,236		—
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$	36,905	$	19,284

Secured Revolving Credit Facility	9 Months Ended
Secured Revolving Credit Facility	Oct. 31, 2019
Debt Disclosure [Abstract]
Secured Revolving Credit Facility	5. Secured Revolving Credit Facility In April 2019, the Company entered into a Credit Agreement with Silicon Valley Bank and other lenders, to provide a revolving line of credit of up to $150.0 million, including a letter of credit sub-facility in the aggregate amount of $10.0 million, and a swingline sub-facility in the aggregate amount of $10.0 million. The Company also has the option to request an incremental facility of up to an additional $75.0 million from one or more of the lenders under the Credit Agreement. The amount the Company may borrow under the Credit Agreement may not exceed the lesser of $150.0 million or the Company’s ordinary course recurring subscription revenue for the most recent month, as determined under the Credit Agreement, multiplied by a number that is (i) 6, for the first year after entry into the Credit Agreement; (ii) 5, for the second year after entry into the Credit Agreement; and (iii) 4, thereafter. Under the terms of the Credit Agreement, revolving loans may be either Eurodollar Loans or ABR Loans. Outstanding Eurodollar Loans incur interest at the Eurodollar Rate, which is defined in the Credit Agreement as LIBOR (or any successor thereto), plus a margin between 2.50% and 3.00%, depending on usage. Outstanding ABR Loans incur interest at the highest of (a) the Prime Rate, as published by the Wall Street Journal, (b) the federal funds rate in effect for such day plus 0.50%, and (c) the Eurodollar Rate plus 1.00%, in each case plus a margin between 1.50% and 2.00%, depending on usage. The Company will be charged a commitment fee of 0.2% to 0.3% per year for committed but unused amounts. The Credit Agreement will terminate on April 19, 2022. The Credit Agreement is collateralized by substantially all of the Company’s current and future property, rights, and assets, including, but not limited to, cash, goods, equipment, contractual rights, financial assets, and intangible assets of the Company and its subsidiaries. The Credit Agreement contains covenants limiting the ability to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock, and make investments, in each case subject to certain exceptions. The Credit Agreement also contains financial covenants requiring the Company to maintain the year-over-year growth rate of its ordinary course recurring subscription revenue above specified rates and to maintain minimum liquidity at specified levels. The Company was in compliance with the financial covenants as of October 31, 2019. The Credit Agreement contains events of default that include, among others, non-payment of principal, interest, or fees, breach of covenants, inaccuracy of representations and warranties, cross defaults to certain other indebtedness, bankruptcy and insolvency events, and material judgments. No amounts were outstanding under the Credit Agreement as of October 31, 2019.

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes The Company recognized an income tax expense of $0.4 million and $0.5 million for the three months ended October 31, 2019 and October 31, 2018, respectively and $1.7 million and $1.0 million for the nine months ended October 31, 2019 and 2018, respectively. The tax expense for the three and nine months ended October 31, 2019 was primarily attributable to pre-tax foreign earnings. The Company’s effective tax rates of (1.24)% and (1.28)% for the three months ended October 31, 2019 and October 31, 2018, respectively, and (1.48)% and (0.94)% for the nine months ended October 31, 2019 and October 31, 2018, respectively, differ from the U.S. statutory tax rate primarily due to valuation allowance recorded against domestic losses and the tax rate differences between the United States and foreign countries. The Company has a full valuation allowance on its U.S. federal and state deferred tax assets. As a result, consistent with the prior year, the Company is unable to record a tax benefit on these losses because of uncertainty of future profitability.

Redeemable Convertible Preferred Stock

9 Months Ended

Oct. 31, 2019

Temporary Equity Disclosure [Abstract]

Redeemable Convertible Preferred Stock

7. Redeemable Convertible Preferred Stock

Upon the close of the Company’s IPO on June 14, 2019, all shares of convertible preferred stock then outstanding, totaling 131,267,586 shares, were automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis and the carrying value, totaling $557.9 million, was reclassified into Class B common stock and additional paid-in capital on the condensed consolidated balance sheet.

The following table summarizes the authorized, issued, and outstanding redeemable convertible preferred stock of the Company as of January 31, 2019:


Class	Issue Price per Share		Shares Authorized	Shares Issued and Outstanding	Net Carrying Value		Liquidation Preference		Redemption Value
	(in thousands, except per share values)
Series A-1	$	0.50000	52,300	52,300	$	76,325	$	52,300	$	623,678
Series B	$	1.40500	21,523	21,352	44,320		30,000		254,623
Series C	$	4.52972	22,275	22,077	99,900		100,000		263,765
Series D	$	5.69153	17,570	17,570	99,845		125,000		211,631
Series D-1	$	5.69153	5,394	5,394	30,626		30,700		64,607
Series E	$	16.46136	18,357	12,575	206,896		207,000		207,000
Total			137,419	131,268	$	557,912	$	545,000	$	1,625,304

Common Stock	9 Months Ended
Common Stock	Oct. 31, 2019
Equity [Abstract]
Common Stock	. Common StockIn connection with the IPO, on June 14, 2019, the Company filed an Amended and Restated Certificate of Incorporation which authorizes the issuance of 2,000,000,000 shares of Class A common stock with a par value of $0.0005 per share, 300,000,000 shares of Class B common stock with a par value of $0.0005 per share, and 100,000,000 shares of undesignated preferred stock with a par value of $0.0005 per share. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to ten votes per share and is convertible into one share of Class A common stock. Class A and Class B common stockholders are not entitled to receive dividends unless declared by our board of directors.

Stock-Based Compensation

9 Months Ended

Oct. 31, 2019

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

9. Stock-Based Compensation

Stock Incentive Plan

In May 2019, the Company’s board of directors adopted, and the stockholders approved the CrowdStrike Holdings, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) with the purpose of granting stock-based awards to employees, directors, officers and consultants, including stock options, restricted stock awards, restricted stock units and performance-based restricted stock units. A total of 8,750,000 shares of Class A common stock were initially available for issuance under the 2019 Plan. The Company’s compensation committee administers the 2019 Plan. The number of shares of our common stock available for issuance under the 2019 Plan is subject to an annual increase on the first day of each fiscal year beginning on February 1, 2020, equal to the lesser of: (i) two percent (2.0%) of outstanding shares of the Company’s capital stock as of the last day of the immediately preceding fiscal year or (ii) such other amount as our board of directors may determine.

The 2011 Plan was terminated on June 10, 2019, which was the business day prior to the effectiveness of the Company’s registration statement on Form S-1 used in connection with the Company’s IPO, and stock-based awards are no longer granted under the 2011 Plan. Any shares underlying stock options that expire or terminate or are forfeited or repurchased under the 2011 Plan will be automatically transferred to the 2019 Plan.

Stock Options

The Company records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model with the assumptions included in the table below. The expected term represents the period that the Company’s share-based awards are expected to be outstanding. The expected term assumptions were determined based on the vesting terms, exercise terms, and contractual lives of the options. The expected stock price volatility is based upon comparable public company data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated option life.

The fair value of each option was estimated on the date of grant using the following assumptions during the period:


	Nine Months Ended October 31,
	2019	2018

Expected term (in years)	6.05	6.05 - 7.52
Risk-free interest rate	2.0% - 2.4%	2.6% - 3.1%
Expected stock price volatility	37.7% - 37.9%	37.8% - 38.9%
Dividend yield	— %	— %

The following table is a summary of stock option activity for the nine months ended October 31, 2019:


	Number of Shares	Weighted-Average Exercise Price Per Share
	(in thousands)
Options outstanding at January 31, 2019	26,535	$	3.87
Granted	880	$	14.65
Exercised	(706)	$	2.14
Canceled	(509)	$	7.34
Options outstanding at April 30, 2019	26,200	$	4.21
Granted	168	$	34.00
Exercised	(4,776)	$	3.62
Canceled	(325)	$	5.06
Options outstanding at July 31, 2019	21,267	$	4.56
Granted	—	$	—
Exercised	(286)	$	2.90
Canceled	(280)	$	7.40
Options outstanding at October 31, 2019	20,701	$	4.55
Options vested and expected to vest at October 31, 2019	20,701	$	4.55
Options exercisable at October 31, 2019	11,871	$	2.30

Options exercisable include 982,200 options that were unvested as of October 31, 2019.

The aggregate intrinsic value of options vested and exercisable was $608.9 million and $181.1 million as of October 31, 2019 and January 31, 2019, respectively. The weighted-average remaining contractual term of options vested and exercisable was 6.4 years and 7.1 years as of October 31, 2019 and January 31, 2019, respectively.

No options were granted for the three months ended October 31, 2019. The weighted-average grant date fair values of all options granted was $5.81 per share during the three months ended October 31, 2018. The weighted-average grant date fair values of all options granted was $9.51 and $5.59 per share during the nine months ended October 31, 2019 and October 31, 2018, respectively. The total intrinsic value of all options exercised was $17.3 million and $13.4 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $107.0 million and $21.0 million during the nine months ended October 31, 2019 and October 31, 2018, respectively.

The aggregate intrinsic value of stock options outstanding as of October 31, 2019 and January 31, 2019 was $939.0 million and $286.1 million, respectively, which represents the excess of the fair value of the Company’s common stock over the exercise price of the options multiplied by the number of options outstanding. The weighted-average remaining contractual term of stock options outstanding was 7.3 years and 7.9 years as of October 31, 2019 and January 31, 2019, respectively.

Total unrecognized stock-based compensation expense related to unvested options was $39.1 million as of October 31, 2019. This expense is expected to be amortized on a straight-line basis over a weighted-average vesting period of 2.3 years. Total unrecognized stock-based compensation expense related to unvested options was $45.8 million as of January 31, 2019. This expense is expected to be amortized on a straight-line basis over a weighted-average vesting period of 3.4 years.

Early Exercise of Employee Options

The 2011 Stock Plan allows for the early exercise of stock options for certain individuals as determined by the Board of Directors. The consideration received for an early exercise of an option is a deposit of the exercise price and the related dollar amount is recorded as a liability for early exercise of unvested stock options in the condensed consolidated balance sheets. This liability is reclassified to additional paid-in capital as the awards vest. If a stock option is early exercised, the unvested shares may be repurchased by the Company in case of employment termination or for any reason, including death and disability, at the price paid by the purchaser for such shares. There were no issued shares of common stock related to early exercised stock options for the three months ended October 31, 2019. During the nine months ended October 31, 2019, the Company issued 1,037,356 shares of common stock related to early exercised stock options. As of October 31, 2019, the number of shares of common stock related to early exercised stock options subject to repurchase was 1,127,811 shares for $9.6 million. As of January 31, 2019, the number

of shares of common stock related to early exercised stock options subject to repurchase was 545,941 shares for $1.2 million. Common stock purchased pursuant to an early exercise of stock options is not deemed to be outstanding for accounting purposes until those shares vest. The Company includes unvested shares subject to repurchase in the number of shares outstanding on the statement of redeemable convertible preferred stock and stockholders’ equity (deficit).

Restricted Stock Units

Beginning in September 2018, the Company began issuing RSUs to certain employees. These RSUs include a service-based vesting condition and a performance-based vesting condition. The service-based vesting condition is generally satisfied based on one of three vesting schedules: (i) vesting of one-fourth of the RSUs on the first “Company vest date” (defined as March 20, June 20, September 20, or December 20) on or following the one-year anniversary of the vesting commencement date with the remainder of the RSUs vesting in twelve equal quarterly installments thereafter, subject to continued service, (ii) vesting in sixteen equal quarterly installments beginning on December 20, 2018, subject to continued service, or (iii) vesting in eight equal quarterly installments beginning on December 20, 2022, subject to continued service. The performance-based vesting condition is satisfied on the earlier of (i) a change in control, in which the consideration paid to holders of shares is either cash, publicly traded securities, or a combination thereof, or (ii) the first Company vest date to occur following the expiration of the lock-up period upon an IPO, subject to continued service through such change in control or lock-up expiration, as applicable. None of the RSUs vest unless the performance-based vesting condition is satisfied. Upon the completion of the IPO, the performance-based vesting condition was met and the Company recognized $17.3 million of deferred expense related to RSUs as of that date in its condensed consolidated statement of operations.

Expense for RSUs that have a service-based condition only are being amortized on a straight-line basis. Expense for RSUs that have both a service-based and a performance-based condition are being amortized under the accelerated attribution method. Total unrecognized stock-based compensation expense related to unvested RSUs was $137.5 million as of October 31, 2019. This expense is expected to be amortized (subject to acceleration or straight-line basis) over a weighted-average vesting period of 2.3 years. Total unrecognized stock-based compensation expense related to unvested restricted stock units was $51.9 million as of January 31, 2019. This expense is expected to be amortized on an accelerated attribution method over a weighted-average vesting period of 2.2 years.

Performance-based Stock Units

Performance-based stock units (“PSUs”) granted under the 2019 Plan are subject to a performance-based vesting condition. PSUs generally vest over a four-year period based on the achievement of specified performance targets for the fiscal year ended January 31, 2020 and subject to continued service through the applicable vesting dates. The compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied. Based on the extent to which the performance targets are achieved, shares ultimately awarded may range from 80% to 100% of the target award amount. If the performance targets are below 80%, no shares will be awarded.

Expense for PSUs are being amortized under the accelerated attribution method. Total unrecognized stock-based compensation expense related to unvested PSUs was $3.5 million as of October 31, 2019. This expense is expected to be amortized over a weighted-average vesting period of 1.9 years.

The following table is a summary of RSU and PSU activities for the nine months ended October 31, 2019:


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
	(in thousands)
RSUs and PSUs outstanding at January 31, 2019	4,059	$	12.66
Granted	853	$	18.32
Vested	—	$	—
Forfeited	(159)	$	12.62
RSUs and PSUs outstanding at April 30, 2019	4,753	$	13.33
Granted	1,014	$	41.35
Vested	—	$	—
Forfeited	(38)	$	20.59
RSUs and PSUs outstanding at July 31, 2019	5,729	$	18.61
Granted	1,224	$	59.93
Vested	—	$	—
Forfeited	(44)	$	32.20
RSUs and PSUs outstanding at October 31, 2019	6,909	$	25.84
RSUs and PSUs expected to vest at October 31, 2019	6,909	$	25.84

Employee Stock Purchase Plan

In May 2019, the board of directors adopted, and the stockholders approved the CrowdStrike Holdings, Inc. 2019 Employee Stock Purchase Plan (“ESPP”), which became effective on June 10, 2019, which was the business day prior to the effectiveness of the Company’s registration statement on Form S-1 used in connection with the Company’s IPO. A total of 3,500,000 shares of Class A common stock were initially reserved for issuance under the ESPP. The Company’s compensation committee administers the ESPP. The number of shares of common stock available for issuance under the ESPP is subject to an annual increase on the first day of each fiscal year beginning on February 1, 2020, equal to the lesser of: (i) one percent (1%) of outstanding shares of the Company’s capital stock as of the last day of the immediately preceding fiscal year or (ii) such other amount as its board of directors may determine.

The ESPP provides for consecutive offering periods that will typically have a duration of approximately 24 months in length and is comprised of four purchase periods of approximately six months in length. The offering periods are scheduled to start on the first trading day on or after June 11 and December 11 of each year. The first offering period commenced on June 11, 2019 and is scheduled to end on the first trading day on or before June 10, 2021.

The ESPP provides eligible employees with an opportunity to purchase shares of the Company’s Class A common stock through payroll deductions of up to 15% of their eligible compensation. A participant may purchase a maximum of 2,500 shares of common stock during a purchase period. Amounts deducted and accumulated by the participant are used to purchase shares of common stock at the end of each six-month purchase period. The purchase price of the shares shall be 85% of the lower of the fair market value of the Class A common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the related offering period. Participants may end their participation at any time during an offering period and will be paid their accrued contributions that have not yet been used to purchase shares of common stock. Participation ends automatically upon termination of employment.

Employee payroll contributions ultimately used to purchase shares are reclassified to stockholders’ equity on the purchase date. ESPP employee payroll contributions accrued at October 31, 2019 totaled $10.2 million and are included within accrued compensation in the condensed consolidated balance sheets. The Company recorded stock-based compensation of $4.0 million and $6.3 million during the three and nine months ended October 31, 2019 in connection with the ESPP.

The fair value of the share purchase rights granted under the ESPP during the nine months ended October 31, 2019 was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:


			Nine Months Ended October 31,
			2019

Expected term (in years)			0.5 - 2.0
Risk-free interest rate			1.9 - 2.2%
Expected stock price volatility			33.0 - 35.7%
Dividend yield			— %

Stock-Based Compensation Expense

Stock-based compensation expense included in the condensed consolidated statements of operations is as follows:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Subscription cost of revenue	$	1,666	$	382	$	3,164	$	533
Professional services cost of revenue	784		53		1,531		156
Sales and marketing	7,355		2,137		15,511		3,941
Research and development	4,696		6,245		10,353		7,232
General and administrative	7,465		4,643		25,018		5,541
Total stock-based compensation expense	$	21,966	$	13,460	$	55,577	$	17,403

Revenue, Deferred Revenue and Remaining Performance Obligations

9 Months Ended

Oct. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue, Deferred Revenue and Remaining Performance Obligations

10. Revenue, Deferred Revenue and Remaining Performance Obligations

The following table summarizes the revenue from contracts by type of customer:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
Channel Partners	$	88,255	71	%	$	46,525	70	%	$	223,152	68	%	$	116,619	69	%
Direct Customers	36,864		29	%	19,854		30	%	106,152		32	%	52,750		31	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

The Company uses channel partners to complement direct sales and marketing efforts. The partners place an order with the Company after negotiating the order directly with an end customer. The partners negotiate pricing with the end customer and in some rare instances are responsible for certain support levels directly with the end customer. The Company’s contract is with the partner and payment to the Company is not contingent on the receipt of payment from the end customer. The Company recognizes the contractual amount charged to the partners as revenue ratably over the term of the arrangement once access to the Company’s solution has been provided to the end customer.

The Company also uses referral partners who refer customers in exchange for a referral fee. The Company negotiates pricing and contracts directly with the end customer. The Company recognizes revenue from the sales to the end customers, ratably over the term of the contract, once access to the Company’s solution has been provided to the end customer.

The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use the Company’s cloud platform:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
United States	$	92,602	74	%	$	50,366	76	%	$	245,055	74	%	$	130,659	77	%
Europe, Middle East, and Africa	17,609		14	%	8,367		13	%	46,029		14	%	19,384		11	%
Asia Pacific	9,985		8	%	4,600		7	%	24,828		8	%	12,262		7	%
Other	4,923		4	%	3,046		4	%	13,392		4	%	7,064		5	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

No single country other than the United States represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Contract Balances

Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. For the three and nine months ended October 31, 2019, the Company recognized revenue of $103.3 million and $203.7 million, respectively, that were included in the corresponding contract liability balance at the beginning of the period.

The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 - 60 days. Contract assets include amounts related to the contractual right to consideration for both completed and partially completed performance obligations that may not have been invoiced.

Changes in deferred revenue for the three and nine months ended October 31, 2019 were as follows (in thousands):


	Carrying Amount
	Three Months Ended October 31, 2019		Nine Months Ended October 31, 2019
Beginning Balance	$	369,762	$	290,067
Additions to deferred revenue	202,996		486,876
Recognition of deferred revenue	(125,119)		(329,304)
Ending Balance	$	447,639	$	447,639

Remaining Performance Obligations

The Company’s subscription contracts with its customers have a typical term of one to three years and most subscription contracts are non-cancelable. Customers typically have the right to terminate their contracts for cause as a result of the Company’s failure to perform. As of October 31, 2019, the aggregate amount of the transaction price allocated to remaining performance obligations was $577.2 million. The Company expects to recognize 71% of the remaining performance obligations in the 12 months following October 31, 2019, with the remainder to be recognized thereafter.

Costs to Obtain and Fulfill a Contract

The Company capitalizes sales commission and associated payroll taxes paid to internal sales personnel that are incremental to the acquisition of channel partner and direct customer contracts and would not have occurred absent the customer contract. These costs are recorded as deferred contract acquisition costs on the condensed consolidated balance sheet.

Sales commissions for renewal of a contract are not considered commensurate with the commissions paid for the acquisition of the initial contract or follow-on upsell given the substantive difference in commission rates in proportion to their respective contract values. Commissions, including referral fees paid to channel partners, paid upon the initial acquisition of a contract or subsequent upsell are amortized over an estimated period of benefit of four years while commissions paid for renewal contracts are amortized over the contractual term of the renewals. Sales commissions associated with professional service contracts are amortized ratably over an estimated period of benefit of six months and included in sales and marketing expense in the condensed consolidated statements of operations. In determining the period of benefit for commissions paid for the acquisition of the initial contract, the Company took into consideration the expected subscription term and expected renewals of customer contracts, the historical duration of relationships with customers, customer retention data, and the life of the developed technology. The Company periodically reviews the carrying amount of deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. The Company did not recognize any impairment losses of deferred contract acquisition costs during the three and nine months ended October 31, 2019.

The following table summarizes the activity of deferred contract acquisition costs:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)
Beginning balance	$	75,783	$	24,641	$	38,765	$	22,334
Adjustment due to adoption of ASU 606	—		—		24,306		—
Capitalization of contract acquisition costs	27,450		13,233		55,238		27,531
Amortization of deferred contract acquisition costs	(9,049)		(7,321)		(24,125)		(19,312)
Ending balance	$	94,184	$	30,553	$	94,184	$	30,553

Deferred contract acquisition costs, current	$	35,924	$	22,022	$	35,924	$	22,022
Deferred contract acquisition costs, noncurrent	58,260		8,531		58,260		8,531
Total deferred contract acquisition costs	$	94,184	$	30,553	$	94,184	$	30,553

Commitments and Contingencies

9 Months Ended

Oct. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

11. Commitments and Contingencies

Lease Commitments

The Company leases its office space under various non-cancelable operating lease agreements. Leases expire at various dates through fiscal year 2027. The aggregate future minimum payments under non-cancelable operating leases as of October 31, 2019 were as follows:


	Operating Leases
	(in thousands)
Fiscal 2020 (remaining three months)	$	2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$	47,511

Rent expense was $3.1 million and $1.8 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $7.1 million and $5.0 million during the nine months ended October 31, 2019 and October 31, 2018, respectively.

Purchase Obligations

The Company enters into long-term non-cancelable agreements with providers to purchase data center capacity, such as bandwidth and colocation space, for the Company’s cloud platform. As of October 31, 2019, the Company is committed to spend $188.5 million on such agreements through 2027. These obligations are included in purchase obligations below.

In the normal course of business, the Company enters into non-cancelable purchase commitments with various parties to purchase products and services such as technology, equipment, office renovations, corporate events, and consulting services. A summary of noncancelable purchase obligations as of October 31, 2019 with expected date of payment is as follows:


	Total Commitments
	(in thousands)
Fiscal 2020 (remaining three months)	$	27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$	226,485

Letters of Credit

As of October 31, 2019 and January 31, 2019, the Company had an unused standby letter of credit for $0.6 million and $0.5 million, respectively, securing its headquarters facility in Sunnyvale, California. As of October 31, 2019 and January 31, 2019, the Company had an unused standby letter of credit for $1.0 million and $0.8 million, respectively, securing its facility in Austin, Texas.

Litigation

The Company is currently involved in proceedings before the Trademark Trial and Appeal Board at the U.S. Patent and Trademark Office (the “USPTO”) regarding its U.S. trademark registrations for “CrowdStrike Falcon” and its U.S. application to register its “Falcon OverWatch” trademark. On November 23, 2016, Fair Isaac Corporation (“FICO”) filed a Petition for Cancellation of the Company’s “CrowdStrike Falcon” trademark registrations and a Notice of Opposition against the Company’s “Falcon OverWatch” trademark application before the USPTO, Trademark Trial and Appeal Board (“TTAB”). On January 3, 2017, the Company filed answers to both the cancellation and opposition proceedings, and the proceedings thereafter were consolidated. On November 21, 2018, the Company filed a Petition for Partial Cancellation or Amendment of one of FICO’s “Falcon” trademark registrations, and on December 10, 2018, the parties filed a joint request to consolidate the proceedings and adjust the schedule. On January 16, 2019, FICO moved to dismiss the Company’s petition, and the TTAB thereafter suspended all proceedings pending its ruling on the motions. On July 2, 2019, the TTAB issued an order granting the request to consolidate the proceedings and granting the motion to dismiss with leave to file an amended petition by July 22, 2019. The Company filed its Amended Petition for Cancellation or Amendment on July 22, 2019. On August 12, 2019, FICO moved to dismiss the Company’s Amended Petition for Cancellation. On October 1, 2019, the TTAB issued an order confirming that all proceedings were suspended as of August 12, 2019, pending disposition of the motion to dismiss. The Company is vigorously defending the case, but given the early stage, although a loss may reasonably be possible, the Company is unable to predict the likelihood of success of Fair Isaac’s claims or estimate a loss or range of loss. As a result, no liability has been recorded as of October 31, 2019 or January 31, 2019.

In addition, from time to time the Company is a party to various litigation matters and subject to claims that arise in the ordinary course of business. In addition, third parties may from time to time assert claims against the Company in the form of letters and other communications. For any claims for which the Company believes a liability is both probable and reasonably estimable, the Company records a liability in the period for which it makes this determination. There is no pending or threatened legal proceeding to which the Company is a party that, in the Company’s opinion, is likely to have a material adverse effect on its condensed consolidated financial statements; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on the Company’s business because of defense and settlement costs, diversion of management resources, and other factors. In addition, the expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect the Company’s results of operations.

Warranties and Indemnification

The Company’s cloud computing services are typically warranted to perform in a manner consistent with general industry standards that are reasonably applicable and materially in accordance with the Company’s online help documentation under normal use and circumstances.

The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if its products or services infringe a third party’s intellectual property rights. In addition, for its Falcon Complete module customers, the Company offers a limited warranty, subject to certain conditions, to cover certain costs incurred by the customer in case of a cybersecurity breach. The Company has entered into an insurance policy to cover its potential liability arising from this limited warranty arrangement. To date, the Company has not incurred any material costs because of such obligations and has not accrued any liabilities related to such obligations in the condensed consolidated financial statements.

The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that would generally enable the Company to recover a portion of any future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. No liabilities have been accrued associated with this indemnification provision as of October 31, 2019 or January 31, 2019.

Geographic Information

9 Months Ended

Oct. 31, 2019

Geographic Areas, Long-Lived Assets [Abstract]

Geographic Information

12. Geographic Information

The Company’s long-lived assets are composed of property and equipment, net, and are summarized by geographic area as follows:


	October 31, 2019		January 31, 2019
	(in thousands)
United States	$	119,760	$	70,699
International	9,744		3,036
Total property and equipment, net	$	129,504	$	73,735

Other than the United States, no other country represented 10% or more of our total property and equipment as of October 31, 2019 or January 31, 2019.

Related Party Transactions	9 Months Ended
Related Party Transactions	Oct. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	13. Related Party Transactions Subscription and Professional Services Revenue from Related Parties During the three and nine months ended October 31, 2019 and 2018, certain investors and companies with whom the Company’s Board of Directors are affiliated purchased subscriptions and professional services. The Company recorded revenue from subscriptions and professional services from related parties of $2.2 million and $1.6 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $6.8 million and $4.3 million during the nine months ended October 31, 2019 and October 31, 2018. Accounts receivable associated with these related parties was $8.0 million and $0.2 million as of October 31, 2019 and January 31, 2019, respectively. Accounts Payable to Related Parties The Company purchased goods and services totaling $0.9 million and $0.6 million, respectively, from certain investors and companies with whom its Board of Directors are affiliated during the three months ended October 31, 2019 and 2018, and $2.4 million and $1.4 million during the nine months ended October 31, 2019 and October 31, 2018. The accounts payable to such vendors was $0.2 million and less than $0.1 million as of October 31, 2019 and January 31, 2019, respectively.

Net Loss Per Share Attributable to Common Stockholders

9 Months Ended

Oct. 31, 2019

Earnings Per Share [Abstract]

Net Loss Per Share Attributable to Common Stockholders

. Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
Common Stock

Net loss attributable to common stockholders	$	—	$	(42,323)	$	—	$	(108,817)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	—		45,287		—		44,344

Net loss per share attributable to common stockholders, basic and diluted	$	—	$	(0.93)	$	—	$	(2.45)

Class A Common Stock

Net loss attributable to common stockholders	$	(3,602)	$	—	$	(9,402)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	20,703		—		10,616		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Class B Common Stock

Net loss attributable to common stockholders	$	(31,903)	$	—	$	(103,969)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	183,393		—		117,393		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Since the Company was in a net loss position for all periods presented, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been antidilutive. The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:


	October 31, 2019	October 31, 2018
	(in thousands)
Shares of common stock issuable upon conversion of redeemable convertible preferred stock	—	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants	—	336
Shares of common stock subject to repurchase from outstanding stock options	1,128	712
Restricted stock awards subject to future vesting	6,909	28
Shares of common stock issuable from stock options	20,701	26,150
Potential common shares excluded from diluted net loss per share	28,738	158,494

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation

Principles of Consolidation

JOBS Act Accounting Election

Use of Estimates

Concentration of Credit Risk and Geographic Information

There were no direct customers who represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Cash and Cash Equivalents

Cash Equivalents and Marketable Securities

Strategic Investments

The Company has elected the measurement alternative for the non-marketable equity investments of the Falcon Fund. Under the measurement alternative, the equity investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The non-marketable equity investments of the Falcon Fund will be valued using significant unobservable inputs or data in inactive markets which require judgment due to the absence of market prices and inherent lack of liquidity. As a result, there could be volatility in the Company’s consolidated statements of operations in future periods due to the valuation and timing of identical or similar investments of the same issuer.

Fair Value of Financial Instruments

Accounts Receivable and Allowance for Doubtful Accounts

Deferred Offering Costs

Property and Equipment, Net


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Capitalized Internal Use Software

Capitalized Internal-Use Software

Intangible Assets, Net

Deferred Contract Acquisition Costs

Deferred Contract Acquisition CostsThe Company capitalizes contract acquisition costs that are incremental to the acquisition of customer contracts. Contract acquisition costs are accrued and capitalized upon execution of the sales contract by the customer. Sales commissions for renewal of a contract are not considered commensurate with the commissions paid for the acquisition of the initial contract or follow-on upsell given the substantive difference in commission rates in proportion to their respective contract values. Commissions, including referral fees paid to channel partners, paid upon the initial acquisition of a contract or subsequent upsell are amortized over an estimated period of benefit of four years while commissions paid for renewal contracts are amortized over the contractual term of the renewals. Sales commissions associated with professional service contract are amortized ratably over an estimated period of benefit of six months. The Company capitalized contract acquisition costs of $27.4 million, which is under ASC606, and $13.2 million, which is under ASC 605, during the three months ended October 31, 2019 and October 31, 2018, respectively, and $55.2 million, which is under ASC 606, and $27.5 million, which is under ASC 605, during the nine months ended October 31, 2019 and October 31, 2018, respectively. Contract acquisition cost amortization expense was $9.0 million, which is under ASC 606, and $7.3 million, which was under ASC 605, during the three months ended October 31, 2019 and October 31, 2018, respectively, and $24.1 million, which is under ASC 606, and $19.3 million, which was under ASC 605, during the nine months ended October 31, 2019 and October 31, 2018, respectively

Impairment of Long Lived Assets

Impairment of Long-Lived Assets

Deferred Revenue

Redeemable Convertible Preferred Stock Warrants

Revenue Recognition - ASC 606

Revenue Recognition – ASC 606

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

1)Identify the contract with a customer

2)Identify the performance obligations in the contract

3)Determine the transaction price

4)Allocate the transaction price to performance obligations in the contract

5)Recognize revenue when or as performance obligations are satisfied

Subscription Revenue

Professional Services Revenue

Contracts with Multiple Performance Obligations

Variable Consideration

Revenue Recognition - ASC 605

Revenue Recognition – ASC 605

Research and Development Expense

Advertising

Stock Based Compensation

Stock-Based Compensation

Business Combinations

Goodwill and Intangible Assets

Leases

Foreign Currency Translation

Income Taxes

Sales Taxes

Segment and Geographic Information

Net Loss per Share

Recently Issued and Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Summary of estimated useful lives of the assets


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Summary of the effect of the adoption of Topic 606

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

Fair Value Measurements and Marketable Securities (Tables)

9 Months Ended

Oct. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis

The Company’s fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis are as follows:


	October 31, 2019														January 31, 2019
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	(in thousands)														(in thousands)
Assets
Cash equivalents⁽¹⁾
Money market funds	$	693,258	$	—	$	—	$	693,258	$	42,132	$	—	$	—	$	42,132
Corporate debt securities	—		8,598		—		8,598		—		27,941		—		27,941
Total cash equivalents	693,258		8,598		—		701,856		42,132		27,941		—		70,073
Marketable securities
Corporate debt securities	—		76,154		—		76,154		—		91,796		—		91,796
U.S. treasury securities	13,929		—		—		13,929		11,451		—		—		11,451
Total marketable securities	13,929		76,154		—		90,083		11,451		91,796		—		103,247
Total assets	$	707,187	$	84,752	$	—	$	791,939	$	53,583	$	119,737	$	—	$	173,320
Liability
Contingent consideration related to business combinations⁽²⁾	$	—	$	—	$	—	$	—	$	—	$	—	$	474	$	474
Redeemable convertible preferred stock warrant liability ⁽³⁾	—		—		—		—		—		—		4,537		4,537
Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—	$	5,011	$	5,011

__________________________________

(1)Included in “Cash and cash equivalents” on the condensed consolidated balance sheets.

Summary of changes in the redeemable convertible preferred stock warrant liability

The following summarizes the changes in the redeemable convertible preferred stock warrant liability, which is classified as a Level 3 instrument:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Balance at beginning of period	$	—	$	3,016	$	4,537	$	961
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	—		880		6,022		2,935
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	—		—		(10,559)		—
Balance at end of period	$	—	$	3,896	$	—	$	3,896

Balance Sheet Components (Tables)

9 Months Ended

Oct. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Summary of prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Prepaid expenses	$	20,515	$	5,982
Prepaid software licenses	14,793		8,408
Other current assets	2,606		1,105
Prepaid hosting services	—		2,915
Prepaid expenses and other current assets	$	37,914	$	18,410

Summary of property and equipment, net

Property and equipment, net consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Data center and other computer equipment	$	67,764	$	44,735
Capitalized internal-use software	27,928		22,209
Leasehold improvements	10,313		10,011
Purchased software	2,557		1,460
Furniture and equipment	3,883		2,553
Construction in process	59,739		19,455
	172,184		100,423
Less: Accumulated depreciation and amortization	(42,680)		(26,688)
Property and equipment, net	$	129,504	$	73,735

Schedule of total intangible assets, net

Total intangible assets, net consisted of the following:


	October 31, 2019		January 31, 2019		Weighted-Average Remaining Useful Life
	(in thousands)					(in months)
Developed technology	$	1,248	$	1,269	12
Customer relationships	615		632		36
Non-compete agreement	123		126		12
	1,986		2,027
Less: Accumulated amortization	(1,349)		(979)
Intangible assets, net	$	637	$	1,048

Schedule of estimated aggregate future amortization expense of intangible assets

The estimated aggregate future amortization expense of intangible assets as of October 31, 2019 is as follows:


	Total
	(in thousands)
Fiscal 2020 (remaining three months)	$	104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	—
Total amortization expense	$	637

Summary of accrued expenses

Accrued expenses consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Web hosting services	$	13,141	$	12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042

Accrued expenses	$	29,460	$	32,541

Summary of accrued payroll and benefits

Accrued payroll and benefits consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Accrued commissions	$	15,290	$	9,499
Employee Stock Purchase Plan	10,236		—
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$	36,905	$	19,284

Redeemable Convertible Preferred Stock (Tables)

9 Months Ended

Oct. 31, 2019

Temporary Equity Disclosure [Abstract]

Schedule of Redeemable Convertible Preferred Stock

The following table summarizes the authorized, issued, and outstanding redeemable convertible preferred stock of the Company as of January 31, 2019:


Class	Issue Price per Share		Shares Authorized	Shares Issued and Outstanding	Net Carrying Value		Liquidation Preference		Redemption Value
	(in thousands, except per share values)
Series A-1	$	0.50000	52,300	52,300	$	76,325	$	52,300	$	623,678
Series B	$	1.40500	21,523	21,352	44,320		30,000		254,623
Series C	$	4.52972	22,275	22,077	99,900		100,000		263,765
Series D	$	5.69153	17,570	17,570	99,845		125,000		211,631
Series D-1	$	5.69153	5,394	5,394	30,626		30,700		64,607
Series E	$	16.46136	18,357	12,575	206,896		207,000		207,000
Total			137,419	131,268	$	557,912	$	545,000	$	1,625,304

Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock option activity

The following table is a summary of stock option activity for the nine months ended October 31, 2019:


	Number of Shares	Weighted-Average Exercise Price Per Share
	(in thousands)
Options outstanding at January 31, 2019	26,535	$	3.87
Granted	880	$	14.65
Exercised	(706)	$	2.14
Canceled	(509)	$	7.34
Options outstanding at April 30, 2019	26,200	$	4.21
Granted	168	$	34.00
Exercised	(4,776)	$	3.62
Canceled	(325)	$	5.06
Options outstanding at July 31, 2019	21,267	$	4.56
Granted	—	$	—
Exercised	(286)	$	2.90
Canceled	(280)	$	7.40
Options outstanding at October 31, 2019	20,701	$	4.55
Options vested and expected to vest at October 31, 2019	20,701	$	4.55
Options exercisable at October 31, 2019	11,871	$	2.30

Schedule of restricted stock units

The following table is a summary of RSU and PSU activities for the nine months ended October 31, 2019:


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
	(in thousands)
RSUs and PSUs outstanding at January 31, 2019	4,059	$	12.66
Granted	853	$	18.32
Vested	—	$	—
Forfeited	(159)	$	12.62
RSUs and PSUs outstanding at April 30, 2019	4,753	$	13.33
Granted	1,014	$	41.35
Vested	—	$	—
Forfeited	(38)	$	20.59
RSUs and PSUs outstanding at July 31, 2019	5,729	$	18.61
Granted	1,224	$	59.93
Vested	—	$	—
Forfeited	(44)	$	32.20
RSUs and PSUs outstanding at October 31, 2019	6,909	$	25.84
RSUs and PSUs expected to vest at October 31, 2019	6,909	$	25.84

Schedule of stock-based compensation expense

Stock-based compensation expense included in the condensed consolidated statements of operations is as follows:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Subscription cost of revenue	$	1,666	$	382	$	3,164	$	533
Professional services cost of revenue	784		53		1,531		156
Sales and marketing	7,355		2,137		15,511		3,941
Research and development	4,696		6,245		10,353		7,232
General and administrative	7,465		4,643		25,018		5,541
Total stock-based compensation expense	$	21,966	$	13,460	$	55,577	$	17,403

Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value on date of grant


			Nine Months Ended October 31,
			2019

Expected term (in years)			0.5 - 2.0
Risk-free interest rate			1.9 - 2.2%
Expected stock price volatility			33.0 - 35.7%
Dividend yield			— %

Stock options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value on date of grant

The fair value of each option was estimated on the date of grant using the following assumptions during the period:


	Nine Months Ended October 31,
	2019	2018

Expected term (in years)	6.05	6.05 - 7.52
Risk-free interest rate	2.0% - 2.4%	2.6% - 3.1%
Expected stock price volatility	37.7% - 37.9%	37.8% - 38.9%
Dividend yield	— %	— %

Revenue, Deferred Revenue and Remaining Performance Obligations (Tables)

9 Months Ended

Oct. 31, 2019

Revenue from Contract with Customer [Abstract]

Summary of revenue from contracts by type of customer

The following table summarizes the revenue from contracts by type of customer:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
Channel Partners	$	88,255	71	%	$	46,525	70	%	$	223,152	68	%	$	116,619	69	%
Direct Customers	36,864		29	%	19,854		30	%	106,152		32	%	52,750		31	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

Summary of revenue by region based on the shipping address of customers

The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use the Company’s cloud platform:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
United States	$	92,602	74	%	$	50,366	76	%	$	245,055	74	%	$	130,659	77	%
Europe, Middle East, and Africa	17,609		14	%	8,367		13	%	46,029		14	%	19,384		11	%
Asia Pacific	9,985		8	%	4,600		7	%	24,828		8	%	12,262		7	%
Other	4,923		4	%	3,046		4	%	13,392		4	%	7,064		5	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

Summary of changes in deferred revenue

Changes in deferred revenue for the three and nine months ended October 31, 2019 were as follows (in thousands):


	Carrying Amount
	Three Months Ended October 31, 2019		Nine Months Ended October 31, 2019
Beginning Balance	$	369,762	$	290,067
Additions to deferred revenue	202,996		486,876
Recognition of deferred revenue	(125,119)		(329,304)
Ending Balance	$	447,639	$	447,639

Summary of the activity of deferred contract acquisition costs

The following table summarizes the activity of deferred contract acquisition costs:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)
Beginning balance	$	75,783	$	24,641	$	38,765	$	22,334
Adjustment due to adoption of ASU 606	—		—		24,306		—
Capitalization of contract acquisition costs	27,450		13,233		55,238		27,531
Amortization of deferred contract acquisition costs	(9,049)		(7,321)		(24,125)		(19,312)
Ending balance	$	94,184	$	30,553	$	94,184	$	30,553

Deferred contract acquisition costs, current	$	35,924	$	22,022	$	35,924	$	22,022
Deferred contract acquisition costs, noncurrent	58,260		8,531		58,260		8,531
Total deferred contract acquisition costs	$	94,184	$	30,553	$	94,184	$	30,553

Commitments and Contingencies (Tables)

9 Months Ended

Oct. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Summary of future minimum payments under noncancelable operating leases


	Operating Leases
	(in thousands)
Fiscal 2020 (remaining three months)	$	2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$	47,511

Summary of noncancelable purchase obligations

A summary of noncancelable purchase obligations as of October 31, 2019 with expected date of payment is as follows:


	Total Commitments
	(in thousands)
Fiscal 2020 (remaining three months)	$	27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$	226,485

Geographic Information (Tables)

9 Months Ended

Oct. 31, 2019

Geographic Areas, Long-Lived Assets [Abstract]

Summary by geographic area of company's long lived assets

The Company’s long-lived assets are composed of property and equipment, net, and are summarized by geographic area as follows:


	October 31, 2019		January 31, 2019
	(in thousands)
United States	$	119,760	$	70,699
International	9,744		3,036
Total property and equipment, net	$	129,504	$	73,735

Net Loss Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Oct. 31, 2019

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net loss per share attributable to common stockholders"

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
Common Stock

Net loss attributable to common stockholders	$	—	$	(42,323)	$	—	$	(108,817)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	—		45,287		—		44,344

Net loss per share attributable to common stockholders, basic and diluted	$	—	$	(0.93)	$	—	$	(2.45)

Class A Common Stock

Net loss attributable to common stockholders	$	(3,602)	$	—	$	(9,402)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	20,703		—		10,616		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Class B Common Stock

Net loss attributable to common stockholders	$	(31,903)	$	—	$	(103,969)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	183,393		—		117,393		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:


	October 31, 2019	October 31, 2018
	(in thousands)
Shares of common stock issuable upon conversion of redeemable convertible preferred stock	—	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants	—	336
Shares of common stock subject to repurchase from outstanding stock options	1,128	712
Restricted stock awards subject to future vesting	6,909	28
Shares of common stock issuable from stock options	20,701	26,150
Potential common shares excluded from diluted net loss per share	28,738	158,494

Description of Business and Basis of Presentation (Details) $ / shares in Units, $ in Thousands		9 Months Ended
	Jun. 14, 2019 USD ($) $ / shares shares	Oct. 31, 2019 USD ($) modules	Oct. 31, 2018 USD ($)
Description of Business and Basis of Presentation
Number of cloud modules \| modules		10
Net proceeds from issuance of common stock from IPO \| $		$ 665,092	$ 0
Class A common stock \| IPO
Description of Business and Basis of Presentation
Common stock issued (in shares) \| shares	20,700,000
Public offering price (in usd per share) \| $ / shares	$ 34.00
Net proceeds from issuance of common stock from IPO \| $	$ 659,200
Underwriters' discounts and commissions and estimated offering expenses \| $	$ 44,800
Common stock conversion ratio	1
Class B common stock \| IPO
Description of Business and Basis of Presentation
Number of shares issued in conversion of common stock (in shares) \| shares	131,267,586
Common stock conversion ratio	1
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1

Summary of Significant Accounting Policies (Details)			1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Jun. 14, 2019 USD ($) shares	Feb. 01, 2019 USD ($)	Jul. 31, 2019 USD ($)	Sep. 30, 2018 unit_Standard_installment unit_Standard_tranche	Oct. 31, 2019 USD ($) unit_Standard_Distributor	Oct. 31, 2018 USD ($) unit_Standard_Distributor	Oct. 31, 2019 USD ($) unit_Standard_Distributor unit_Standard_item unit_Standard_installment segment	Oct. 31, 2018 USD ($) unit_Standard_Distributor	Jan. 31, 2019 USD ($) unit_Standard_customer
Concentration Risk [Line Items]
Allowance for doubtful accounts					$ 1,400,000		$ 1,400,000		$ 1,000,000.0
Deferred offering costs		$ 3,000,000.0							2,900,000
Payments of deferred offering costs							$ 5,872,000	$ 0
Estimated economic lives							5 years
Impairments of internal use software					0	$ 0
Capitalized amount of internal use software					2,200,000	1,800,000	$ 5,700,000	5,000,000.0
Amortization expense associated with internal use software					1,600,000	1,200,000	4,600,000	3,500,000
Net book value of capitalized internal use software					12,600,000		$ 12,600,000		$ 11,500,000
Commission amortization period							4 years
Professional services contract amortization							6 months
Capitalization of contract acquisition costs					27,450,000	13,233,000	$ 55,238,000	27,531,000
Contract acquisition cost amortization expense					9,000,000.0	7,300,000	24,100,000	19,300,000
Impairment losses of long lived assets					$ 0	0	$ 0	0
Subscription term					12 months		12 months
Advertising costs					$ 2,200,000	1,500,000	$ 5,500,000	2,600,000
Vesting period							4 years
Number of reporting units \| unit_Standard_item							1
Goodwill impairment					0	0	$ 0	0
Income tax expense					434,000	535,000	$ 1,664,000	1,018,000
Number of operating segments \| segment							1
Number of reportable segments \| segment							1
ASC 2014-09
Concentration Risk [Line Items]
Cumulative effect adjustment to opening accumulated deficit, net of tax		23,400,000
Reduction in the amortization of deferred contract acquisition costs		23,700,000
ASC 2014-09 \| Impact of Adoption
Concentration Risk [Line Items]
Reduction in revenue		$ 300,000
Adjustment
Concentration Risk [Line Items]
Income tax expense					0	$ 0	$ 0	$ 0
Service-based vesting
Concentration Risk [Line Items]
Number of vesting schedules				3			3
Service-based vesting \| Vesting one
Concentration Risk [Line Items]
Vesting percentage							25.00%
Number of quarterly installments \| unit_Standard_installment				12			12
Service-based vesting \| Vesting two
Concentration Risk [Line Items]
Number of quarterly installments \| unit_Standard_installment				16			16
Service-based vesting \| Vesting three
Concentration Risk [Line Items]
Number of quarterly installments \| unit_Standard_installment				8			8
Performance-based vesting
Concentration Risk [Line Items]
Stock-based compensation expense deferred	$ 17,300,000
Capitalized internal-use software
Concentration Risk [Line Items]
Estimated economic lives							3 years
Class B common stock
Concentration Risk [Line Items]
Shares issued upon conversion of warrants (in shares) \| shares	336,386
Shares issued (in shares) \| shares	322,278
IPO \| Class B common stock
Concentration Risk [Line Items]
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1
FalconFund
Concentration Risk [Line Items]
Sharing percentage of distributions by the fund			50.00%
Duration of fund			10 years
Extendable term of fund			3 years
Net assets					$ 0		$ 0
Minimum
Concentration Risk [Line Items]
Estimated economic lives							3 years
Subscription fees payable term (in days)							30 days
Subscription term					1 year		1 year
Maximum
Concentration Risk [Line Items]
Subscription fees payable term (in days)							60 days
Subscription term					3 years		3 years
Maximum \| FalconFund
Concentration Risk [Line Items]
Amount agreed to commit			$ 10,000,000.0
Accel \| FalconFund
Concentration Risk [Line Items]
Sharing percentage of distributions by the fund			50.00%
Accel \| Minimum
Concentration Risk [Line Items]
Percentage of capital stock held			5.00%
Accel \| Maximum \| FalconFund
Concentration Risk [Line Items]
Amount agreed to commit			$ 10,000,000.0
Channel partners \| Revenue
Concentration Risk [Line Items]
Concentration risk, percentage					10.00%	15.00%	11.00%	17.00%
Number of distributors \| unit_Standard_Distributor					1	1	1	1
Customers \| Accounts receivable
Concentration Risk [Line Items]
Number of customers \| unit_Standard_customer									2
Customers \| Accounts receivable \| Customer 1
Concentration Risk [Line Items]
Concentration risk, percentage									10.00%
Customers \| Accounts receivable \| Customer 2
Concentration Risk [Line Items]
Concentration risk, percentage									19.00%

Summary of Significant Accounting Policies - Property and Equipment, Net (Details)	9 Months Ended
	Oct. 31, 2019
Data center and other computer equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Data center and other computer equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Furniture and equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Purchased software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Purchased software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years

Summary of Significant Accounting Policies - Revenue Recognition - ASC 606 (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Feb. 01, 2019	Jan. 31, 2019
Assets:
Deferred contract acquisition costs, current	$ 35,924	$ 22,022	$ 35,924	$ 22,022	$ 22,816	$ 28,847
Deferred contract acquisition costs, noncurrent	58,260	8,531	58,260	8,531	40,255	9,918
Liabilities:
Accrued expenses	29,460		29,460		33,096	32,541
Deferred revenue, current	335,801		335,801		219,033	218,700
Stockholders' Equity:
Accumulated deficit	(609,079)		(609,079)		$ (495,708)	(519,126)
Condensed Consolidated Statement of Operations
Total revenue	125,119	66,379	329,304	169,369
Operating expenses
Sales and marketing	68,675	46,614	190,792	123,344
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Net loss per share, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Without Adoption (ASC 605)
Assets:
Deferred contract acquisition costs, current	$ 38,750		$ 38,750			28,847
Deferred contract acquisition costs, noncurrent	15,767		15,767			9,918
Liabilities:
Accrued expenses	29,117		29,117			32,541
Deferred revenue, current	335,662		335,662			218,700
Stockholders' Equity:
Accumulated deficit	(648,264)		(648,264)			(519,126)
Condensed Consolidated Statement of Operations
Total revenue	125,091		329,111
Operating expenses
Sales and marketing	75,412		206,366
Net loss	$ (42,270)		$ (129,138)
Net loss per share, basic and diluted (in usd per share)	$ (0.21)		$ (1.01)
ASC 2014-09 \| Impact of Adoption
Assets:
Deferred contract acquisition costs, current	$ 2,826		$ 2,826			(6,031)
Deferred contract acquisition costs, noncurrent	(42,493)		(42,493)			30,337
Liabilities:
Accrued expenses	(343)		(343)			555
Deferred revenue, current	(139)		(139)			333
Stockholders' Equity:
Accumulated deficit	(39,185)		(39,185)			$ 23,418
Condensed Consolidated Statement of Operations
Total revenue	(28)		(193)
Operating expenses
Sales and marketing	6,737		15,574
Net loss	$ (6,765)		$ (15,767)

Fair Value Measurements and Marketable Securities - Financial Assets and Liabilities (Details) $ in Thousands		3 Months Ended	9 Months Ended
	Jun. 14, 2019 shares	Apr. 30, 2019 USD ($)	Oct. 31, 2019 USD ($) unit_Standard_item	Jan. 31, 2019 USD ($)
Assets
Marketable securities			$ 90,083	$ 103,247
Liability
Number of probability adjusted milestone payments \| unit_Standard_item			3
Probability adjusted milestone payment amount			$ 200
First milestone payment				200
Write-off of contingent consideration		$ 500
Class B common stock
Liability
Shares issued upon conversion of warrants (in shares) \| shares	336,386
Shares issued (in shares) \| shares	322,278
Class B common stock \| IPO
Liability
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1
Discount rate \| Minimum
Liability
Business combination, measurement input			3
Discount rate \| Maximum
Liability
Business combination, measurement input			3.02
Recurring
Assets
Cash equivalents			$ 701,856	70,073
Marketable securities			90,083	103,247
Total assets			791,939	173,320
Liability
Contingent consideration related to business combinations				474
Redeemable convertible preferred stock warrant liability				4,537
Total liabilities				5,011
Recurring \| Money market funds
Assets
Cash equivalents			693,258	42,132
Recurring \| Corporate debt securities
Assets
Cash equivalents			8,598	27,941
Marketable securities			76,154	91,796
Recurring \| U.S. treasury securities
Assets
Marketable securities			13,929	11,451
Level 1 \| Recurring
Assets
Cash equivalents			693,258	42,132
Marketable securities			13,929	11,451
Total assets			707,187	53,583
Level 1 \| Recurring \| Money market funds
Assets
Cash equivalents			693,258	42,132
Level 1 \| Recurring \| U.S. treasury securities
Assets
Marketable securities			13,929	11,451
Level 2 \| Recurring
Assets
Cash equivalents			8,598	27,941
Marketable securities			76,154	91,796
Total assets			84,752	119,737
Level 2 \| Recurring \| Corporate debt securities
Assets
Cash equivalents			8,598	27,941
Marketable securities			$ 76,154	91,796
Level 3 \| Recurring
Liability
Contingent consideration related to business combinations				474
Redeemable convertible preferred stock warrant liability				4,537
Total liabilities				$ 5,011

Fair Value Measurements and Marketable Securities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Fair Value Disclosures [Abstract]
Other-than-temporary impairments			$ 0
Remaining contractual maturities of marketable securities			1 year
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	$ 0	$ (900,000)	$ (6,000,000.0)	$ (2,900,000)

Fair Value Measurements and Marketable Securities - Redeemable convertible preferred stock warrant liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	$ 0	$ (900,000)	$ (6,000,000.0)	$ (2,900,000)
Level 3 \| Redeemable convertible preferred stock warrant
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	0	3,016,000	4,537,000	961,000
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	0	880,000	6,022,000	2,935,000
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	0		(10,559,000)
Balance at end of period	$ 0	$ 3,896,000	$ 0	$ 3,896,000

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 20,515	$ 5,982
Prepaid software licenses	14,793	8,408
Other current assets	2,606	1,105
Prepaid hosting services	0	2,915
Prepaid expenses and other current assets	$ 37,914	$ 18,410

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Property and Equipment, Net
Property, Plant and Equipment, Gross	$ 172,184	$ 100,423
Less: Accumulated depreciation and amortization	(42,680)	(26,688)
Property and equipment, net	129,504	73,735
Data center and other computer equipment
Property and Equipment, Net
Property, Plant and Equipment, Gross	67,764	44,735
Capitalized internal-use software
Property and Equipment, Net
Property, Plant and Equipment, Gross	27,928	22,209
Leasehold improvements
Property and Equipment, Net
Property, Plant and Equipment, Gross	10,313	10,011
Purchased software
Property and Equipment, Net
Property, Plant and Equipment, Gross	2,557	1,460
Furniture and equipment
Property and Equipment, Net
Property, Plant and Equipment, Gross	3,883	2,553
Construction in process
Property and Equipment, Net
Property, Plant and Equipment, Gross	$ 59,739	$ 19,455

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Depreciation and amortization	$ 5,800	$ 3,800	$ 16,023	$ 10,199
Amortization of intangible assets	$ 100	$ 100	$ 385	$ 435
Useful lives			5 years
Developed technology
Finite-Lived Intangible Assets [Line Items]
Useful lives			3 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful lives			5 years
Non-compete agreement
Finite-Lived Intangible Assets [Line Items]
Useful lives			3 years
Data center and other computer equipment
Finite-Lived Intangible Assets [Line Items]
Purchases			$ 57,000

Balance Sheet Components - Intangible Assets, Net (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2019	Jan. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 1,986	$ 2,027
Less: Accumulated amortization	(1,349)	(979)
Intangible assets, net	637	1,048
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 1,248	1,269
Weighted-Average Remaining Useful Life	12 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 615	632
Weighted-Average Remaining Useful Life	36 months
Non-compete agreement
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 123	$ 126
Weighted-Average Remaining Useful Life	12 months

Balance Sheet Components - Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	0
Intangible assets, net	$ 637	$ 1,048

Balance Sheet Components - Accrued Expenses (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Feb. 01, 2019	Jan. 31, 2019
Accrued Expenses
Web hosting services	$ 13,141		$ 12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042
Accrued expenses	29,460	$ 33,096	32,541
Accrued Payroll and Benefits
Accrued commissions	15,290		9,499
Employee Stock Purchase Plan	10,236		0
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$ 36,905		$ 19,284

Secured Revolving Credit Facility (Details)	1 Months Ended
Secured Revolving Credit Facility (Details)	Apr. 30, 2019 USD ($) unit_Standard_item	Oct. 31, 2019 USD ($)	Jan. 31, 2019 USD ($)
Minimum
Line of Credit Facility [Line Items]
Commitment fee (as a percent)	0.20%
Maximum
Line of Credit Facility [Line Items]
Commitment fee (as a percent)	0.30%
Revolving line of credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000.0
Incremental borrowing facility	$ 75,000,000.0
Borrowing facility multiple factor - first year \| unit_Standard_item	6
Borrowing facility multiple factor - second year \| unit_Standard_item	5
Borrowing facility multiple factor - thereafter	4
Amount outstanding		$ 0	$ 0
Letter of credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 10,000,000.0
Swingline
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 10,000,000.0
Eurodollar Loans \| LIBOR \| Minimum
Line of Credit Facility [Line Items]
Margin (as a percent)	2.50%
Eurodollar Loans \| LIBOR \| Maximum
Line of Credit Facility [Line Items]
Margin (as a percent)	3.00%
ABR Loans \| Federal funds rate
Line of Credit Facility [Line Items]
Margin (as a percent)	0.50%
ABR Loans \| Eurodollar Rate
Line of Credit Facility [Line Items]
Margin (as a percent)	1.00%
ABR Loans \| Eurodollar Rate \| Minimum
Line of Credit Facility [Line Items]
Margin (as a percent)	1.50%
ABR Loans \| Eurodollar Rate \| Maximum
Line of Credit Facility [Line Items]
Margin (as a percent)	2.00%

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Income Tax Disclosure [Abstract]
Income tax expense	$ 434	$ 535	$ 1,664	$ 1,018
Effective tax rate (as a percent)	(1.24%)	(1.28%)	(1.48%)	(0.94%)

Redeemable Convertible Preferred Stock - Conversion (Details) $ in Thousands			9 Months Ended
	Jun. 14, 2019 USD ($) shares	Jun. 13, 2019	Oct. 31, 2019 USD ($)	Oct. 31, 2018 USD ($)
Redeemable Convertible Preferred Stock
Value of converted shares			$ 557,912	$ 0
IPO \| Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
Number of shares converted (in shares) \| shares	131,267,586
Preferred stock conversion ratio		1
Value of converted shares	$ 557,900

Redeemable Convertible Preferred Stock (Details) - USD ($)	Oct. 31, 2019	Jan. 31, 2019
Redeemable Convertible Preferred Stock
Shares Authorized (in shares)	0	137,419,000
Shares Issued (in shares)	0	131,268,000
Net Carrying Value		$ 557,912,000
Liquidation Preference	$ 0	545,000,000
Redemption Value		$ 1,625,304,000
Series A-1
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 0.50000
Shares Authorized (in shares)		52,300,000
Shares Issued (in shares)		52,300,000
Net Carrying Value		$ 76,325,000
Liquidation Preference		52,300,000
Redemption Value		$ 623,678,000
Series B
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 1.40500
Shares Authorized (in shares)		21,523,000
Shares Issued (in shares)		21,352,000
Net Carrying Value		$ 44,320,000
Liquidation Preference		30,000,000
Redemption Value		$ 254,623,000
Series C
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 4.52972
Shares Authorized (in shares)		22,275,000
Shares Issued (in shares)		22,077,000
Net Carrying Value		$ 99,900,000
Liquidation Preference		100,000,000
Redemption Value		$ 263,765,000
Series D
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 5.69153
Shares Authorized (in shares)		17,570,000
Shares Issued (in shares)		17,570,000
Net Carrying Value		$ 99,845,000
Liquidation Preference		125,000,000
Redemption Value		$ 211,631,000
Series D-1
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 5.69153
Shares Authorized (in shares)		5,394,000
Shares Issued (in shares)		5,394,000
Net Carrying Value		$ 30,626,000
Liquidation Preference		30,700,000
Redemption Value		$ 64,607,000
Series E
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 16.46136
Shares Authorized (in shares)		18,357,000
Shares Issued (in shares)		12,575,000
Net Carrying Value		$ 206,896,000
Liquidation Preference		207,000,000
Redemption Value		$ 207,000,000

Common Stock (Details)	Jun. 14, 2019 unit_Standard_Vote $ / shares shares	Oct. 31, 2019 $ / shares shares	Jan. 31, 2019 $ / shares shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		0	220,000,000
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Preferred stock, shares authorized (in shares) \| shares		100,000,000	0
Preferred stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Class A common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		2,000,000,000	0
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Class B common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		300,000,000	0
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
IPO
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares) \| shares	100,000,000
Preferred stock, par value (in usd per share) \| $ / shares	$ 0.0005
IPO \| Class A common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares	2,000,000,000
Common stock, par value (in usd per share) \| $ / shares	$ 0.0005
Number of votes per share \| unit_Standard_Vote	1
Common stock conversion ratio	1
IPO \| Class B common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares	300,000,000
Common stock, par value (in usd per share) \| $ / shares	$ 0.0005
Number of votes per share \| unit_Standard_Vote	10
Common stock conversion ratio	1

Stock-Based Compensation (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended				9 Months Ended		12 Months Ended
	May 31, 2019 unit_Standard_item shares	Sep. 30, 2018 unit_Standard_installment unit_Standard_tranche	Oct. 31, 2019 USD ($) shares	Jul. 31, 2019 shares	Apr. 30, 2019 shares	Oct. 31, 2018 USD ($) $ / shares	Oct. 31, 2019 USD ($) unit_Standard_installment $ / shares shares	Oct. 31, 2018 USD ($) $ / shares	Jan. 31, 2019 USD ($) shares	Jun. 14, 2019 USD ($)
Stock Based Compensation
Vesting period							4 years
Number of shares to be vested \| shares							0
Employee payroll contributions accrued			$ 36,905				$ 36,905		$ 19,284
Stock-based compensation			21,966			$ 13,460	55,577	$ 17,403
2019 Plan \| Class A common stock
Stock Based Compensation
Maximum number of shares of common stock that may be issued (in shares) \| shares	8,750,000
Threshold percentage of outstanding shares	2.00%
Employee Stock Purchase Plan
Stock Based Compensation
Threshold percentage of outstanding shares	1.00%
Offering period	24 months
Number of purchase periods \| unit_Standard_item	4
Duration of purchase periods	6 months
Percentage of eligible compensation	15.00%
Maximum number of shares each participant can purchase during purchase period (in shares) \| shares	2,500
Purchase price, threshold percentage of fair market value	85.00%
Employee payroll contributions accrued			10,200				10,200
Stock-based compensation			$ 4,000				$ 6,300
Employee Stock Purchase Plan \| Class A common stock
Stock Based Compensation
Maximum number of shares of common stock that may be issued (in shares) \| shares	3,500,000
Service-based vesting
Stock Based Compensation
Number of vesting schedules		3					3
Stock options
Stock Based Compensation
Options unvested (in shares) \| shares			982,200				982,200
Aggregate intrinsic value of options vested and exercisable			$ 608,900				$ 608,900		$ 181,100
Weighted-average remaining contractual term of options vested and exercisable (in years)							6 years 4 months 24 days		7 years 1 month 6 days
Options granted (in shares) \| shares			0	168,000	880,000
Weighted-average grant date fair value of options granted (in usd per share) \| $ / shares						$ 5.81	$ 9.51	$ 5.59
Total intrinsic value of options exercised			$ 17,300			$ 13,400	$ 107,000	$ 21,000
Aggregate intrinsic value of stock options outstanding			939,000				$ 939,000		$ 286,100
Weighted-average remaining contractual term of stock options outstanding (in years)							7 years 3 months 18 days		7 years 10 months 24 days
Total unrecognized stock-based compensation expenses related to unvested options			$ 39,100				$ 39,100		$ 45,800
Expected to be amortized over weighted-average vesting period (in years)							2 years 3 months 18 days		3 years 4 months 24 days
Shares issued for exercise of stock options (in shares) \| shares			0				1,037,356
Number of shares of common stock related to early exercised stock options subject to repurchase (in shares) \| shares			1,127,811				1,127,811		545,941
Value of common stock related to early exercised stock options subject to repurchase			$ 9,600				$ 9,600		$ 1,200
Performance-based vesting
Stock Based Compensation
Stock-based compensation expense deferred										$ 17,300
RSUs
Stock Based Compensation
Expected to be amortized over weighted-average vesting period (in years)							2 years 3 months 18 days		2 years 2 months 12 days
Total unrecognized stock-based compensation expenses related to unvested RSUs			$ 137,500				$ 137,500		$ 51,900
PSUs
Stock Based Compensation
Expected to be amortized over weighted-average vesting period (in years)			1 year 10 months 24 days
Total unrecognized stock-based compensation expenses related to unvested RSUs			$ 3,500				$ 3,500
Vesting period							4 years
PSUs \| Minimum
Stock Based Compensation
Vesting percentage							80.00%
PSUs \| Maximum
Stock Based Compensation
Vesting percentage							100.00%
Vesting one \| Service-based vesting
Stock Based Compensation
Vesting percentage							25.00%
Number of quarterly installments \| unit_Standard_installment		12					12
Vesting two \| Service-based vesting
Stock Based Compensation
Number of quarterly installments \| unit_Standard_installment		16					16
Vesting three \| Service-based vesting
Stock Based Compensation
Number of quarterly installments \| unit_Standard_installment		8					8

Stock-Based Compensation - Stock options - Assumptions (Details)	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Stock options
Stock Based Compensation
Expected term (in years)	6 years 18 days
Dividend yield	0.00%	0.00%
Employee Stock Purchase Plan
Stock Based Compensation
Dividend yield	0.00%
Minimum \| Stock options
Stock Based Compensation
Expected term (in years)		6 years 18 days
Risk-free interest rate	2.00%	2.60%
Expected stock price volatility	37.70%	37.80%
Minimum \| Employee Stock Purchase Plan
Stock Based Compensation
Expected term (in years)	6 months
Risk-free interest rate	1.90%
Expected stock price volatility	33.00%
Maximum \| Stock options
Stock Based Compensation
Expected term (in years)		7 years 6 months 7 days
Risk-free interest rate	2.40%	3.10%
Expected stock price volatility	37.90%	38.90%
Maximum \| Employee Stock Purchase Plan
Stock Based Compensation
Expected term (in years)	2 years
Risk-free interest rate	2.20%
Expected stock price volatility	35.70%

Stock-Based Compensation - Stock options - Summary (Details) - Stock options - $ / shares	3 Months Ended			9 Months Ended
	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019	Oct. 31, 2019
Number of Shares
Options outstanding at beginning of period (in shares)	21,267,000	26,200,000	26,535,000	26,535,000
Granted (in shares)	0	168,000	880,000
Exercised (in shares)	(286,000)	(4,776,000)	(706,000)
Canceled (in shares)	(280,000)	(325,000)	(509,000)
Options outstanding at end of period (in shares)	20,701,000	21,267,000	26,200,000	20,701,000
Options vested and expected to vest at end of period (in shares)	20,701,000			20,701,000
Options exercisable at end of period (in shares)	11,871,000			11,871,000
Weighted-Average Exercise Price Per Share
Options outstanding at beginning of period (in usd per share)	$ 4.56	$ 4.21	$ 3.87	$ 3.87
Granted (in usd per share)	0	34.00	14.65
Exercised (in usd per share)	2.90	3.62	2.14
Canceled (in usd per share)	7.40	5.06	7.34
Options outstanding at end of period (in usd per share)	4.55	$ 4.56	$ 4.21	4.55
Options vested and expected to vest at end of period (in usd per share)	4.55			4.55
Options exercisable at end of period (in usd per share)	$ 2.30			$ 2.30

Stock-Based Compensation - RSU activity (Details) - RSUs - $ / shares shares in Thousands	3 Months Ended
	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019
Number of Shares
RSUs outstanding at beginning of period (in shares)	5,729	4,753	4,059
Granted (in shares)	1,224	1,014	853
Vested (in shares)	0	0	0
Forfeited (in shares)	(44)	(38)	(159)
RSUs outstanding at end of period (in shares)	6,909	5,729	4,753
RSUs expected to vest at end of period (in shares)	6,909
Weighted-Average Grant Date Fair Value Per Share
RSUs outstanding at beginning of period (in usd per share)	$ 18.61	$ 13.33	$ 12.66
Granted (in usd per share)	59.93	41.35	18.32
Vested (in usd per share)	0	0	0
Forfeited (in usd per share)	32.20	20.59	12.62
RSUs outstanding at end of period (in usd per share)	25.84	$ 18.61	$ 13.33
RSUs expected to vest at end of period (in usd per share)	$ 25.84

Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 21,966	$ 13,460	$ 55,577	$ 17,403
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,355	2,137	15,511	3,941
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	4,696	6,245	10,353	7,232
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,465	4,643	25,018	5,541
Subscription \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,666	382	3,164	533
Professional services \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 784	$ 53	$ 1,531	$ 156

Revenue, Deferred Revenue and Remaining Performance Obligations - Revenue from contracts type of customer and Region based on shipping address of customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Disaggregation of Revenue [Line Items]
Total revenue	$ 125,119	$ 66,379	$ 329,304	$ 169,369
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
United States
Disaggregation of Revenue [Line Items]
Total revenue	$ 92,602	$ 50,366	$ 245,055	$ 130,659
Percentage of revenue	74.00%	76.00%	74.00%	77.00%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 17,609	$ 8,367	$ 46,029	$ 19,384
Percentage of revenue	14.00%	13.00%	14.00%	11.00%
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 9,985	$ 4,600	$ 24,828	$ 12,262
Percentage of revenue	8.00%	7.00%	8.00%	7.00%
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 4,923	$ 3,046	$ 13,392	$ 7,064
Percentage of revenue	4.00%	4.00%	4.00%	5.00%
Channel Partners
Disaggregation of Revenue [Line Items]
Total revenue	$ 88,255	$ 46,525	$ 223,152	$ 116,619
Percentage of revenue	71.00%	70.00%	68.00%	69.00%
Direct Customers
Disaggregation of Revenue [Line Items]
Total revenue	$ 36,864	$ 19,854	$ 106,152	$ 52,750
Percentage of revenue	29.00%	30.00%	32.00%	31.00%

Revenue, Deferred Revenue and Remaining Performance Obligations (Details)	3 Months Ended	9 Months Ended
	Oct. 31, 2019 USD ($)	Oct. 31, 2019 USD ($)
Contract with Customer, Liability [Line Items]
Revenue included in the contract liability balance	$ 103,300,000	$ 203,700,000
Subscription term	12 months	12 months
Transaction price allocated to remaining performance obligations	$ 577,200,000	$ 577,200,000
Percentage of performance obligation expected to be recognized		71.00%
Commission amortization period		4 years
Professional services contract amortization		6 months
Impairment loss, deferred contract acquisition costs	$ 0	$ 0
Minimum
Contract with Customer, Liability [Line Items]
Payment terms		30 days
Subscription term	1 year	1 year
Maximum
Contract with Customer, Liability [Line Items]
Payment terms		60 days
Subscription term	3 years	3 years

Revenue, Deferred Revenue and Remaining Performance Obligations - Changes in Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2019
Revenue from Contract with Customer [Abstract]
Balance, beginning	$ 369,762	$ 290,067
Additions to deferred revenue	202,996	486,876
Recognition of deferred revenue	(125,119)	(329,304)
Balance, ending	$ 447,639	$ 447,639

Revenue, Deferred Revenue and Remaining Performance Obligations - Deferred contract acquisition costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Feb. 01, 2019	Jan. 31, 2019	Oct. 31, 2018
Deferred contract acquisition costs
Beginning balance	$ 75,783	$ 24,641	$ 38,765	$ 22,334
Capitalization of contract acquisition costs	27,450	13,233	55,238	27,531
Amortization of deferred contract acquisition costs	(9,049)	(7,321)	(24,125)	(19,312)
Ending balance	94,184	30,553	94,184	30,553
Deferred contract acquisition costs, current					$ 35,924	$ 22,816	$ 28,847	$ 22,022
Deferred contract acquisition costs, noncurrent					58,260	$ 40,255	9,918	8,531
Total deferred contract acquisition costs	75,783	24,641	38,765	22,334	$ 94,184		$ 38,765	$ 30,553
ASC 2014-09
Deferred contract acquisition costs
Adjustment due to adoption of ASU 606	$ 0	$ 0	$ 24,306	$ 0

Commitments and Contingencies (Details) - USD ($)	3 Months Ended		9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Jan. 31, 2019
Line of Credit Facility [Line Items]
Rent expense	$ 3,100,000	$ 1,800,000	$ 7,100,000	$ 5,000,000.0
Commitment to spend	188,500,000		188,500,000
Liability recorded	0		0		$ 0
Liabilities accrued	0		0		0
Sunnyvale, California
Line of Credit Facility [Line Items]
Unused standby letter of credit	600,000		600,000		500,000
Austin, Texas
Line of Credit Facility [Line Items]
Unused standby letter of credit	$ 1,000,000.0		$ 1,000,000.0		$ 800,000

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

Commitments and Contingencies - Lease Commitments (Details) $ in Thousands	Oct. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$ 47,511

Commitments and Contingencies - Purchase Obligations (Details) $ in Thousands	Oct. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$ 226,485

Geographic Information (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Geographic Information
Property and equipment, net	$ 129,504	$ 73,735
United States
Geographic Information
Property and equipment, net	119,760	70,699
International
Geographic Information
Property and equipment, net	$ 9,744	$ 3,036

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Jan. 31, 2019
Related Party Transaction [Line Items]
Revenue from subscriptions and professional services from related parties	$ 2.2	$ 1.6	$ 6.8	$ 4.3
Accounts receivable associated with related parties	8.0		8.0		$ 0.2
Purchases from related parties	0.9	$ 0.6	2.4	$ 1.4
Accounts payable to vendors	$ 0.2		$ 0.2
Maximum
Related Party Transaction [Line Items]
Accounts payable to vendors					$ 0.1

Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	204,096,000	45,287,000	128,009,000	44,344,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (3,602)		$ (9,402)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	20,703,000		10,616,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)		$ (0.89)
Class B common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (31,903)		$ (103,969)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	183,393,000		117,393,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)		$ (0.89)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Net Loss Per Share Attributable to Common Stockholders - Antidilutive (Details) - shares shares in Thousands	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	28,738	158,494
Redeemable Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	0	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	0	336
Shares of common stock subject to repurchase from outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	1,128	712
Restricted stock awards subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	6,909	28
Shares of common stock issuable from stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	20,701	26,150

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Oct. 31, 2019	Nov. 29, 2019
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2019
Document Transition Report	false
Entity File Number	001-38933
Entity Registrant Name	CROWDSTRIKE HOLDINGS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-3788918
Entity Address, Address Line One	150 Mathilda Place
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Sunnyvale
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94086
Title of 12(b) Security	Class A common stock, par value $0.0005 per share
Trading Symbol	CRWD
Security Exchange Name	NASDAQ
City Area Code	888
Local Phone Number	512-8906
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001535527
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A common stock
Entity Common Stock, Shares Outstanding		40,871,355
Class B common stock
Entity Common Stock, Shares Outstanding		164,673,516

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Current assets:
Cash and cash equivalents	$ 743,605	$ 88,408
Marketable securities	90,083	103,247
Accounts receivable, net of allowance for doubtful accounts of $1.4 million and $1.0 million as of October 31, 2019 and January 31, 2019, respectively	145,694	92,476
Deferred contract acquisition costs, current	35,924	28,847
Prepaid expenses and other current assets	37,914	18,410
Total current assets	1,053,220	331,388
Property and equipment, net	129,504	73,735
Deferred contract acquisition costs, noncurrent	58,260	9,918
Goodwill	7,794	7,947
Intangible assets, net	637	1,048
Other assets	6,639	9,183
Total assets	1,256,054	433,219
Current liabilities:
Accounts payable	5,244	6,855
Accrued expenses	29,460	32,541
Accrued payroll and benefits	36,905	19,284
Deferred revenue	335,801	218,700
Other current liabilities	8,194	4,040
Total current liabilities	415,604	281,420
Deferred revenue, noncurrent	111,838	71,367
Other liabilities, noncurrent	11,570	10,313
Total liabilities	539,012	363,100
Redeemable Convertible Preferred Stock
Redeemable convertible preferred stock, $0.0005 par value; no shares and 137,419 shares authorized as of October 31, 2019 and January 31, 2019, respectively; no shares and 131,268 shares issued and outstanding as of October 31, 2019 and January 31, 2019, respectively; liquidation preference $0 and $545,000 as of October 31, 2019 and January 31, 2019, respectively		557,912
Stockholders’ Equity (Deficit)
Preferred stock, $0.0005 par value; 100,000 shares and no shares authorized as of October 31, 2019 and January 31, 2019, respectively; no shares issued and outstanding as of October 31, 2019 and January 31, 2019, respectively	0	0
Common stock, value		24
Additional paid-in capital	1,326,116	31,211
Accumulated deficit	(609,079)	(519,126)
Accumulated other comprehensive income (loss)	(98)	98
Total stockholders’ equity (deficit)	717,042	(487,793)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	1,256,054	$ 433,219
Class A and Class B common stock
Stockholders’ Equity (Deficit)
Common stock, value	$ 103

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Oct. 31, 2019	Jan. 31, 2019
Accounts receivable, allowance for doubtful accounts	$ 1,400,000	$ 1,000,000.0
Redeemable preferred stock, par value (in dollars per share)	$ 0.0005	$ 0.0005
Redeemable preferred stock, shares authorized (in shares)	0	137,419,000
Redeemable preferred stock, shares issued (in shares)	0	131,268,000
Redeemable preferred stock, shares outstanding (in shares)	0	131,268,000
Redeemable preferred stock, liquidation preference	$ 0	$ 545,000,000
Preferred stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Preferred stock, shares authorized (in shares)	100,000,000	0
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	0	220,000,000
Common stock, shares issued (in shares)	0	47,421,000
Common stock, shares outstanding (in shares)	0	47,421,000
Class A common stock
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	2,000,000,000	0
Common stock, shares issued (in shares)	20,761,000	0
Common stock, shares outstanding (in shares)	20,761,000	0
Class B common stock
Common stock, par value (in usd per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized (in shares)	300,000,000	0
Common stock, shares issued (in shares)	184,718,000	0
Common stock, shares outstanding (in shares)	184,718,000	0

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Revenue
Total revenue	$ 125,119	$ 66,379	$ 329,304	$ 169,369
Cost of revenue
Total cost of revenue	37,355	22,274	98,211	60,243
Gross profit	87,764	44,105	231,093	109,126
Operating expenses
Sales and marketing	68,675	46,614	190,792	123,344
Research and development	35,992	25,968	91,497	62,546
General and administrative	21,615	13,614	63,737	28,868
Total operating expenses	126,282	86,196	346,026	214,758
Loss from operations	(38,518)	(42,091)	(114,933)	(105,632)
Interest expense	(132)	0	(297)	(428)
Other income (expense), net	3,579	303	3,523	(1,739)
Loss before provision for income taxes	(35,071)	(41,788)	(111,707)	(107,799)
Provision for income taxes	(434)	(535)	(1,664)	(1,018)
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	204,096,000	45,287,000	128,009,000	44,344,000
Subscription
Revenue
Total revenue	$ 114,221	$ 57,651	$ 297,787	$ 146,570
Cost of revenue
Total cost of revenue	29,221	17,302	77,858	47,077
Professional services
Revenue
Total revenue	10,898	8,728	31,517	22,799
Cost of revenue
Total cost of revenue	$ 8,134	$ 4,972	$ 20,353	$ 13,166

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Statement of Comprehensive Income [Abstract]
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Other comprehensive loss:
Foreign currency translation adjustments	410	(415)	(213)	(1,105)
Unrealized gain (loss) on available-for-sale securities, net of tax	22	(11)	17	(13)
Other comprehensive income (loss)	432	(426)	(196)	(1,118)
Total comprehensive loss	$ (35,073)	$ (42,749)	$ (113,567)	$ (109,935)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Redeemable Convertible Preferred Stock
Beginning Balance at Jan. 31, 2018						$ 351,016
Beginning Balance (in shares) at Jan. 31, 2018						118,693,000
Redeemable Convertible Preferred Stock
Issuance of Series E redeemable convertible preferred stock, net of issuance costs						$ 206,896
Issuance of Series E redeemable convertible preferred stock, net of issuance costs (Shares)						12,575,000
Ending Balance at Oct. 31, 2018						$ 557,912
Ending Balance (in shares) at Oct. 31, 2018						131,268,000
Beginning Balance at Jan. 31, 2018	$ (369,474)	$ 22	$ 8,482	$ (378,948)	$ 970
Beginning Balance (in shares) at Jan. 31, 2018		44,231,000
Stockholders' Deficit
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs ( in shares)		106,000
Issuance of common stock upon exercise of options	2,792	$ 1	2,791
Issuance of common stock upon exercise of options (in shares)		2,418,000
Issuance of common stock related to early exercise options (in shares)		38,000
Vesting of early exercised options	191		191
Stock-based compensation expense	17,403		17,403
Net loss	(108,817)			(108,817)
Other comprehensive income	(1,118)				(1,118)
Issuance of restricted stock awards (in shares)		36,000
Repurchase of stock options	(2,330)		(2,330)
Ending Balance at Oct. 31, 2018	(461,353)	$ 23	26,638	(487,866)	(148)
Ending Balance (in shares) at Oct. 31, 2018		46,829,000
Beginning Balance at Jul. 31, 2018						$ 550,912
Beginning Balance (in shares) at Jul. 31, 2018						130,843,000
Redeemable Convertible Preferred Stock
Issuance of Series E redeemable convertible preferred stock, net of issuance costs						$ 7,000
Issuance of Series E redeemable convertible preferred stock, net of issuance costs (Shares)						425,000
Ending Balance at Oct. 31, 2018						$ 557,912
Ending Balance (in shares) at Oct. 31, 2018						131,268,000
Beginning Balance at Jul. 31, 2018	(433,429)	$ 22	11,814	(445,543)	278
Beginning Balance (in shares) at Jul. 31, 2018		45,609,000
Stockholders' Deficit
Issuance of common stock upon exercise of options	1,278	$ 1	1,277
Issuance of common stock upon exercise of options (in shares)		1,220,000
Vesting of early exercised options	87		87
Stock-based compensation expense	13,460		13,460
Net loss	(42,323)			(42,323)
Other comprehensive income	(426)				(426)
Ending Balance at Oct. 31, 2018	(461,353)	$ 23	26,638	(487,866)	(148)
Ending Balance (in shares) at Oct. 31, 2018		46,829,000
Stockholders' Deficit
Cumulative effect of accounting change			101	(101)
Beginning Balance at Jan. 31, 2019	$ 557,912					$ 557,912
Beginning Balance (in shares) at Jan. 31, 2019	131,268,000					131,268,000
Ending Balance at Oct. 31, 2019						$ 0
Ending Balance (in shares) at Oct. 31, 2019	0					0
Beginning Balance at Jan. 31, 2019	$ (487,793)	$ 24	31,211	(519,126)	98
Beginning Balance (in shares) at Jan. 31, 2019		47,421,000
Stockholders' Deficit
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs	659,218	$ 11	659,207
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs ( in shares)		20,700,000
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	557,912	$ 66	557,846			$ (557,912)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		131,268,000				(131,268,000)
Reclassification of redeemable convertible preferred stock warrant liability to additional paid-in capital upon initial public offering	10,559		10,559
Net exercise of common stock warrants ( in shares)		322,000
Issuance of common stock upon exercise of options	9,391	$ 2	9,389
Issuance of common stock upon exercise of options (in shares)		4,731,000
Issuance of common stock related to early exercise options (in shares)		1,037,000
Vesting of early exercised options	1,816		1,816
Stock-based compensation expense	55,577		55,577
Capitalized stock-based compensation	511		511
Net loss	(113,371)			(113,371)
Other comprehensive income	(196)				(196)
Ending Balance at Oct. 31, 2019	$ 717,042	$ 103	1,326,116	(609,079)	(98)
Ending Balance (in shares) at Oct. 31, 2019		205,479,000
Beginning Balance at Jul. 31, 2019						$ 0
Beginning Balance (in shares) at Jul. 31, 2019						0
Ending Balance at Oct. 31, 2019						$ 0
Ending Balance (in shares) at Oct. 31, 2019	0					0
Beginning Balance at Jul. 31, 2019	$ 728,097	$ 103	1,302,098	(573,574)	(530)
Beginning Balance (in shares) at Jul. 31, 2019		205,193,000
Stockholders' Deficit
Issuance of common stock upon exercise of options	824		824
Issuance of common stock upon exercise of options (in shares)		286,000
Vesting of early exercised options	962		962
Stock-based compensation expense	21,966		21,966
Capitalized stock-based compensation	266		266
Net loss	(35,505)			(35,505)
Other comprehensive income	432				432
Ending Balance at Oct. 31, 2019	717,042	$ 103	$ 1,326,116	(609,079)	$ (98)
Ending Balance (in shares) at Oct. 31, 2019		205,479,000
Stockholders' Deficit
Cumulative effect of accounting change	$ 23,418			$ 23,418

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2018	Oct. 31, 2018
Statement of Stockholders' Equity [Abstract]
Payments of deferred offering costs	$ 104	$ 104

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Operating activities
Net loss	$ (113,371)	$ (108,817)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	16,023	10,199
Loss on disposal of fixed assets	0	223
Amortization of intangible assets	385	435
Amortization of deferred contract acquisition costs	24,125	19,312
Change in fair value of redeemable convertible preferred stock warrant liability	6,022	2,935
Allowance for doubtful accounts	413	485
Stock-based compensation expense	55,577	17,403
Accretion of marketable securities purchased at a discount	(1,313)	(625)
Non-cash interest expense	293	187
Changes in operating assets and liabilities
Accounts receivable	(53,631)	(17,936)
Deferred contract acquisition costs	(55,238)	(27,531)
Prepaid expenses and other assets	(19,883)	(2,307)
Accounts payable	(3,773)	(6,280)
Accrued expenses and other current liabilities	3,405	(2,331)
Accrued payroll and benefits	17,621	3,498
Deferred revenue	157,239	72,219
Other liabilities, noncurrent	(58)	155
Net cash provided by (used in) operating activities	33,836	(38,776)
Investing activities
Purchases of property and equipment	(66,848)	(21,664)
Capitalized internal-use software	(5,208)	(5,042)
Purchases of marketable securities	(187,697)	(135,253)
Proceeds from sales of marketable securities	4,473	0
Maturities of marketable securities	197,764	30,600
Net cash used in investing activities	(57,516)	(131,359)
Financing activities
Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts	665,092	0
Proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs	0	206,896
Repayment of loan payable	0	(6,158)
Proceeds from revolving line of credit	0	10,000
Repayment of revolving line of credit	0	(20,000)
Repayment of notes receivable from related parties	0	198
Payments of contingent consideration	0	(184)
Payments of indemnity holdback	0	(500)
Repurchase of stock options	0	(2,330)
Payments of deferred offering costs	(5,872)	0
Proceeds from issuance of common stock upon exercise of stock options	9,350	2,792
Proceeds from the issuance of common stock upon exercise of early exercisable stock options	10,264	0
Net cash provided by financing activities	678,834	190,714
Effect of foreign exchange rates on cash and cash equivalents	43	(296)
Net increase in cash and cash equivalents	655,197	20,283
Cash and cash equivalents, beginning of period	88,408	63,179
Cash and cash equivalents, end of period	743,605	83,462
Supplemental disclosure of cash flow information:
Interest paid	3	449
Income taxes paid	1,054	576
Supplemental disclosure of non-cash investing and financing activities:
Indemnity holdback consideration associated with business combinations	0	1,299
Contingent consideration associated with business combinations	0	420
Conversion of redeemable convertible preferred stock to common stock	557,912	0
Conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital	10,559	0
Net (decrease) increase in deferred offering costs, accrued but not paid	(2,858)	552
Net (decrease) increase in property and equipment included in accounts payable and accrued expenses	$ (715)	$ 625

Description of Business and Basis of Presentation	9 Months Ended
Description of Business and Basis of Presentation	Oct. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	1. Description of Business and Basis of Presentation CrowdStrike Holdings, Inc. (the “Company”) was formed on November 7, 2011. The Company provides a leading cloud-delivered solution for next-generation endpoint protection that offers 10 cloud modules on its Falcon platform via a SaaS subscription-based model that spans multiple large security markets, including endpoint security, security and IT operations (including vulnerability management), and threat intelligence. The Company is headquartered in Sunnyvale, California. The Company conducts its business in the United States, as well as locations internationally, including in Australia, Germany, India, Romania, and the United Kingdom. On June 14, 2019, the Company closed its initial public offering (“IPO”), in which it sold 20,700,000 shares of Class A common stock. The shares were sold at a public offering price of $34.00 per share for net proceeds of $659.2 million, after deducting underwriters’ discounts and commissions and offering expenses of $44.8 million. Immediately prior to the closing of the IPO, all outstanding shares of redeemable convertible preferred stock automatically converted into 131,267,586 shares of Class B common stock on a one-to-one basis. Additionally, in connection with the IPO all of the Company’s outstanding common stock was reclassified into shares of Class B common stock on a one-for-one basis. Redeemable convertible preferred stock warrants also converted into 336,386 warrants to purchase Class B common stock on a one-to-one basis.

Summary of Significant Accounting Policies

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

Principles of Consolidation

JOBS Act Accounting Election

Use of Estimates

Concentration of Credit Risk and Geographic Information

There were no direct customers who represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Cash Equivalents and Marketable Securities

Strategic Investments

Fair Value of Financial Instruments

Accounts Receivable and Allowance for Doubtful Accounts

Deferred Offering Costs

Property and Equipment, Net


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Capitalized Internal-Use Software

Intangible Assets, Net

Deferred Contract Acquisition Costs

Impairment of Long-Lived Assets

Deferred Revenue

Redeemable Convertible Preferred Stock Warrants

Revenue Recognition – ASC 606

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

1)Identify the contract with a customer

2)Identify the performance obligations in the contract

3)Determine the transaction price

4)Allocate the transaction price to performance obligations in the contract

5)Recognize revenue when or as performance obligations are satisfied

Subscription Revenue

Professional Services Revenue

Contracts with Multiple Performance Obligations

Variable Consideration

Revenue Recognition – ASC 605

Research and Development Expense

Advertising

Stock-Based Compensation

Business Combinations

Goodwill and Intangible Assets

Leases

Foreign Currency Translation

Income Taxes

Sales Taxes

Segment and Geographic Information

Net Loss per Share

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Fair Value Measurements and Marketable Securities

9 Months Ended

Oct. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements and Marketable Securities

3. Fair Value Measurements and Marketable Securities

The hierarchy is broken down into three levels as follows:

Level 1 Assets and liabilities whose values are based on unadjusted quoted market prices for identical assets and liabilities in active markets

Level 2 Assets and liabilities whose values are based on quoted prices in markets that are not active or inputs that are observable for substantially the full term of the asset or liability

Level 3 Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement

Categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The Company’s fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis are as follows:


	October 31, 2019														January 31, 2019
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	(in thousands)														(in thousands)
Assets
Cash equivalents⁽¹⁾
Money market funds	$	693,258	$	—	$	—	$	693,258	$	42,132	$	—	$	—	$	42,132
Corporate debt securities	—		8,598		—		8,598		—		27,941		—		27,941
Total cash equivalents	693,258		8,598		—		701,856		42,132		27,941		—		70,073
Marketable securities
Corporate debt securities	—		76,154		—		76,154		—		91,796		—		91,796
U.S. treasury securities	13,929		—		—		13,929		11,451		—		—		11,451
Total marketable securities	13,929		76,154		—		90,083		11,451		91,796		—		103,247
Total assets	$	707,187	$	84,752	$	—	$	791,939	$	53,583	$	119,737	$	—	$	173,320
Liability
Contingent consideration related to business combinations⁽²⁾	$	—	$	—	$	—	$	—	$	—	$	—	$	474	$	474
Redeemable convertible preferred stock warrant liability ⁽³⁾	—		—		—		—		—		—		4,537		4,537
Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—	$	5,011	$	5,011

__________________________________

(1)Included in “Cash and cash equivalents” on the condensed consolidated balance sheets.

There were no transfers between the levels of the fair value hierarchy during the three and nine months ended October 31, 2019 or October 31, 2018.

The remaining contractual maturities of marketable securities as of October 31, 2019 and January 31, 2019 were less than one year.

The following summarizes the changes in the redeemable convertible preferred stock warrant liability, which is classified as a Level 3 instrument:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Balance at beginning of period	$	—	$	3,016	$	4,537	$	961
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	—		880		6,022		2,935
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	—		—		(10,559)		—
Balance at end of period	$	—	$	3,896	$	—	$	3,896

- Definition

+ References + Details

Balance Sheet Components

9 Months Ended

Oct. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

4. Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Prepaid expenses	$	20,515	$	5,982
Prepaid software licenses	14,793		8,408
Other current assets	2,606		1,105
Prepaid hosting services	—		2,915
Prepaid expenses and other current assets	$	37,914	$	18,410

Property and Equipment, Net

Property and equipment, net consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Data center and other computer equipment	$	67,764	$	44,735
Capitalized internal-use software	27,928		22,209
Leasehold improvements	10,313		10,011
Purchased software	2,557		1,460
Furniture and equipment	3,883		2,553
Construction in process	59,739		19,455
	172,184		100,423
Less: Accumulated depreciation and amortization	(42,680)		(26,688)
Property and equipment, net	$	129,504	$	73,735

Intangible Assets, Net

Total intangible assets, net consisted of the following:


	October 31, 2019		January 31, 2019		Weighted-Average Remaining Useful Life
	(in thousands)					(in months)
Developed technology	$	1,248	$	1,269	12
Customer relationships	615		632		36
Non-compete agreement	123		126		12
	1,986		2,027
Less: Accumulated amortization	(1,349)		(979)
Intangible assets, net	$	637	$	1,048

The estimated aggregate future amortization expense of intangible assets as of October 31, 2019 is as follows:


	Total
	(in thousands)
Fiscal 2020 (remaining three months)	$	104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	—
Total amortization expense	$	637

The developed technology, customer relationships, and non-compete agreement assets are being amortized over 3 years, 5 years, and 3 years, respectively.

Accrued Expenses

Accrued expenses consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Web hosting services	$	13,141	$	12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042

Accrued expenses	$	29,460	$	32,541

Accrued Payroll and Benefits

Accrued payroll and benefits consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Accrued commissions	$	15,290	$	9,499
Employee Stock Purchase Plan	10,236		—
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$	36,905	$	19,284

Secured Revolving Credit Facility	9 Months Ended
Secured Revolving Credit Facility	Oct. 31, 2019
Debt Disclosure [Abstract]
Secured Revolving Credit Facility	5. Secured Revolving Credit Facility In April 2019, the Company entered into a Credit Agreement with Silicon Valley Bank and other lenders, to provide a revolving line of credit of up to $150.0 million, including a letter of credit sub-facility in the aggregate amount of $10.0 million, and a swingline sub-facility in the aggregate amount of $10.0 million. The Company also has the option to request an incremental facility of up to an additional $75.0 million from one or more of the lenders under the Credit Agreement. The amount the Company may borrow under the Credit Agreement may not exceed the lesser of $150.0 million or the Company’s ordinary course recurring subscription revenue for the most recent month, as determined under the Credit Agreement, multiplied by a number that is (i) 6, for the first year after entry into the Credit Agreement; (ii) 5, for the second year after entry into the Credit Agreement; and (iii) 4, thereafter. Under the terms of the Credit Agreement, revolving loans may be either Eurodollar Loans or ABR Loans. Outstanding Eurodollar Loans incur interest at the Eurodollar Rate, which is defined in the Credit Agreement as LIBOR (or any successor thereto), plus a margin between 2.50% and 3.00%, depending on usage. Outstanding ABR Loans incur interest at the highest of (a) the Prime Rate, as published by the Wall Street Journal, (b) the federal funds rate in effect for such day plus 0.50%, and (c) the Eurodollar Rate plus 1.00%, in each case plus a margin between 1.50% and 2.00%, depending on usage. The Company will be charged a commitment fee of 0.2% to 0.3% per year for committed but unused amounts. The Credit Agreement will terminate on April 19, 2022. The Credit Agreement is collateralized by substantially all of the Company’s current and future property, rights, and assets, including, but not limited to, cash, goods, equipment, contractual rights, financial assets, and intangible assets of the Company and its subsidiaries. The Credit Agreement contains covenants limiting the ability to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock, and make investments, in each case subject to certain exceptions. The Credit Agreement also contains financial covenants requiring the Company to maintain the year-over-year growth rate of its ordinary course recurring subscription revenue above specified rates and to maintain minimum liquidity at specified levels. The Company was in compliance with the financial covenants as of October 31, 2019. The Credit Agreement contains events of default that include, among others, non-payment of principal, interest, or fees, breach of covenants, inaccuracy of representations and warranties, cross defaults to certain other indebtedness, bankruptcy and insolvency events, and material judgments. No amounts were outstanding under the Credit Agreement as of October 31, 2019.

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes The Company recognized an income tax expense of $0.4 million and $0.5 million for the three months ended October 31, 2019 and October 31, 2018, respectively and $1.7 million and $1.0 million for the nine months ended October 31, 2019 and 2018, respectively. The tax expense for the three and nine months ended October 31, 2019 was primarily attributable to pre-tax foreign earnings. The Company’s effective tax rates of (1.24)% and (1.28)% for the three months ended October 31, 2019 and October 31, 2018, respectively, and (1.48)% and (0.94)% for the nine months ended October 31, 2019 and October 31, 2018, respectively, differ from the U.S. statutory tax rate primarily due to valuation allowance recorded against domestic losses and the tax rate differences between the United States and foreign countries. The Company has a full valuation allowance on its U.S. federal and state deferred tax assets. As a result, consistent with the prior year, the Company is unable to record a tax benefit on these losses because of uncertainty of future profitability.

Redeemable Convertible Preferred Stock

9 Months Ended

Oct. 31, 2019

Temporary Equity Disclosure [Abstract]

Redeemable Convertible Preferred Stock

7. Redeemable Convertible Preferred Stock

The following table summarizes the authorized, issued, and outstanding redeemable convertible preferred stock of the Company as of January 31, 2019:


Class	Issue Price per Share		Shares Authorized	Shares Issued and Outstanding	Net Carrying Value		Liquidation Preference		Redemption Value
	(in thousands, except per share values)
Series A-1	$	0.50000	52,300	52,300	$	76,325	$	52,300	$	623,678
Series B	$	1.40500	21,523	21,352	44,320		30,000		254,623
Series C	$	4.52972	22,275	22,077	99,900		100,000		263,765
Series D	$	5.69153	17,570	17,570	99,845		125,000		211,631
Series D-1	$	5.69153	5,394	5,394	30,626		30,700		64,607
Series E	$	16.46136	18,357	12,575	206,896		207,000		207,000
Total			137,419	131,268	$	557,912	$	545,000	$	1,625,304

Common Stock	9 Months Ended
Common Stock	Oct. 31, 2019
Equity [Abstract]
Common Stock	. Common StockIn connection with the IPO, on June 14, 2019, the Company filed an Amended and Restated Certificate of Incorporation which authorizes the issuance of 2,000,000,000 shares of Class A common stock with a par value of $0.0005 per share, 300,000,000 shares of Class B common stock with a par value of $0.0005 per share, and 100,000,000 shares of undesignated preferred stock with a par value of $0.0005 per share. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to ten votes per share and is convertible into one share of Class A common stock. Class A and Class B common stockholders are not entitled to receive dividends unless declared by our board of directors.

Stock-Based Compensation

9 Months Ended

Oct. 31, 2019

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

9. Stock-Based Compensation

Stock Incentive Plan

Stock Options

The fair value of each option was estimated on the date of grant using the following assumptions during the period:


	Nine Months Ended October 31,
	2019	2018

Expected term (in years)	6.05	6.05 - 7.52
Risk-free interest rate	2.0% - 2.4%	2.6% - 3.1%
Expected stock price volatility	37.7% - 37.9%	37.8% - 38.9%
Dividend yield	— %	— %

The following table is a summary of stock option activity for the nine months ended October 31, 2019:


	Number of Shares	Weighted-Average Exercise Price Per Share
	(in thousands)
Options outstanding at January 31, 2019	26,535	$	3.87
Granted	880	$	14.65
Exercised	(706)	$	2.14
Canceled	(509)	$	7.34
Options outstanding at April 30, 2019	26,200	$	4.21
Granted	168	$	34.00
Exercised	(4,776)	$	3.62
Canceled	(325)	$	5.06
Options outstanding at July 31, 2019	21,267	$	4.56
Granted	—	$	—
Exercised	(286)	$	2.90
Canceled	(280)	$	7.40
Options outstanding at October 31, 2019	20,701	$	4.55
Options vested and expected to vest at October 31, 2019	20,701	$	4.55
Options exercisable at October 31, 2019	11,871	$	2.30

Options exercisable include 982,200 options that were unvested as of October 31, 2019.

Early Exercise of Employee Options

Restricted Stock Units

Performance-based Stock Units

The following table is a summary of RSU and PSU activities for the nine months ended October 31, 2019:


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
	(in thousands)
RSUs and PSUs outstanding at January 31, 2019	4,059	$	12.66
Granted	853	$	18.32
Vested	—	$	—
Forfeited	(159)	$	12.62
RSUs and PSUs outstanding at April 30, 2019	4,753	$	13.33
Granted	1,014	$	41.35
Vested	—	$	—
Forfeited	(38)	$	20.59
RSUs and PSUs outstanding at July 31, 2019	5,729	$	18.61
Granted	1,224	$	59.93
Vested	—	$	—
Forfeited	(44)	$	32.20
RSUs and PSUs outstanding at October 31, 2019	6,909	$	25.84
RSUs and PSUs expected to vest at October 31, 2019	6,909	$	25.84

Employee Stock Purchase Plan


			Nine Months Ended October 31,
			2019

Expected term (in years)			0.5 - 2.0
Risk-free interest rate			1.9 - 2.2%
Expected stock price volatility			33.0 - 35.7%
Dividend yield			— %

Stock-Based Compensation Expense

Stock-based compensation expense included in the condensed consolidated statements of operations is as follows:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Subscription cost of revenue	$	1,666	$	382	$	3,164	$	533
Professional services cost of revenue	784		53		1,531		156
Sales and marketing	7,355		2,137		15,511		3,941
Research and development	4,696		6,245		10,353		7,232
General and administrative	7,465		4,643		25,018		5,541
Total stock-based compensation expense	$	21,966	$	13,460	$	55,577	$	17,403

Revenue, Deferred Revenue and Remaining Performance Obligations

9 Months Ended

Oct. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue, Deferred Revenue and Remaining Performance Obligations

10. Revenue, Deferred Revenue and Remaining Performance Obligations

The following table summarizes the revenue from contracts by type of customer:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
Channel Partners	$	88,255	71	%	$	46,525	70	%	$	223,152	68	%	$	116,619	69	%
Direct Customers	36,864		29	%	19,854		30	%	106,152		32	%	52,750		31	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use the Company’s cloud platform:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
United States	$	92,602	74	%	$	50,366	76	%	$	245,055	74	%	$	130,659	77	%
Europe, Middle East, and Africa	17,609		14	%	8,367		13	%	46,029		14	%	19,384		11	%
Asia Pacific	9,985		8	%	4,600		7	%	24,828		8	%	12,262		7	%
Other	4,923		4	%	3,046		4	%	13,392		4	%	7,064		5	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

No single country other than the United States represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Contract Balances

Changes in deferred revenue for the three and nine months ended October 31, 2019 were as follows (in thousands):


	Carrying Amount
	Three Months Ended October 31, 2019		Nine Months Ended October 31, 2019
Beginning Balance	$	369,762	$	290,067
Additions to deferred revenue	202,996		486,876
Recognition of deferred revenue	(125,119)		(329,304)
Ending Balance	$	447,639	$	447,639

Remaining Performance Obligations

Costs to Obtain and Fulfill a Contract

The following table summarizes the activity of deferred contract acquisition costs:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)
Beginning balance	$	75,783	$	24,641	$	38,765	$	22,334
Adjustment due to adoption of ASU 606	—		—		24,306		—
Capitalization of contract acquisition costs	27,450		13,233		55,238		27,531
Amortization of deferred contract acquisition costs	(9,049)		(7,321)		(24,125)		(19,312)
Ending balance	$	94,184	$	30,553	$	94,184	$	30,553

Deferred contract acquisition costs, current	$	35,924	$	22,022	$	35,924	$	22,022
Deferred contract acquisition costs, noncurrent	58,260		8,531		58,260		8,531
Total deferred contract acquisition costs	$	94,184	$	30,553	$	94,184	$	30,553

Commitments and Contingencies

9 Months Ended

Oct. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

11. Commitments and Contingencies

Lease Commitments


	Operating Leases
	(in thousands)
Fiscal 2020 (remaining three months)	$	2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$	47,511

Purchase Obligations


	Total Commitments
	(in thousands)
Fiscal 2020 (remaining three months)	$	27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$	226,485

Letters of Credit

Litigation

Warranties and Indemnification

Geographic Information

9 Months Ended

Oct. 31, 2019

Geographic Areas, Long-Lived Assets [Abstract]

Geographic Information

12. Geographic Information

The Company’s long-lived assets are composed of property and equipment, net, and are summarized by geographic area as follows:


	October 31, 2019		January 31, 2019
	(in thousands)
United States	$	119,760	$	70,699
International	9,744		3,036
Total property and equipment, net	$	129,504	$	73,735

Other than the United States, no other country represented 10% or more of our total property and equipment as of October 31, 2019 or January 31, 2019.

Related Party Transactions	9 Months Ended
Related Party Transactions	Oct. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	13. Related Party Transactions Subscription and Professional Services Revenue from Related Parties During the three and nine months ended October 31, 2019 and 2018, certain investors and companies with whom the Company’s Board of Directors are affiliated purchased subscriptions and professional services. The Company recorded revenue from subscriptions and professional services from related parties of $2.2 million and $1.6 million during the three months ended October 31, 2019 and October 31, 2018, respectively, and $6.8 million and $4.3 million during the nine months ended October 31, 2019 and October 31, 2018. Accounts receivable associated with these related parties was $8.0 million and $0.2 million as of October 31, 2019 and January 31, 2019, respectively. Accounts Payable to Related Parties The Company purchased goods and services totaling $0.9 million and $0.6 million, respectively, from certain investors and companies with whom its Board of Directors are affiliated during the three months ended October 31, 2019 and 2018, and $2.4 million and $1.4 million during the nine months ended October 31, 2019 and October 31, 2018. The accounts payable to such vendors was $0.2 million and less than $0.1 million as of October 31, 2019 and January 31, 2019, respectively.

Net Loss Per Share Attributable to Common Stockholders

9 Months Ended

Oct. 31, 2019

Earnings Per Share [Abstract]

Net Loss Per Share Attributable to Common Stockholders

. Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
Common Stock

Net loss attributable to common stockholders	$	—	$	(42,323)	$	—	$	(108,817)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	—		45,287		—		44,344

Net loss per share attributable to common stockholders, basic and diluted	$	—	$	(0.93)	$	—	$	(2.45)

Class A Common Stock

Net loss attributable to common stockholders	$	(3,602)	$	—	$	(9,402)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	20,703		—		10,616		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Class B Common Stock

Net loss attributable to common stockholders	$	(31,903)	$	—	$	(103,969)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	183,393		—		117,393		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—


	October 31, 2019	October 31, 2018
	(in thousands)
Shares of common stock issuable upon conversion of redeemable convertible preferred stock	—	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants	—	336
Shares of common stock subject to repurchase from outstanding stock options	1,128	712
Restricted stock awards subject to future vesting	6,909	28
Shares of common stock issuable from stock options	20,701	26,150
Potential common shares excluded from diluted net loss per share	28,738	158,494

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Basis of Presentation

Principles of Consolidation

JOBS Act Accounting Election

Use of Estimates

Concentration of Credit Risk and Geographic Information

There were no direct customers who represented 10% or more of the Company’s total revenue during the three and nine months ended October 31, 2019 and October 31, 2018.

Cash and Cash Equivalents

Cash Equivalents and Marketable Securities

Strategic Investments

Fair Value of Financial Instruments

Accounts Receivable and Allowance for Doubtful Accounts

Deferred Offering Costs

Property and Equipment, Net


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Capitalized Internal Use Software

Capitalized Internal-Use Software

Intangible Assets, Net

Deferred Contract Acquisition Costs

Impairment of Long Lived Assets

Impairment of Long-Lived Assets

Deferred Revenue

Redeemable Convertible Preferred Stock Warrants

Revenue Recognition - ASC 606

Revenue Recognition – ASC 606

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

1)Identify the contract with a customer

2)Identify the performance obligations in the contract

3)Determine the transaction price

4)Allocate the transaction price to performance obligations in the contract

5)Recognize revenue when or as performance obligations are satisfied

Subscription Revenue

Professional Services Revenue

Contracts with Multiple Performance Obligations

Variable Consideration

Revenue Recognition - ASC 605

Revenue Recognition – ASC 605

Research and Development Expense

Advertising

Stock Based Compensation

Stock-Based Compensation

Business Combinations

Goodwill and Intangible Assets

Leases

Foreign Currency Translation

Income Taxes

Sales Taxes

Segment and Geographic Information

Net Loss per Share

Recently Issued and Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Oct. 31, 2019

Accounting Policies [Abstract]

Summary of estimated useful lives of the assets


Data center and other computer equipment			3 - 5 years
Furniture and equipment			5 years
Purchased software			3 - 5 years
Capitalized internal-use software			3 years
Leasehold improvements			Estimated useful life or term of the lease, whichever is shorter

Summary of the effect of the adoption of Topic 606

The following table summarizes cumulative effect of changes from the adoption of Topic 606 on the Company’s Condensed Consolidated Balance Sheets as of February 1, 2019:


	Balance at January 31, 2019		Cumulative Effect Adjustments Due to the Adoption of Topic 606		Balance at February 1, 2019
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	28,847	$	(6,031)	$	22,816
Deferred contract acquisition costs, noncurrent	9,918		30,337		40,255

Liabilities:
Accrued expenses	32,541		555		33,096
Deferred revenue, current	218,700		333		219,033

Stockholders’ Deficit:
Accumulated deficit	(519,126)		23,418		(495,708)


	October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Balance Sheet

Assets:
Deferred contract acquisition costs, current	$	35,924	$	2,826	$	38,750
Deferred contract acquisition costs, noncurrent	58,260		(42,493)		15,767

Liabilities:
Accrued expenses	29,460		(343)		29,117
Deferred revenue, current	335,801		(139)		335,662


Stockholders' Equity:
Accumulated deficit	(609,079)		(39,185)		(648,264)


	Three Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	125,119	$	(28)	$	125,091
Operating expenses:
Sales and marketing	68,675		6,737		75,412

Net loss	(35,505)		(6,765)		(42,270)

Net loss per share, basic and diluted	$	(0.17)			$	(0.21)


	Nine Months Ended October 31, 2019
	As Reported (ASC 606)		Impact of Adoption		Without Adoption (ASC 605)
	(in thousands)
Condensed Consolidated Statement of Operations

Revenue	$	329,304	$	(193)	$	329,111
Operating expenses:
Sales and marketing	190,792		15,574		206,366

Net loss	(113,371)		(15,767)		(129,138)

Net loss per share, basic and diluted	$	(0.89)			$	(1.01)

Fair Value Measurements and Marketable Securities (Tables)

9 Months Ended

Oct. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis

The Company’s fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis are as follows:


	October 31, 2019														January 31, 2019
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
	(in thousands)														(in thousands)
Assets
Cash equivalents⁽¹⁾
Money market funds	$	693,258	$	—	$	—	$	693,258	$	42,132	$	—	$	—	$	42,132
Corporate debt securities	—		8,598		—		8,598		—		27,941		—		27,941
Total cash equivalents	693,258		8,598		—		701,856		42,132		27,941		—		70,073
Marketable securities
Corporate debt securities	—		76,154		—		76,154		—		91,796		—		91,796
U.S. treasury securities	13,929		—		—		13,929		11,451		—		—		11,451
Total marketable securities	13,929		76,154		—		90,083		11,451		91,796		—		103,247
Total assets	$	707,187	$	84,752	$	—	$	791,939	$	53,583	$	119,737	$	—	$	173,320
Liability
Contingent consideration related to business combinations⁽²⁾	$	—	$	—	$	—	$	—	$	—	$	—	$	474	$	474
Redeemable convertible preferred stock warrant liability ⁽³⁾	—		—		—		—		—		—		4,537		4,537
Total liabilities	$	—	$	—	$	—	$	—	$	—	$	—	$	5,011	$	5,011

__________________________________

(1)Included in “Cash and cash equivalents” on the condensed consolidated balance sheets.

Summary of changes in the redeemable convertible preferred stock warrant liability

The following summarizes the changes in the redeemable convertible preferred stock warrant liability, which is classified as a Level 3 instrument:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Balance at beginning of period	$	—	$	3,016	$	4,537	$	961
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	—		880		6,022		2,935
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	—		—		(10,559)		—
Balance at end of period	$	—	$	3,896	$	—	$	3,896

Balance Sheet Components (Tables)

9 Months Ended

Oct. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Summary of prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Prepaid expenses	$	20,515	$	5,982
Prepaid software licenses	14,793		8,408
Other current assets	2,606		1,105
Prepaid hosting services	—		2,915
Prepaid expenses and other current assets	$	37,914	$	18,410

Summary of property and equipment, net

Property and equipment, net consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Data center and other computer equipment	$	67,764	$	44,735
Capitalized internal-use software	27,928		22,209
Leasehold improvements	10,313		10,011
Purchased software	2,557		1,460
Furniture and equipment	3,883		2,553
Construction in process	59,739		19,455
	172,184		100,423
Less: Accumulated depreciation and amortization	(42,680)		(26,688)
Property and equipment, net	$	129,504	$	73,735

Schedule of total intangible assets, net

Total intangible assets, net consisted of the following:


	October 31, 2019		January 31, 2019		Weighted-Average Remaining Useful Life
	(in thousands)					(in months)
Developed technology	$	1,248	$	1,269	12
Customer relationships	615		632		36
Non-compete agreement	123		126		12
	1,986		2,027
Less: Accumulated amortization	(1,349)		(979)
Intangible assets, net	$	637	$	1,048

Schedule of estimated aggregate future amortization expense of intangible assets

The estimated aggregate future amortization expense of intangible assets as of October 31, 2019 is as follows:


	Total
	(in thousands)
Fiscal 2020 (remaining three months)	$	104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	—
Total amortization expense	$	637

Summary of accrued expenses

Accrued expenses consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Web hosting services	$	13,141	$	12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042

Accrued expenses	$	29,460	$	32,541

Summary of accrued payroll and benefits

Accrued payroll and benefits consisted of the following:


	October 31, 2019		January 31, 2019
	(in thousands)
Accrued commissions	$	15,290	$	9,499
Employee Stock Purchase Plan	10,236		—
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$	36,905	$	19,284

Redeemable Convertible Preferred Stock (Tables)

9 Months Ended

Oct. 31, 2019

Temporary Equity Disclosure [Abstract]

Schedule of Redeemable Convertible Preferred Stock

The following table summarizes the authorized, issued, and outstanding redeemable convertible preferred stock of the Company as of January 31, 2019:


Class	Issue Price per Share		Shares Authorized	Shares Issued and Outstanding	Net Carrying Value		Liquidation Preference		Redemption Value
	(in thousands, except per share values)
Series A-1	$	0.50000	52,300	52,300	$	76,325	$	52,300	$	623,678
Series B	$	1.40500	21,523	21,352	44,320		30,000		254,623
Series C	$	4.52972	22,275	22,077	99,900		100,000		263,765
Series D	$	5.69153	17,570	17,570	99,845		125,000		211,631
Series D-1	$	5.69153	5,394	5,394	30,626		30,700		64,607
Series E	$	16.46136	18,357	12,575	206,896		207,000		207,000
Total			137,419	131,268	$	557,912	$	545,000	$	1,625,304

Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of stock option activity

The following table is a summary of stock option activity for the nine months ended October 31, 2019:


	Number of Shares	Weighted-Average Exercise Price Per Share
	(in thousands)
Options outstanding at January 31, 2019	26,535	$	3.87
Granted	880	$	14.65
Exercised	(706)	$	2.14
Canceled	(509)	$	7.34
Options outstanding at April 30, 2019	26,200	$	4.21
Granted	168	$	34.00
Exercised	(4,776)	$	3.62
Canceled	(325)	$	5.06
Options outstanding at July 31, 2019	21,267	$	4.56
Granted	—	$	—
Exercised	(286)	$	2.90
Canceled	(280)	$	7.40
Options outstanding at October 31, 2019	20,701	$	4.55
Options vested and expected to vest at October 31, 2019	20,701	$	4.55
Options exercisable at October 31, 2019	11,871	$	2.30

Schedule of restricted stock units

The following table is a summary of RSU and PSU activities for the nine months ended October 31, 2019:


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
	(in thousands)
RSUs and PSUs outstanding at January 31, 2019	4,059	$	12.66
Granted	853	$	18.32
Vested	—	$	—
Forfeited	(159)	$	12.62
RSUs and PSUs outstanding at April 30, 2019	4,753	$	13.33
Granted	1,014	$	41.35
Vested	—	$	—
Forfeited	(38)	$	20.59
RSUs and PSUs outstanding at July 31, 2019	5,729	$	18.61
Granted	1,224	$	59.93
Vested	—	$	—
Forfeited	(44)	$	32.20
RSUs and PSUs outstanding at October 31, 2019	6,909	$	25.84
RSUs and PSUs expected to vest at October 31, 2019	6,909	$	25.84

Schedule of stock-based compensation expense

Stock-based compensation expense included in the condensed consolidated statements of operations is as follows:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)						(in thousands)
Subscription cost of revenue	$	1,666	$	382	$	3,164	$	533
Professional services cost of revenue	784		53		1,531		156
Sales and marketing	7,355		2,137		15,511		3,941
Research and development	4,696		6,245		10,353		7,232
General and administrative	7,465		4,643		25,018		5,541
Total stock-based compensation expense	$	21,966	$	13,460	$	55,577	$	17,403

Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value on date of grant


			Nine Months Ended October 31,
			2019

Expected term (in years)			0.5 - 2.0
Risk-free interest rate			1.9 - 2.2%
Expected stock price volatility			33.0 - 35.7%
Dividend yield			— %

Stock options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of assumptions used to estimate fair value on date of grant

The fair value of each option was estimated on the date of grant using the following assumptions during the period:


	Nine Months Ended October 31,
	2019	2018

Expected term (in years)	6.05	6.05 - 7.52
Risk-free interest rate	2.0% - 2.4%	2.6% - 3.1%
Expected stock price volatility	37.7% - 37.9%	37.8% - 38.9%
Dividend yield	— %	— %

Revenue, Deferred Revenue and Remaining Performance Obligations (Tables)

9 Months Ended

Oct. 31, 2019

Revenue from Contract with Customer [Abstract]

Summary of revenue from contracts by type of customer

The following table summarizes the revenue from contracts by type of customer:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
Channel Partners	$	88,255	71	%	$	46,525	70	%	$	223,152	68	%	$	116,619	69	%
Direct Customers	36,864		29	%	19,854		30	%	106,152		32	%	52,750		31	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

Summary of revenue by region based on the shipping address of customers

The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use the Company’s cloud platform:


	Three Months Ended October 31,														Nine Months Ended October 31,
	2019						2018						2019				2018
	Amount		% Revenue		Amount		% Revenue		Amount		% Revenue		Amount		% Revenue
	(in thousands, except percentages)														(in thousands, except percentages)
United States	$	92,602	74	%	$	50,366	76	%	$	245,055	74	%	$	130,659	77	%
Europe, Middle East, and Africa	17,609		14	%	8,367		13	%	46,029		14	%	19,384		11	%
Asia Pacific	9,985		8	%	4,600		7	%	24,828		8	%	12,262		7	%
Other	4,923		4	%	3,046		4	%	13,392		4	%	7,064		5	%
Total revenue	$	125,119	100	%	$	66,379	100	%	$	329,304	100	%	$	169,369	100	%

Summary of changes in deferred revenue

Changes in deferred revenue for the three and nine months ended October 31, 2019 were as follows (in thousands):


	Carrying Amount
	Three Months Ended October 31, 2019		Nine Months Ended October 31, 2019
Beginning Balance	$	369,762	$	290,067
Additions to deferred revenue	202,996		486,876
Recognition of deferred revenue	(125,119)		(329,304)
Ending Balance	$	447,639	$	447,639

Summary of the activity of deferred contract acquisition costs

The following table summarizes the activity of deferred contract acquisition costs:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
	(in thousands)
Beginning balance	$	75,783	$	24,641	$	38,765	$	22,334
Adjustment due to adoption of ASU 606	—		—		24,306		—
Capitalization of contract acquisition costs	27,450		13,233		55,238		27,531
Amortization of deferred contract acquisition costs	(9,049)		(7,321)		(24,125)		(19,312)
Ending balance	$	94,184	$	30,553	$	94,184	$	30,553

Deferred contract acquisition costs, current	$	35,924	$	22,022	$	35,924	$	22,022
Deferred contract acquisition costs, noncurrent	58,260		8,531		58,260		8,531
Total deferred contract acquisition costs	$	94,184	$	30,553	$	94,184	$	30,553

Commitments and Contingencies (Tables)

9 Months Ended

Oct. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Summary of future minimum payments under noncancelable operating leases


	Operating Leases
	(in thousands)
Fiscal 2020 (remaining three months)	$	2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$	47,511

Summary of noncancelable purchase obligations

A summary of noncancelable purchase obligations as of October 31, 2019 with expected date of payment is as follows:


	Total Commitments
	(in thousands)
Fiscal 2020 (remaining three months)	$	27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$	226,485

Geographic Information (Tables)

9 Months Ended

Oct. 31, 2019

Geographic Areas, Long-Lived Assets [Abstract]

Summary by geographic area of company's long lived assets

The Company’s long-lived assets are composed of property and equipment, net, and are summarized by geographic area as follows:


	October 31, 2019		January 31, 2019
	(in thousands)
United States	$	119,760	$	70,699
International	9,744		3,036
Total property and equipment, net	$	129,504	$	73,735

Net Loss Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Oct. 31, 2019

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net loss per share attributable to common stockholders"

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended October 31,						Nine Months Ended October 31,
	2019		2018		2019		2018
Common Stock

Net loss attributable to common stockholders	$	—	$	(42,323)	$	—	$	(108,817)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	—		45,287		—		44,344

Net loss per share attributable to common stockholders, basic and diluted	$	—	$	(0.93)	$	—	$	(2.45)

Class A Common Stock

Net loss attributable to common stockholders	$	(3,602)	$	—	$	(9,402)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	20,703		—		10,616		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Class B Common Stock

Net loss attributable to common stockholders	$	(31,903)	$	—	$	(103,969)	$	—

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	183,393		—		117,393		—

Net loss per share attributable to common stockholders, basic and diluted	$	(0.17)	$	—	$	(0.89)	$	—

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share


	October 31, 2019	October 31, 2018
	(in thousands)
Shares of common stock issuable upon conversion of redeemable convertible preferred stock	—	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants	—	336
Shares of common stock subject to repurchase from outstanding stock options	1,128	712
Restricted stock awards subject to future vesting	6,909	28
Shares of common stock issuable from stock options	20,701	26,150
Potential common shares excluded from diluted net loss per share	28,738	158,494

Description of Business and Basis of Presentation (Details) $ / shares in Units, $ in Thousands		9 Months Ended
	Jun. 14, 2019 USD ($) $ / shares shares	Oct. 31, 2019 USD ($) modules	Oct. 31, 2018 USD ($)
Description of Business and Basis of Presentation
Number of cloud modules \| modules		10
Net proceeds from issuance of common stock from IPO \| $		$ 665,092	$ 0
Class A common stock \| IPO
Description of Business and Basis of Presentation
Common stock issued (in shares) \| shares	20,700,000
Public offering price (in usd per share) \| $ / shares	$ 34.00
Net proceeds from issuance of common stock from IPO \| $	$ 659,200
Underwriters' discounts and commissions and estimated offering expenses \| $	$ 44,800
Common stock conversion ratio	1
Class B common stock \| IPO
Description of Business and Basis of Presentation
Number of shares issued in conversion of common stock (in shares) \| shares	131,267,586
Common stock conversion ratio	1
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1

Summary of Significant Accounting Policies (Details)			1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Jun. 14, 2019 USD ($) shares	Feb. 01, 2019 USD ($)	Jul. 31, 2019 USD ($)	Sep. 30, 2018 unit_Standard_installment unit_Standard_tranche	Oct. 31, 2019 USD ($) unit_Standard_Distributor	Oct. 31, 2018 USD ($) unit_Standard_Distributor	Oct. 31, 2019 USD ($) unit_Standard_Distributor unit_Standard_installment unit_Standard_item segment	Oct. 31, 2018 USD ($) unit_Standard_Distributor	Jan. 31, 2019 USD ($) unit_Standard_customer
Concentration Risk [Line Items]
Allowance for doubtful accounts					$ 1,400,000		$ 1,400,000		$ 1,000,000.0
Deferred offering costs		$ 3,000,000.0							2,900,000
Payments of deferred offering costs							$ 5,872,000	$ 0
Estimated economic lives							5 years
Impairments of internal use software					0	$ 0
Capitalized amount of internal use software					2,200,000	1,800,000	$ 5,700,000	5,000,000.0
Amortization expense associated with internal use software					1,600,000	1,200,000	4,600,000	3,500,000
Net book value of capitalized internal use software					12,600,000		$ 12,600,000		$ 11,500,000
Commission amortization period							4 years
Professional services contract amortization							6 months
Capitalization of contract acquisition costs					27,450,000	13,233,000	$ 55,238,000	27,531,000
Contract acquisition cost amortization expense					9,000,000.0	7,300,000	24,100,000	19,300,000
Impairment losses of long lived assets					$ 0	0	$ 0	0
Subscription term					12 months		12 months
Advertising costs					$ 2,200,000	1,500,000	$ 5,500,000	2,600,000
Vesting period							4 years
Number of reporting units \| unit_Standard_item							1
Goodwill impairment					0	0	$ 0	0
Income tax expense					434,000	535,000	$ 1,664,000	1,018,000
Number of operating segments \| segment							1
Number of reportable segments \| segment							1
ASC 2014-09
Concentration Risk [Line Items]
Cumulative effect adjustment to opening accumulated deficit, net of tax		23,400,000
Reduction in the amortization of deferred contract acquisition costs		23,700,000
ASC 2014-09 \| Impact of Adoption
Concentration Risk [Line Items]
Reduction in revenue		$ 300,000
Adjustment
Concentration Risk [Line Items]
Income tax expense					0	$ 0	$ 0	$ 0
Service-based vesting
Concentration Risk [Line Items]
Number of vesting schedules				3			3
Service-based vesting \| Vesting one
Concentration Risk [Line Items]
Vesting percentage							25.00%
Number of quarterly installments \| unit_Standard_installment				12			12
Service-based vesting \| Vesting two
Concentration Risk [Line Items]
Number of quarterly installments \| unit_Standard_installment				16			16
Service-based vesting \| Vesting three
Concentration Risk [Line Items]
Number of quarterly installments \| unit_Standard_installment				8			8
Performance-based vesting
Concentration Risk [Line Items]
Stock-based compensation expense deferred	$ 17,300,000
Capitalized internal-use software
Concentration Risk [Line Items]
Estimated economic lives							3 years
Class B common stock
Concentration Risk [Line Items]
Shares issued upon conversion of warrants (in shares) \| shares	336,386
Shares issued (in shares) \| shares	322,278
IPO \| Class B common stock
Concentration Risk [Line Items]
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1
FalconFund
Concentration Risk [Line Items]
Sharing percentage of distributions by the fund			50.00%
Duration of fund			10 years
Extendable term of fund			3 years
Net assets					$ 0		$ 0
Minimum
Concentration Risk [Line Items]
Estimated economic lives							3 years
Subscription fees payable term (in days)							30 days
Subscription term					1 year		1 year
Maximum
Concentration Risk [Line Items]
Subscription fees payable term (in days)							60 days
Subscription term					3 years		3 years
Maximum \| FalconFund
Concentration Risk [Line Items]
Amount agreed to commit			$ 10,000,000.0
Accel \| FalconFund
Concentration Risk [Line Items]
Sharing percentage of distributions by the fund			50.00%
Accel \| Minimum
Concentration Risk [Line Items]
Percentage of capital stock held			5.00%
Accel \| Maximum \| FalconFund
Concentration Risk [Line Items]
Amount agreed to commit			$ 10,000,000.0
Channel partners \| Revenue
Concentration Risk [Line Items]
Concentration risk, percentage					10.00%	15.00%	11.00%	17.00%
Number of distributors \| unit_Standard_Distributor					1	1	1	1
Customers \| Accounts receivable
Concentration Risk [Line Items]
Number of customers \| unit_Standard_customer									2
Customers \| Accounts receivable \| Customer 1
Concentration Risk [Line Items]
Concentration risk, percentage									10.00%
Customers \| Accounts receivable \| Customer 2
Concentration Risk [Line Items]
Concentration risk, percentage									19.00%

Summary of Significant Accounting Policies - Property and Equipment, Net (Details)	9 Months Ended
	Oct. 31, 2019
Data center and other computer equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Data center and other computer equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Furniture and equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Purchased software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Purchased software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years

Summary of Significant Accounting Policies - Revenue Recognition - ASC 606 (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Feb. 01, 2019	Jan. 31, 2019
Assets:
Deferred contract acquisition costs, current	$ 35,924	$ 22,022	$ 35,924	$ 22,022	$ 22,816	$ 28,847
Deferred contract acquisition costs, noncurrent	58,260	8,531	58,260	8,531	40,255	9,918
Liabilities:
Accrued expenses	29,460		29,460		33,096	32,541
Deferred revenue, current	335,801		335,801		219,033	218,700
Stockholders' Equity:
Accumulated deficit	(609,079)		(609,079)		$ (495,708)	(519,126)
Condensed Consolidated Statement of Operations
Total revenue	125,119	66,379	329,304	169,369
Operating expenses
Sales and marketing	68,675	46,614	190,792	123,344
Net loss	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Net loss per share, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Without Adoption (ASC 605)
Assets:
Deferred contract acquisition costs, current	$ 38,750		$ 38,750			28,847
Deferred contract acquisition costs, noncurrent	15,767		15,767			9,918
Liabilities:
Accrued expenses	29,117		29,117			32,541
Deferred revenue, current	335,662		335,662			218,700
Stockholders' Equity:
Accumulated deficit	(648,264)		(648,264)			(519,126)
Condensed Consolidated Statement of Operations
Total revenue	125,091		329,111
Operating expenses
Sales and marketing	75,412		206,366
Net loss	$ (42,270)		$ (129,138)
Net loss per share, basic and diluted (in usd per share)	$ (0.21)		$ (1.01)
ASC 2014-09 \| Impact of Adoption
Assets:
Deferred contract acquisition costs, current	$ 2,826		$ 2,826			(6,031)
Deferred contract acquisition costs, noncurrent	(42,493)		(42,493)			30,337
Liabilities:
Accrued expenses	(343)		(343)			555
Deferred revenue, current	(139)		(139)			333
Stockholders' Equity:
Accumulated deficit	(39,185)		(39,185)			$ 23,418
Condensed Consolidated Statement of Operations
Total revenue	(28)		(193)
Operating expenses
Sales and marketing	6,737		15,574
Net loss	$ (6,765)		$ (15,767)

Fair Value Measurements and Marketable Securities - Financial Assets and Liabilities (Details) $ in Thousands		3 Months Ended	9 Months Ended
	Jun. 14, 2019 shares	Apr. 30, 2019 USD ($)	Oct. 31, 2019 USD ($) unit_Standard_item	Jan. 31, 2019 USD ($)
Assets
Marketable securities			$ 90,083	$ 103,247
Liability
Number of probability adjusted milestone payments \| unit_Standard_item			3
Probability adjusted milestone payment amount			$ 200
First milestone payment				200
Write-off of contingent consideration		$ 500
Class B common stock
Liability
Shares issued upon conversion of warrants (in shares) \| shares	336,386
Shares issued (in shares) \| shares	322,278
Class B common stock \| IPO
Liability
Conversion of warrants, warrants issued (in shares) \| shares	336,386
Warrant conversion ratio	1
Discount rate \| Minimum
Liability
Business combination, measurement input			3
Discount rate \| Maximum
Liability
Business combination, measurement input			3.02
Recurring
Assets
Cash equivalents			$ 701,856	70,073
Marketable securities			90,083	103,247
Total assets			791,939	173,320
Liability
Contingent consideration related to business combinations				474
Redeemable convertible preferred stock warrant liability				4,537
Total liabilities				5,011
Recurring \| Money market funds
Assets
Cash equivalents			693,258	42,132
Recurring \| Corporate debt securities
Assets
Cash equivalents			8,598	27,941
Marketable securities			76,154	91,796
Recurring \| U.S. treasury securities
Assets
Marketable securities			13,929	11,451
Level 1 \| Recurring
Assets
Cash equivalents			693,258	42,132
Marketable securities			13,929	11,451
Total assets			707,187	53,583
Level 1 \| Recurring \| Money market funds
Assets
Cash equivalents			693,258	42,132
Level 1 \| Recurring \| U.S. treasury securities
Assets
Marketable securities			13,929	11,451
Level 2 \| Recurring
Assets
Cash equivalents			8,598	27,941
Marketable securities			76,154	91,796
Total assets			84,752	119,737
Level 2 \| Recurring \| Corporate debt securities
Assets
Cash equivalents			8,598	27,941
Marketable securities			$ 76,154	91,796
Level 3 \| Recurring
Liability
Contingent consideration related to business combinations				474
Redeemable convertible preferred stock warrant liability				4,537
Total liabilities				$ 5,011

Fair Value Measurements and Marketable Securities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Fair Value Disclosures [Abstract]
Other-than-temporary impairments			$ 0
Remaining contractual maturities of marketable securities			1 year
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	$ 0	$ (900,000)	$ (6,000,000.0)	$ (2,900,000)

Fair Value Measurements and Marketable Securities - Redeemable convertible preferred stock warrant liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	$ 0	$ (900,000)	$ (6,000,000.0)	$ (2,900,000)
Level 3 \| Redeemable convertible preferred stock warrant
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	0	3,016,000	4,537,000	961,000
Adjustment resulting from change in fair value recognized in the condensed consolidated statements of operations	0	880,000	6,022,000	2,935,000
Reclassification of liability for redeemable convertible preferred stock warrants to additional paid-in capital upon initial public offering	0		(10,559,000)
Balance at end of period	$ 0	$ 3,896,000	$ 0	$ 3,896,000

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 20,515	$ 5,982
Prepaid software licenses	14,793	8,408
Other current assets	2,606	1,105
Prepaid hosting services	0	2,915
Prepaid expenses and other current assets	$ 37,914	$ 18,410

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Property and Equipment, Net
Property, Plant and Equipment, Gross	$ 172,184	$ 100,423
Less: Accumulated depreciation and amortization	(42,680)	(26,688)
Property and equipment, net	129,504	73,735
Data center and other computer equipment
Property and Equipment, Net
Property, Plant and Equipment, Gross	67,764	44,735
Capitalized internal-use software
Property and Equipment, Net
Property, Plant and Equipment, Gross	27,928	22,209
Leasehold improvements
Property and Equipment, Net
Property, Plant and Equipment, Gross	10,313	10,011
Purchased software
Property and Equipment, Net
Property, Plant and Equipment, Gross	2,557	1,460
Furniture and equipment
Property and Equipment, Net
Property, Plant and Equipment, Gross	3,883	2,553
Construction in process
Property and Equipment, Net
Property, Plant and Equipment, Gross	$ 59,739	$ 19,455

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Depreciation and amortization	$ 5,800	$ 3,800	$ 16,023	$ 10,199
Amortization of intangible assets	$ 100	$ 100	$ 385	$ 435
Useful lives			5 years
Developed technology
Finite-Lived Intangible Assets [Line Items]
Useful lives			3 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Useful lives			5 years
Non-compete agreement
Finite-Lived Intangible Assets [Line Items]
Useful lives			3 years
Data center and other computer equipment
Finite-Lived Intangible Assets [Line Items]
Purchases			$ 57,000

Balance Sheet Components - Intangible Assets, Net (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2019	Jan. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 1,986	$ 2,027
Less: Accumulated amortization	(1,349)	(979)
Intangible assets, net	637	1,048
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 1,248	1,269
Weighted-Average Remaining Useful Life	12 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 615	632
Weighted-Average Remaining Useful Life	36 months
Non-compete agreement
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 123	$ 126
Weighted-Average Remaining Useful Life	12 months

Balance Sheet Components - Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 104
Fiscal 2021	325
Fiscal 2022	123
Fiscal 2023	85
Fiscal 2024	0
Intangible assets, net	$ 637	$ 1,048

Balance Sheet Components - Accrued Expenses (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Feb. 01, 2019	Jan. 31, 2019
Accrued Expenses
Web hosting services	$ 13,141		$ 12,224
Other accrued expenses	12,154		13,275
Accrued purchases of property and equipment	4,165		7,042
Accrued expenses	29,460	$ 33,096	32,541
Accrued Payroll and Benefits
Accrued commissions	15,290		9,499
Employee Stock Purchase Plan	10,236		0
Accrued bonuses	6,299		5,459
Accrued payroll and related expenses	5,080		4,326
Accrued payroll and benefits	$ 36,905		$ 19,284

Secured Revolving Credit Facility (Details)	1 Months Ended
Secured Revolving Credit Facility (Details)	Apr. 30, 2019 USD ($) unit_Standard_item	Oct. 31, 2019 USD ($)	Jan. 31, 2019 USD ($)
Minimum
Line of Credit Facility [Line Items]
Commitment fee (as a percent)	0.20%
Maximum
Line of Credit Facility [Line Items]
Commitment fee (as a percent)	0.30%
Revolving line of credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000.0
Incremental borrowing facility	$ 75,000,000.0
Borrowing facility multiple factor - first year \| unit_Standard_item	6
Borrowing facility multiple factor - second year \| unit_Standard_item	5
Borrowing facility multiple factor - thereafter	4
Amount outstanding		$ 0	$ 0
Letter of credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 10,000,000.0
Swingline
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 10,000,000.0
Eurodollar Loans \| LIBOR \| Minimum
Line of Credit Facility [Line Items]
Margin (as a percent)	2.50%
Eurodollar Loans \| LIBOR \| Maximum
Line of Credit Facility [Line Items]
Margin (as a percent)	3.00%
ABR Loans \| Federal funds rate
Line of Credit Facility [Line Items]
Margin (as a percent)	0.50%
ABR Loans \| Eurodollar Rate
Line of Credit Facility [Line Items]
Margin (as a percent)	1.00%
ABR Loans \| Eurodollar Rate \| Minimum
Line of Credit Facility [Line Items]
Margin (as a percent)	1.50%
ABR Loans \| Eurodollar Rate \| Maximum
Line of Credit Facility [Line Items]
Margin (as a percent)	2.00%

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Income Tax Disclosure [Abstract]
Income tax expense	$ 434	$ 535	$ 1,664	$ 1,018
Effective tax rate (as a percent)	(1.24%)	(1.28%)	(1.48%)	(0.94%)

Redeemable Convertible Preferred Stock - Conversion (Details) $ in Thousands			9 Months Ended
	Jun. 14, 2019 USD ($) shares	Jun. 13, 2019	Oct. 31, 2019 USD ($)	Oct. 31, 2018 USD ($)
Redeemable Convertible Preferred Stock
Value of converted shares			$ 557,912	$ 0
IPO \| Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
Number of shares converted (in shares) \| shares	131,267,586
Preferred stock conversion ratio		1
Value of converted shares	$ 557,900

Redeemable Convertible Preferred Stock (Details) - USD ($)	Oct. 31, 2019	Jan. 31, 2019
Redeemable Convertible Preferred Stock
Shares Authorized (in shares)	0	137,419,000
Shares Issued (in shares)	0	131,268,000
Net Carrying Value		$ 557,912,000
Liquidation Preference	$ 0	545,000,000
Redemption Value		$ 1,625,304,000
Series A-1
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 0.50000
Shares Authorized (in shares)		52,300,000
Shares Issued (in shares)		52,300,000
Net Carrying Value		$ 76,325,000
Liquidation Preference		52,300,000
Redemption Value		$ 623,678,000
Series B
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 1.40500
Shares Authorized (in shares)		21,523,000
Shares Issued (in shares)		21,352,000
Net Carrying Value		$ 44,320,000
Liquidation Preference		30,000,000
Redemption Value		$ 254,623,000
Series C
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 4.52972
Shares Authorized (in shares)		22,275,000
Shares Issued (in shares)		22,077,000
Net Carrying Value		$ 99,900,000
Liquidation Preference		100,000,000
Redemption Value		$ 263,765,000
Series D
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 5.69153
Shares Authorized (in shares)		17,570,000
Shares Issued (in shares)		17,570,000
Net Carrying Value		$ 99,845,000
Liquidation Preference		125,000,000
Redemption Value		$ 211,631,000
Series D-1
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 5.69153
Shares Authorized (in shares)		5,394,000
Shares Issued (in shares)		5,394,000
Net Carrying Value		$ 30,626,000
Liquidation Preference		30,700,000
Redemption Value		$ 64,607,000
Series E
Redeemable Convertible Preferred Stock
Issue Price per Share (in usd per share)		$ 16.46136
Shares Authorized (in shares)		18,357,000
Shares Issued (in shares)		12,575,000
Net Carrying Value		$ 206,896,000
Liquidation Preference		207,000,000
Redemption Value		$ 207,000,000

Common Stock (Details)	Jun. 14, 2019 unit_Standard_Vote $ / shares shares	Oct. 31, 2019 $ / shares shares	Jan. 31, 2019 $ / shares shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		0	220,000,000
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Preferred stock, shares authorized (in shares) \| shares		100,000,000	0
Preferred stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Class A common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		2,000,000,000	0
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
Class B common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares		300,000,000	0
Common stock, par value (in usd per share) \| $ / shares		$ 0.0005	$ 0.0005
IPO
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares) \| shares	100,000,000
Preferred stock, par value (in usd per share) \| $ / shares	$ 0.0005
IPO \| Class A common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares	2,000,000,000
Common stock, par value (in usd per share) \| $ / shares	$ 0.0005
Number of votes per share \| unit_Standard_Vote	1
Common stock conversion ratio	1
IPO \| Class B common stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares) \| shares	300,000,000
Common stock, par value (in usd per share) \| $ / shares	$ 0.0005
Number of votes per share \| unit_Standard_Vote	10
Common stock conversion ratio	1

Stock-Based Compensation (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended				9 Months Ended		12 Months Ended
	May 31, 2019 unit_Standard_item shares	Sep. 30, 2018 unit_Standard_installment unit_Standard_tranche	Oct. 31, 2019 USD ($) shares	Jul. 31, 2019 shares	Apr. 30, 2019 shares	Oct. 31, 2018 USD ($) $ / shares	Oct. 31, 2019 USD ($) unit_Standard_installment $ / shares shares	Oct. 31, 2018 USD ($) $ / shares	Jan. 31, 2019 USD ($) shares	Jun. 14, 2019 USD ($)
Stock Based Compensation
Vesting period							4 years
Number of shares to be vested \| shares							0
Employee payroll contributions accrued			$ 36,905				$ 36,905		$ 19,284
Stock-based compensation			21,966			$ 13,460	55,577	$ 17,403
2019 Plan \| Class A common stock
Stock Based Compensation
Maximum number of shares of common stock that may be issued (in shares) \| shares	8,750,000
Threshold percentage of outstanding shares	2.00%
Employee Stock Purchase Plan
Stock Based Compensation
Threshold percentage of outstanding shares	1.00%
Offering period	24 months
Number of purchase periods \| unit_Standard_item	4
Duration of purchase periods	6 months
Percentage of eligible compensation	15.00%
Maximum number of shares each participant can purchase during purchase period (in shares) \| shares	2,500
Purchase price, threshold percentage of fair market value	85.00%
Employee payroll contributions accrued			10,200				10,200
Stock-based compensation			$ 4,000				$ 6,300
Employee Stock Purchase Plan \| Class A common stock
Stock Based Compensation
Maximum number of shares of common stock that may be issued (in shares) \| shares	3,500,000
Service-based vesting
Stock Based Compensation
Number of vesting schedules		3					3
Stock options
Stock Based Compensation
Options unvested (in shares) \| shares			982,200				982,200
Aggregate intrinsic value of options vested and exercisable			$ 608,900				$ 608,900		$ 181,100
Weighted-average remaining contractual term of options vested and exercisable (in years)							6 years 4 months 24 days		7 years 1 month 6 days
Options granted (in shares) \| shares			0	168,000	880,000
Weighted-average grant date fair value of options granted (in usd per share) \| $ / shares						$ 5.81	$ 9.51	$ 5.59
Total intrinsic value of options exercised			$ 17,300			$ 13,400	$ 107,000	$ 21,000
Aggregate intrinsic value of stock options outstanding			939,000				$ 939,000		$ 286,100
Weighted-average remaining contractual term of stock options outstanding (in years)							7 years 3 months 18 days		7 years 10 months 24 days
Total unrecognized stock-based compensation expenses related to unvested options			$ 39,100				$ 39,100		$ 45,800
Expected to be amortized over weighted-average vesting period (in years)							2 years 3 months 18 days		3 years 4 months 24 days
Shares issued for exercise of stock options (in shares) \| shares			0				1,037,356
Number of shares of common stock related to early exercised stock options subject to repurchase (in shares) \| shares			1,127,811				1,127,811		545,941
Value of common stock related to early exercised stock options subject to repurchase			$ 9,600				$ 9,600		$ 1,200
Performance-based vesting
Stock Based Compensation
Stock-based compensation expense deferred										$ 17,300
RSUs
Stock Based Compensation
Expected to be amortized over weighted-average vesting period (in years)							2 years 3 months 18 days		2 years 2 months 12 days
Total unrecognized stock-based compensation expenses related to unvested RSUs			$ 137,500				$ 137,500		$ 51,900
PSUs
Stock Based Compensation
Expected to be amortized over weighted-average vesting period (in years)			1 year 10 months 24 days
Total unrecognized stock-based compensation expenses related to unvested RSUs			$ 3,500				$ 3,500
Vesting period							4 years
PSUs \| Minimum
Stock Based Compensation
Vesting percentage							80.00%
PSUs \| Maximum
Stock Based Compensation
Vesting percentage							100.00%
Vesting one \| Service-based vesting
Stock Based Compensation
Vesting percentage							25.00%
Number of quarterly installments \| unit_Standard_installment		12					12
Vesting two \| Service-based vesting
Stock Based Compensation
Number of quarterly installments \| unit_Standard_installment		16					16
Vesting three \| Service-based vesting
Stock Based Compensation
Number of quarterly installments \| unit_Standard_installment		8					8

Stock-Based Compensation - Stock options - Assumptions (Details)	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Stock options
Stock Based Compensation
Expected term (in years)	6 years 18 days
Dividend yield	0.00%	0.00%
Employee Stock Purchase Plan
Stock Based Compensation
Dividend yield	0.00%
Minimum \| Stock options
Stock Based Compensation
Expected term (in years)		6 years 18 days
Risk-free interest rate	2.00%	2.60%
Expected stock price volatility	37.70%	37.80%
Minimum \| Employee Stock Purchase Plan
Stock Based Compensation
Expected term (in years)	6 months
Risk-free interest rate	1.90%
Expected stock price volatility	33.00%
Maximum \| Stock options
Stock Based Compensation
Expected term (in years)		7 years 6 months 7 days
Risk-free interest rate	2.40%	3.10%
Expected stock price volatility	37.90%	38.90%
Maximum \| Employee Stock Purchase Plan
Stock Based Compensation
Expected term (in years)	2 years
Risk-free interest rate	2.20%
Expected stock price volatility	35.70%

Stock-Based Compensation - Stock options - Summary (Details) - Stock options - $ / shares	3 Months Ended			9 Months Ended
	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019	Oct. 31, 2019
Number of Shares
Options outstanding at beginning of period (in shares)	21,267,000	26,200,000	26,535,000	26,535,000
Granted (in shares)	0	168,000	880,000
Exercised (in shares)	(286,000)	(4,776,000)	(706,000)
Canceled (in shares)	(280,000)	(325,000)	(509,000)
Options outstanding at end of period (in shares)	20,701,000	21,267,000	26,200,000	20,701,000
Options vested and expected to vest at end of period (in shares)	20,701,000			20,701,000
Options exercisable at end of period (in shares)	11,871,000			11,871,000
Weighted-Average Exercise Price Per Share
Options outstanding at beginning of period (in usd per share)	$ 4.56	$ 4.21	$ 3.87	$ 3.87
Granted (in usd per share)	0	34.00	14.65
Exercised (in usd per share)	2.90	3.62	2.14
Canceled (in usd per share)	7.40	5.06	7.34
Options outstanding at end of period (in usd per share)	4.55	$ 4.56	$ 4.21	4.55
Options vested and expected to vest at end of period (in usd per share)	4.55			4.55
Options exercisable at end of period (in usd per share)	$ 2.30			$ 2.30

Stock-Based Compensation - RSU activity (Details) - RSUs - $ / shares shares in Thousands	3 Months Ended
	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019
Number of Shares
RSUs outstanding at beginning of period (in shares)	5,729	4,753	4,059
Granted (in shares)	1,224	1,014	853
Vested (in shares)	0	0	0
Forfeited (in shares)	(44)	(38)	(159)
RSUs outstanding at end of period (in shares)	6,909	5,729	4,753
RSUs expected to vest at end of period (in shares)	6,909
Weighted-Average Grant Date Fair Value Per Share
RSUs outstanding at beginning of period (in usd per share)	$ 18.61	$ 13.33	$ 12.66
Granted (in usd per share)	59.93	41.35	18.32
Vested (in usd per share)	0	0	0
Forfeited (in usd per share)	32.20	20.59	12.62
RSUs outstanding at end of period (in usd per share)	25.84	$ 18.61	$ 13.33
RSUs expected to vest at end of period (in usd per share)	$ 25.84

Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 21,966	$ 13,460	$ 55,577	$ 17,403
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,355	2,137	15,511	3,941
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	4,696	6,245	10,353	7,232
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	7,465	4,643	25,018	5,541
Subscription \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,666	382	3,164	533
Professional services \| Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 784	$ 53	$ 1,531	$ 156

Revenue, Deferred Revenue and Remaining Performance Obligations - Revenue from contracts type of customer and Region based on shipping address of customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Disaggregation of Revenue [Line Items]
Total revenue	$ 125,119	$ 66,379	$ 329,304	$ 169,369
Percentage of revenue	100.00%	100.00%	100.00%	100.00%
United States
Disaggregation of Revenue [Line Items]
Total revenue	$ 92,602	$ 50,366	$ 245,055	$ 130,659
Percentage of revenue	74.00%	76.00%	74.00%	77.00%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 17,609	$ 8,367	$ 46,029	$ 19,384
Percentage of revenue	14.00%	13.00%	14.00%	11.00%
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 9,985	$ 4,600	$ 24,828	$ 12,262
Percentage of revenue	8.00%	7.00%	8.00%	7.00%
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 4,923	$ 3,046	$ 13,392	$ 7,064
Percentage of revenue	4.00%	4.00%	4.00%	5.00%
Channel Partners
Disaggregation of Revenue [Line Items]
Total revenue	$ 88,255	$ 46,525	$ 223,152	$ 116,619
Percentage of revenue	71.00%	70.00%	68.00%	69.00%
Direct Customers
Disaggregation of Revenue [Line Items]
Total revenue	$ 36,864	$ 19,854	$ 106,152	$ 52,750
Percentage of revenue	29.00%	30.00%	32.00%	31.00%

Revenue, Deferred Revenue and Remaining Performance Obligations (Details)	3 Months Ended	9 Months Ended
	Oct. 31, 2019 USD ($)	Oct. 31, 2019 USD ($)
Contract with Customer, Liability [Line Items]
Revenue included in the contract liability balance	$ 103,300,000	$ 203,700,000
Subscription term	12 months	12 months
Transaction price allocated to remaining performance obligations	$ 577,200,000	$ 577,200,000
Percentage of performance obligation expected to be recognized		71.00%
Commission amortization period		4 years
Professional services contract amortization		6 months
Impairment loss, deferred contract acquisition costs	$ 0	$ 0
Minimum
Contract with Customer, Liability [Line Items]
Payment terms		30 days
Subscription term	1 year	1 year
Maximum
Contract with Customer, Liability [Line Items]
Payment terms		60 days
Subscription term	3 years	3 years

Revenue, Deferred Revenue and Remaining Performance Obligations - Changes in Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2019
Revenue from Contract with Customer [Abstract]
Balance, beginning	$ 369,762	$ 290,067
Additions to deferred revenue	202,996	486,876
Recognition of deferred revenue	(125,119)	(329,304)
Balance, ending	$ 447,639	$ 447,639

Revenue, Deferred Revenue and Remaining Performance Obligations - Deferred contract acquisition costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Feb. 01, 2019	Jan. 31, 2019	Oct. 31, 2018
Deferred contract acquisition costs
Beginning balance	$ 75,783	$ 24,641	$ 38,765	$ 22,334
Capitalization of contract acquisition costs	27,450	13,233	55,238	27,531
Amortization of deferred contract acquisition costs	(9,049)	(7,321)	(24,125)	(19,312)
Ending balance	94,184	30,553	94,184	30,553
Deferred contract acquisition costs, current					$ 35,924	$ 22,816	$ 28,847	$ 22,022
Deferred contract acquisition costs, noncurrent					58,260	$ 40,255	9,918	8,531
Total deferred contract acquisition costs	75,783	24,641	38,765	22,334	$ 94,184		$ 38,765	$ 30,553
ASC 2014-09
Deferred contract acquisition costs
Adjustment due to adoption of ASU 606	$ 0	$ 0	$ 24,306	$ 0

Commitments and Contingencies (Details) - USD ($)	3 Months Ended		9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Jan. 31, 2019
Line of Credit Facility [Line Items]
Rent expense	$ 3,100,000	$ 1,800,000	$ 7,100,000	$ 5,000,000.0
Commitment to spend	188,500,000		188,500,000
Liability recorded	0		0		$ 0
Liabilities accrued	0		0		0
Sunnyvale, California
Line of Credit Facility [Line Items]
Unused standby letter of credit	600,000		600,000		500,000
Austin, Texas
Line of Credit Facility [Line Items]
Unused standby letter of credit	$ 1,000,000.0		$ 1,000,000.0		$ 800,000

- Definition

+ References + Details

Commitments and Contingencies - Lease Commitments (Details) $ in Thousands	Oct. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 2,141
Fiscal 2021	9,121
Fiscal 2022	8,868
Fiscal 2023	8,488
Fiscal 2024	8,452
Thereafter	10,441
Total minimum lease payments	$ 47,511

Commitments and Contingencies - Purchase Obligations (Details) $ in Thousands	Oct. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Fiscal 2020 (remaining three months)	$ 27,077
Fiscal 2021	83,148
Fiscal 2022	92,786
Fiscal 2023	10,930
Fiscal 2024	8,125
Thereafter	4,419
Total purchase commitments	$ 226,485

Geographic Information (Details) - USD ($) $ in Thousands	Oct. 31, 2019	Jan. 31, 2019
Geographic Information
Property and equipment, net	$ 129,504	$ 73,735
United States
Geographic Information
Property and equipment, net	119,760	70,699
International
Geographic Information
Property and equipment, net	$ 9,744	$ 3,036

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018	Jan. 31, 2019
Related Party Transaction [Line Items]
Revenue from subscriptions and professional services from related parties	$ 2.2	$ 1.6	$ 6.8	$ 4.3
Accounts receivable associated with related parties	8.0		8.0		$ 0.2
Purchases from related parties	0.9	$ 0.6	2.4	$ 1.4
Accounts payable to vendors	$ 0.2		$ 0.2
Maximum
Related Party Transaction [Line Items]
Accounts payable to vendors					$ 0.1

Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (35,505)	$ (42,323)	$ (113,371)	$ (108,817)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	204,096,000	45,287,000	128,009,000	44,344,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)	$ (0.93)	$ (0.89)	$ (2.45)
Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (3,602)		$ (9,402)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	20,703,000		10,616,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)		$ (0.89)
Class B common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common stockholders	$ (31,903)		$ (103,969)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in shares)	183,393,000		117,393,000
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted (in usd per share)	$ (0.17)		$ (0.89)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Net Loss Per Share Attributable to Common Stockholders - Antidilutive (Details) - shares shares in Thousands	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	28,738	158,494
Redeemable Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	0	131,268
Shares of common stock issuable upon conversion of redeemable convertible preferred stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	0	336
Shares of common stock subject to repurchase from outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	1,128	712
Restricted stock awards subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	6,909	28
Shares of common stock issuable from stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares excluded from diluted net loss per share (in shares)	20,701	26,150